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Abstract
In addition to the four canonical ribonucleosides (adenosine, uridine, guanosine, cytosine),
transfer RNAs (tRNA) and ribosomal RNAs (rRNA) are comprised of more than 100 enzyme-
catalyzed modifications, with about 20-35 found in any one organism. Many of these
modifications are highly conserved in all domains of life, which suggests important biological
roles for RNA modifications in cell physiology. Several recent studies have demonstrated that
individual tRNA modifications and their biosynthetic pathways affect cellular stress responses.
The presence of 20-35 different RNA modifications in all translationally-related non-coding
RNAs suggested the possibility of systems behavior of RNA modifications in translational facets
of cellular responses. The studies presented in this thesis utilize a quantitative systems-level
approach to test the hypothesis that the spectrum of tRNA modifications represents a cellular
program involved in modulating stress response pathways.
To initiate these studies, a novel mass spectrometric platform was developed to
characterize and quantify the spectrum of modified ribonucleosides in an organism, starting
with the ~25 ribonucleosides in S. cerevisiae tRNA. This approach was used to compare tRNA
modification spectra from cells exposed to four mechanistically distinct toxicants: hydrogen
peroxide, methyl methanesulfonate, arsenite, and hypochlorite. Multivariate statistical analysis
revealed both dose- and agent-specific signatures in the relative quantities of tRNA
modifications. Further, modifications that change significantly after exposure were shown to
confer resistance to the cytotoxicity of the agent. These observations demonstrate the
dynamic nature of tRNA modifications and their critical role in translational control of cellular
stress responses. Also, application of the mass spectrometric method revealed several new
biosynthetic pathways for tRNA modifications in yeast. These studies comprise Chapters 2 and
3.
Chapter 4 is aimed at characterizing the link between tRNA modifications and
translational control of cellular responses. One of the tRNA modifications that increased
significantly following exposure of yeast to hydrogen peroxide is 5-methylcytosine (m5 C), which
is located at the wobble position of the leucine tRNA for coding UUG. This suggested that it
might affect translation of mRNA containing this codon. While there are 6 codons for leucine,
the usage of the codon UUG for specifying leucine in the set of homologous ribosomal proteins
differs widely. Using proteomics approach, it was demonstrated that m5C regulates the levels
of the homologous ribosomal protein genes rp/22a and rp/22b, with hydrogen peroxide
exposure causing an increase in the proportion of ribosomes containing rpI22a. Further, loss of
rp/22a conferred sensitivity to hydrogen peroxide exposure. These results suggest that the
system of tRNA modifications controls cellular responses partly by determining the composition
of ribosomes involved in the selective translation of critical response proteins.
As observed in Chapter 3, tRNA modifications spectrum changes specifically in responses
to mechanistically distinct toxic agents; in Chapter 5, a series of studies was designed to test the
hypothesis that each of these unique signatures represents a common response to different
toxicant classes. To test this hypothesis, yeast cells were exposed to four different oxidizing
agents (hydrogen peroxide, tert-butyl hydroperoxide, peroxynitrite, and gamma-radiation) and
five different alkylating agents (methyl methanesulfonate, ethyl methanesulfonate, isopropyl
methanesulfonate, N-methyl-N'-nitro-N-nitrosoguanidine, and N-nitroso-N-methylurea) at
concentrations producing similar levels of cytotoxicity. The spectrum of tRNA modifications
was then quantified and the results subjected to multivariate statistical analysis to identify
consistent patterns. The results reveal class-specific patterns of changes, with distinct tRNA
modification spectra for oxidants and alkylating agents. At a finer level of analysis, the studies
revealed subclass signatures for SN1 and SN2 alkylating agents. The results from these
experiments were used to develop a data-driven model that predicts exposures to the two
classes of toxic agents accurately. Such a model may be useful for assessing ribonucleoside
spectra as biomarkers of exposure.
Appendix A describes the preliminary characterization of the spectrum of modified
ribonucleosides from Mycobacterium bovis BCG tRNA. Surveys of tRNA enzymatic hydrolysates
with mass spectrometric techniques reveal the presence of modified ribonucleosides that are
highly conserved among various species of organisms, as well as candidates of novel
modifications.
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Chapter 1
Background and Significance
Goals of this thesis
The goals of this thesis project are to further our understanding of the biological roles of
tRNA secondary modifications in cellular response to stress and to explore the utility of changes
in the spectrum of tRNA modifications as biomarker of specific physiological states. We
hypothesize that changes in the levels of specific tRNA modifications are involved in regulating
translation by selection of specific codons enriched in stress response proteins and by
regulating other facets of the interaction of tRNA molecules with ribosomes.
Cellular responses to stress
To survive in an ever-changing environment, cells maintain biological homeostasis by
balancing a wide variety of biological processes, with alterations of any of these processes
affecting all others. Imbalance in these systems can be deleterious to cell survival. For instance,
increasing the temperature of a cell by only several degrees can disrupt protein homeostasis by
causing proteins to unfold, misfold, and aggregate (1-4). To survive these insults, cells have
developed a large number of response pathways to adapt to environmental changes. The
response begins with changes in biochemical homeostasis in a variety of metabolic pathways by
changes in protein secondary modifications caused by signaling cascades (5, 6). At the next
level of response, signaling cascades lead to changes in transcription levels of hundreds of
genes (7-14). From here, there are numerous mechanisms controlling expression of genes,
including alternative splicing of pre-mRNA, RNA interference, and protein degradation. These
pathways will be considered in the following sections.
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One common cellular response mechanism among all organisms involves modulating
protein activity by post-translational modifications or allosteric regulation. One of the most
intensively studied post-translational modifications is phosphorylation of serine and threonine
amino acid residues by protein kinases and dephosphorylation by phosphatases. This
modification activates or deactivates proteins for various functions, including signaling cascades,
metabolism, and regulation of transcription. In signaling pathways, one kinase regulates the
activity of another kinase by phosphorylation, for example in the signaling cascades mediated
by mitogen-activiated protein kinases (MAPKs), MAPK kinases (MAPKK) and MAPKK kinases (15,
16). These pathways magnify the signal intensities when signals reach downstream of the
cascades; also as each protein can be phosphorylated by more than one kinase, the diversity of
signaling is promoted (15, 16). Some of these signaling pathways lead to activation or
deactivation of enzymes directly involved in the stress response. For instance, carbamoyl
phosphate synthetase 11, a rate-limiting enzyme in pyrimidine nucleotide biosynthesis, is
activated by phosphorylation under oxidative stress (17). However, the purpose of most of
these signaling pathways is to regulate transcription. Using p53 as an example, during cellular
exposure to a broad range of genotoxic stress, this transcription factor is subjected to several
modifications, including phosphorylation, at multiple amino acid residues (18, 19). These
modifications activate p53 to initiate the transcription of genes related to DNA repair, cell-cycle
arrest, and apoptosis; p53 can potentially bind to more than 100 genes in human genome (20).
A second level of control of gene expression involves alteration of mRNA sequence by
alternative splicing. While expression levels of proteins can be controlled at the level of
transcription, it is now clear that this is not the only mechanism of regulation because the levels
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of mRNA and protein for most genes are not well correlated (21, 22). Also, some studies have
demonstrated that most genes that are up-regulated in transcription level in response to stress
do not confer resistance to the stress (23). At the post-transcriptional level, alternative splicing
of pre-mRNA plays important roles in cellular response in higher eukaryotes. Pre-mRNA splicing
is catalyzed by the spliceosome that is composed of both protein and RNA, with the activities of
dozens of RNA-binding proteins, regulated by expression level and post-translational
modifications (24, 25). Depending on the cellular conditions, different parts of a DNA transcript
are removed to form mature mRNA. Thus, different proteins can be expressed from the same
gene to adapt changes in cellular state. For instance, heat shock induces alternative splicing in
the non-coding region of HSP47 pre-mRNA, which results in a mature mRNA that is translated
more efficiently under the stress (26). Also, the pre-mRNA of a negative regulator of p53,
MDM2, is alternatively spliced following exposure to genotoxic agents, which leads to the
activation of DNA damage response (27). Finally, cold shock causes alternative splicing in pre-
mRNA of neurofibromatosis type 1 in many types of cells (28). In general, more than half of
mammalian transcripts are spliced differently in different cells of the same organism (29).
Another mechanism of post-transcriptional regulation of cellular response is RNA
interference (30, 31). mRNAs hybridize with complementing small RNA fragments
(approximately 22 nucleotides in length) to form a double-stranded structure that inhibits the
mRNA from being translated and, in many cases, initiates cleavage of the mRNA (32). These
small RNA fragments include small interfering RNAs, PIWI interacting RNAs, and micro RNAs
(miRNAs). miRNAs are generated from DNA transcripts that form a single-stranded stem-loop
structure that is cleaved at specific position by an RNase Ill enzyme, such as Dicer, to form
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miRNAs. It has been shown that miRNAs are involved in cellular response. For instances,
translation of p53 mRNA is suppressed by miRNA miR-125b in normal conditions. The level of
this miRNA decreases following DNA damage to allow a higher level of expression of p53 (33).
A similar mechanism is employed to regulate the expression of a cationic amino acid
transporter during amino acid depletion (34). Interestingly, individual deletion of some miRNA
genes causes no changes in normal conditions (35-37). However, they lead to an increase in
sensitivity to stress (38-41).
The issue of translational control of cellular stress responses will be addressed shortly, but
it is important to note mechanisms for protein degradation. As cellular response to stress,
asides from regulations during transcription and post-transcription, abundance levels of
proteins can also be controlled by protein degradation, with considerable variation in protein
half-life (42, 43). The rate of degradation of specific proteins changes during stress. For
example, one of the pathways of degradation is initiated by post-translationally modifying the
target protein with poly-ubiquitin. Under normal conditions, half-life of the transcription factor
p53 is short as it is frequently poly-ubiquitinated by MDM2, while under stress, poly-
ubiquitination of p53 is reduced to allow p53 to initiate the transcription of stress-response
genes (44-47).
In the remaining portions of this chapter, I will review the mechanisms involved in
protein synthesis, with a focus on the role of the family of transfer RNAs (tRNA) and their
extensive system of ribonucleoside modifications. I will explore the molecular functions of
tRNA secondary modifications and how this leads to the hypothesis that tRNA secondary
modifications are involved in cellular response.
Protein synthesis is a RNA-catalyzed process
As illustrated by several studies, multiple stresses induce the phosphorylation of protein
elF2 to stop translation (48, 49) and thus to conserve resources for the cell to express specific
stress-related genes (50). While cellular response to stress occurs in all other steps of the
lifetime of proteins, it is logical to expect regulations during the process of protein synthesis. It
has been demonstrated that changing the rate of translating a mRNA can alter the function of
protein products (51). This implies that alternating the speed of translation may gain the same
benefits as gaining from alternative splicing. Also, changing in the fidelity of translation can
promote cellular immune responses (52, 53). However, mainly due to the complexity of
ribosomal machinery, mechanisms of its regulation remain eluded. Following the advances in
our understandings in the mechanism of protein synthesis, evidence of regulation during
protein synthesis is emerging from recent studies.
Protein synthesis in biological systems is one of the most extensively studied facets of cell
and molecular biology. The process involves at least three species of RNA: messenger RNA
(mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA) (54, 55). mRNAs carry sequence
information of proteins from the genome. They convey information in a linear reading frame
with 64 codons, with each codon comprising three nucleotides that represent one of the
twenty amino acids or termination of synthesis. The information is read by tRNAs that interact
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with the ribosome-mRNA complex to form polymers of amino acids. Each amino acid is coded
by at least one tRNA, with the amino acid physically linked to the tRNA by an ester linkage at
the 3'-0 catalyzed by a specific aminoacyl-tRNA synthetase. Activated by acylation, the amino
group of the amino acid carries out nucleophilic attack on the carbonyl group at the C-terminus
of the growing peptide that is bound to an adjacent tRNA (peptidyl-tRNA). A new peptide bond
is then formed and the peptide is elongated by one amino acid.
This whole process of protein synthesis is carried out on the ribosome, a protein-RNA
complex consisting two subunits. In prokaryotes, the large subunit contains two rRNAs, 23S
and 5S, so named for the sedimentation coefficient of the RNA molecule, and the small subunit
contains only one rRNA, 16S rRNA. In eukaryotes, the large subunit contains three rRNAs, 28S,
5.8S, and 5S, and the small subunit contains an 18S rRNA. These two subunits play distinct
roles. The formation of peptide bonds is carried out in the large subunit and the binding
between mRNA and tRNA is controlled by the small subunit. Previous studies demonstrated
that the two ribosomal subunits are able to perform their functions independently. Without
the small subunit, the large subunit is still able to catalyze the formation of peptide bonds
between analogs of peptidyl-tRNA and aminoacyl-tRNA (56, 57). Similarly, the small subunit,
with only itself, binds mRNA; this mRNA-small subunit complex then binds specific tRNAs by
hybridization of complementing codon and anticodon (58). The large subunit interacts with the
acceptor stems of tRNAs, especially with the 3'-terminus that always ends with the sequence
CCA, while the small subunit interacts with the anticodon stems. With the two subunits
together in a complex, a ribosome contains three tRNA binding sites that are known as the A, P.
and E. During protein synthesis, two adjacent codons in the mRNA, from 5' to 3', are localized
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in the P and A sites respectively. These two codons determine which tRNAs are bound to the
two sites. At the beginning of each cycle of elongation, a peptidyl-tRNA is located at the P site,
a deacylated tRNA at the E site, and no tRNA at the A site. With the selection based upon the
mRNA codon in the A site, a specific species of aminoacyl-tRNA is delivered to the A site by a
protein complex, EF-Tu. This binding initiates the release of deacylated tRNA in the E site.
tRNA in the P site is then deacylated by the formation of peptide bond between the peptide
and the amino group of the aminoacyl-tRNA at the A site. With the aid of protein complex EF-G,
the deacylated tRNA in the P site is then transferred to the E site and the peptidyl-tRNA in the A
site to the P site. Through this process, one amino acid is added to the peptide and a new cycle
of elongation can be started again. In this complex biological process, RNAs contribute to two
reactions. First, they catalyze the formation of peptide bonds and second, they decode the
information stored in mRNAs.
Both rRNA and tRNA play key roles in catalyzing peptide bond formation. The crystal
structures of H. marismortui ribosomal large subunit and its complexes with tRNA analogs were
determined (59). These structures suggest that the active site of peptide bond formation is
solely composed of rRNAs; in the P site, C74 and C75 of the peptidyl-tRNA base-pair with two
Gs from 23S rRNA, and, in the A site, C75 of the aminoacyl-tRNA also base-pairs with a G from
23S rRNA. These binding patterns fix the orientations of substrates so that the amino group of
aminoacyl-tRNA in the A site is pointed directly to the carbonyl group of the peptide that is
covalently linked to the tRNA in the P site. It was proposed that substrate orientation accounts
for most of the catalytic power of ribosome (60). The crystal structures also suggest that the 2'-
OH group of A76 from peptidyl-tRNA at P site interacts strongly with the amino group of
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aminoacyl-tRNA in the A site. Replacing A76 with a 2'-deoxyA76 leads to a decrease in reaction
rate of 102- to 106-fold (61, 62). It is proposed that the 2'- OH group catalyzes the reaction by
acting as both general acid and general base (63). To activate the formation of peptide bond, it
removes a proton from the amino group to make it a better nucleophile. To favor the break of
ester bond between peptide carbonyl group and the P site tRNA, it donates the proton to 3'- 0
of A76 in the leaving tRNA.
tRNA and rRNA are also involved in maintaining translational fidelity. Binding of
aminoacyl-tRNA to the A site is primarily determined by the base-pairing between codon and
anticodon. However, forming a completely complementary codon-anticodon (cognate)
complex is only slightly more energetically favorable than forming one that has one mismatch
(near-cognate) in many cases. This small difference in free energy is predicted to result in one
misincorporation in every ten amino acids (64). In reality, however, the error rate of amino acid
incorporation is one in every 1000 to 100,000 (65), due to several factors. Several pieces of
information point to enhancement of fidelity by 16S rRNA. Studies support that three
nucleotides on 16S rRNA (A1492, A1493, and G530) are essential for mRNA decoding (66, 67).
Crystal structures of the ribosome small subunit reveal that the conformation of these three
nucleotides changes when cognate codon-anticodon interactions occur in the A site (58, 68, 69).
This induces A1493 to form hydrogen bonds with the first base of the codon, and with its
pairing base from the anticodon. Similarly, the base pair that consists of the second base of the
codon interacts with A1492 while the conformation of A1492 is stabilized by G530. These
interactions stabilize the mRNA-tRNA complex. However, the rRNA-tRNA-mRNA interactions
cannot be formed if the two bases of the pair are not complementary. Thus, the formation of
cognate pairs is much more energetically favorable than the formation of non-cognate ones.
The evidence described above points to a central role for RNA in the structure and activity
of the protein synthesizing machinery. Indeed, it has been hypothesized that the earliest
"ribosome" is composed entirely with RNA (70).
Maturation of transfer RNA
Among the several species of RNA involved in protein synthesis, tRNA is particularly
interesting as it is involved in both decoding the mRNA and forming the peptide bonds. To
become fully functional, transcripts of pre-tRNA proceed through a series of maturation steps
(71) that differ for the various tRNA species (72-74). One of the first steps involves removal of a
5'-terminal sequence from pre-tRNAs with ribonuclease P (75, 76). Interestingly, this enzyme is
composed of both RNA and protein, with the RNA subunit of E. coli or B. subtilis capable of
catalyzing this reaction in vitro (77). An additional 3'-terminal sequence is removed by any of
several exoribonucleases and endoribonucleases that differ for the various species of pre-tRNA
(78). This end is then capped with a CCA sequence in some eukaryotic tRNA species by the
action of ATP(CTP):tRNA nucleotidyl transferase (79, 80). Some pre-tRNAs have a 14-60 nt
intron located one nucleotide downstream of the anticodon (81, 82), with the intron removed
in three reactions in nucleus. First, the intron is removed by a tRNA splicing endonuclease that
is located at the nuclear membrane (83). A tRNA ligase then rejoins the two cleaved fragments
using GTP and ATP (81, 84), which leaves a 2'-phosphate at the junction of ligation. The
phosphate is removed by a NAD-dependent 2'-phosphotransferase to finish the process (85).
RNA secondary modifications
In addition to these changes in tRNA sequence, maturation of tRNA also requires
modification of the nucleobases and ribosyl moieties. Current estimates place the number of
known RNA post-transcriptional or secondary modifications at approximately 100, each
requiring one or more specific RNA modifying enzymes (86). The known set of 25
ribonucleoside modifications in S. cerevisiae tRNA are shown in Figure 1-1. The modifications
range in complexity from simple methylations at endo- and exocyclic nitrogens of the
nucleobases and the 2'-hydroxyl group, to complex and branching modifications of the
nucleobase such as N-threonyl-carbamoyl-adenosine and wybutosine (Figure 1-1). These
modifications are positioned throughout the tRNA molecules in a variety of conserved locations,
but the most frequently modified site involves the anticodon loop (Table 1-1 and 1-2).
Currently, about 50 genes encoding tRNA modifying enzymes have been identified in S.
cerevisiae (Table 1-2).
While all other RNA processing steps appear to take place in the nucleus, reactions to
generate the ribonucleoside secondary modifications occur in both the nucleus and cytoplasm.
The modified nucleosides are derivatives of the four canonical nucleosides (adenosine, uridine,
guanosine, and cytosine) and are formed at different steps during pre-tRNA processing. For
example, when yeast tRNATyr was injected into nuclei of Xenopus laevis oocytes, 5 modifications
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were observed to form before 5'-terminal processing occurred, 11 modifications formed after
the 5' processing, and 2 modifications formed after splicing (87). While the size and sequence
of pre-tRNAs direct the formation of modifications, these processes are also affected by several
other factors.
Another example of the complexity of RNA modification involves the distinction between
tRNAs generated from a single transcript and those arising as a single transcript. In some cases,
several tRNA genes are transcribed as a single multimeric pre-tRNA that is cleaved to form
monomeric pre-tRNAs. In a strain of E. coli with lack of nucleases to process pre-tRNAs, the
accumulated multimeric pre-tRNAs already contained some modifications, including m5U54, Y,
and D (88). For the precursor of a specific leucine tRNA, the modification m'G37 only exists in
monomeric pre-tRNA but not in the multimeric form, while another modification, Gm18, is only
formed on mature tRNA (89). However, in wild-type E. coli, most modifications are generated
after all the cleaving and splicing steps (90). For example, in vitro studies on tRNA m5U54-
methyltransferase demonstrated that monomeric pre-tRNAs are preferred as substrates over
multimeric pre-tRNAs (91). These studies suggest that tRNA modifications are determined by
the abundance level of tRNAs and their precursors, and the activities of modifying enzymes.
In addition to control by substrate and enzyme concentrations, the timing and location of
tRNA modifications is also affected by cellular compartmentalization of enzymes. Many
enzymes for modifying tRNA at position 34 and 37 are located in cytoplasm or in mitochondria
(92). Thus, modifications on these positions are usually the last steps of the maturation
processing as they can only occur when pre-tRNAs are translocated to the cytosol (93).
Furthermore, the sequence of modifications may be affected by interactions between enzymes.
Some tRNA modifying enzymes are a part of large multi-enzyme complexes, which may lead to
specific ordering of individual processes (94, 95). For example, m5C can only be formed at
position 34 in pre-tRNA with an intron, though the sequence of the intron does not affect its
formation (96). This suggests that the splicing is coupled with the formation of m5C.
Degradation of transfer RNA
Matured tRNAs are extremely stable with half-lives in the range of days as determined by
several studies (97, 98). Recently, Chernyakov and coworkers found that two 5'-3'
exonucleases Rat1 and Xrnl are involved in degradation of hypomodified tRNAs and this
process is regulated by Met22 (99), suggesting the presence of a biological mechanism for tRNA
quality control.
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Figure 1-1. Structures of modified nucleosides from S. cerevisiae tRNA. R represents ribosyl
group.
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Table 1-1. Locations of modifications in S. cerevisiae tRNA. In this table, each column
represents one species of tRNA; each row represents one species of modifications.
tRNA modification
m 11
m'A
t 6A
i6A
Ar(p)
Am
m C
ac C
m3C
Cm
m'G
m2Gm2G
m2 
Gm
m7G
yW
Y
Position of modification
34
37
58
37
37
64
4
34, 40, 48, 49
12
32
32, 34
28, 34, 36, 65, 67
55
31
13, 35
32
1
16, 17
20
47
20A, 20B
54m5U
Um
mcmU 5
mcm5 S U
ncmU 5
ncm 5Um
Unknown
DUS1
DUS2
DUS3
DUS4
TRM2
Unknown
TRM9, ELP1-ELP6, KTI11-KTI13
TRM9, NFS1, ELP1-EPL6, KTl11-KT113
ELP1-EPL6, KTl11-KT113
ELP1-EPL6, KTl11-KT113
Table 1-2. Genes those are responsible for the formation of tRNA secondary modifications in S.
cerevisiae.
Genes responsible for modification
TADZ TAD3
TAD1, TRM5
TRM6, TRM61
Unknown
MOD5
RIT1
Unknown
TRM4
TAN1
Unknown
TRM7
Unknown
TRM10
TRM5
TRM11
Unknown
TRM1
TRM3
TRM7
TRM8, TRM82
TRM5
Pusi
PUS3
PUS4
PUS6
PUS7
PUS8, PUS9
Functions of tRNA secondary modifications
Modified ribonucleosides are present in all organisms that have been studied. As noted
earlier, there are at least 107 RNA modifications; 92 of which are found in tRNA (86, 100, 101).
Some modifications are common to all three phylogenetic domains of life and some are even
located at the identical locations in specific tRNA species from widely differing organisms (102).
This high degree of conservation suggests that the modified ribonucleosides have important
functions in cell physiology. However, while it has been shown that individual tRNA
modifications are involved in many biological processes, including aminoacylation of tRNA and
decoding of codon during translation, there is surprisingly little known about the biological
function of the system of modifications.
Some tRNA modifications are essential to maintain the specificity of tRNA aminoacylation.
For example, unmodified yeast tRNAAsP has an altered tertiary structure that causes
mischarging of the tRNA by arginine aminoacyl tRNA synthetase (ArgRS) (103, 104).
Modifications at several positions are particularly important in aminoacylation. At position 10
of yeast tRNAPhe, the modification m2G affect the kinetics of aminoacylation (105). E. coli
tRNAPhe has no modification at G1O and replacing G1O with m2 G10 makes this tRNA a better
substrate for yeast PheRS. Interestingly, m2 GO on the E. coli tRNAPhe diminishes the efficiency
of aminoacylation by the E. coli PheRS. It is proposed that m2G10 affects aminoacylation by
altering tRNA structure, since this modification is not directly involved in interacting with PheRS
or catalyzing the reaction. For direct interactions, tRNA recognition by aminoacyl tRNA
synthase involves mainly the anticodon region. In an E. coli tRNA1e, the wobble position 34 is
modified as lysidine (k2C) and, the absence of this modification causes mischarging by MetRS
(106, 107). Another example involves loss of mnm 5s2U34 in tRNA Gn, tRNAGlu, and tRNA' in E.
coli, which leads to a significant decrease in the acylation activities on these tRNAs (108-111).
The modification mannosyl-queuosine at position 34 of mammalian tRNAASP has a similar effect
(112). At position 35, the middle base of the anticodon, Y35 of tRNA T r is proposed to form
hydrogen bonds with TyrRS (113). However, modifications surrounding the anticodon also
affect aminoacylation. For example, m'G37 of yeast tRNAAsp prevents misaminoacylation and
t A37 of tRNA"* promotes aminoacylation (114).
Besides aminoacylation, modified ribonucleosides in the anticodon region play significant
roles in the efficiency of codon reading. Some modifications at the wobble position stabilize
the codon-anticodon interactions. For example, a yeast leucine-inserting amber suppressor
tRNA (SUP53) contains m5C at the wobble position, with loss of the modification leading to less
efficient suppression of the amber stop codon (96). This indicates that the modification plays a
significant role in binding of the tRNA to its corresponding codon. In some situations, lacking a
modified nucleoside causes misreading of codons. In E. coli, deletion of either mnmE or gidA,
the products of which are involved in the synthesis of mnms2 U34, causes a +2 frameshift when
reading the sequence GAGAGA (115). More importantly, tRNA modifications are involved in
codon recognition. Codons in some codon boxes correspond to two different amino acids (the
four codons that have the same first and second bases are listed in the same codon box). Some
modified nucleotides restrict wobbling to avoid misincorporation. For example, mcm 5s2 U34 in
yeast tRNAGlu limits the tRNA to pair with A (116). Similarly, mnms2 U at the wobble position of
E. coli tRNA l, tRNALys, and tRNA only forms a strong base pair with A, with the base pair to G
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being weak (108, 117). Many wobble modifications with similar structures, including mcm 5 U,
ncm5 U, cmnm5 U, and mchm 5 U, are involved in restricting codon recognition (118). These
modifications restrict the conformation of the nucleobases to favor base pairing with A (119-
121). Modifications on cytosine, such as Cm, ac4C, f5C, and k2C, can also stabilize a
conformation that promotes base pairing with A and inhibits that with other ribonucleotides
(122-125). In contrast, some other modifications elevate the flexibility of base pairing. In some
codon boxes, all four codons code for the same amino acid and so, efficiency of translation can
be improved if a single species of tRNA can recognize all four codons. However, no canonical
nucleobases can base pair with all four ribonucleosides. Some organisms have modified
ribonucleosides at wobble position to extend the number of codons recognized by specific
species of tRNA. For example, E. coli, tRNA Val, tRNASer, and tRNAAla contain cmo U34 and B.
subtilis tRNA Va, tRNA P, tRNA Thr, and tRNAAla contain mo U34 (126-129), in which these two
modification allow the tRNA to interact with codons with A, U, and G at the wobble position
(126, 128, 130, 131).
There are also other functions for modified ribonucleosides. For example, tRNA
modifications may be involved in signaling for translocation of tRNA. In bean (Phaseolus
vulgaris) and potato (Solanum tuberosum), a nuclear-encoded tRNAVal is located in both cytosol
and mitochondria. While the tRNAval in mitochondria has Gm18, this modification is absent in
cytosolic tRNAVal (132, 133). Methyltransferase activities for formation of Gm have been
identified in cytosol but not in mitochondria (134), which suggests that Gm18 determines the
final destination of the tRNAvaI. Modified nucleotides also affect the lifetime of tRNA. In yeast,
tRNAVal(AAC) lacking m7G and m5C is degraded rapidly by some 5'-3' exonucleases (99, 135).
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Degradation of tRNAser(CGA) and tRNAser(UGA) is also observed when these tRNAs lack ac4C and
Um (136). As the roles of many modified nucleotides are poorly understood, tRNA
modifications are potentially involved in many other biological pathways.
Changes in levels of tRNA modifications as cellular response to stress
There are emerging evidence that tRNA modifications are involved in cellular responses to
stress. From the discussion above, it is obvious that modifications in tRNA affect both the rate
and fidelity of protein synthesis. There are several examples in which misincorporation of
amino acids and frameshifts in codon reading frame are employed as regulatory mechanisms
(137-139). For instance, protein synthesis of a mammalian glutathione peroxidase involves site-
specific frameshift by suppressor serine tRNAs, which is necessary to incorporate a non-
canonical amino acid, selenocystein, into the enzyme active site for adapting changes in
physiological conditions (140). Modified ribonucleosides thus have the potential to regulate
these pathways.
Many genes for tRNA modifying enzymes are not essential for cells growing in rich culture
medium. However, deletion of these genes generates an increase in the cellular sensitivity to
specific stresses. For example, the methyl transferase TRM1 is responsible for the formation of
m 22G in yeast tRNA. While it does not affect cell growth, loss of trml leads to sensitivity to heat,
benomyl, 5-florouracil, and cycloheximide (141-143). Similarly, the m5C-methyltransferase
TRM4 confers resistance to heat, caffeine, and rapamycin (144, 145), while 2'-0-
methyltransferase TRM7 confers resistance to hydrogen peroxide, streptomycin, sulfanilamide,
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and cycloheximide (146-148). The m7G-methyltransferase TRM8 confers resistance to heat,
cycloheximide, and 5-fluorouracil (142, 146, 149) and m2G-methyltransferase TRM11 confers
resistance to killer toxins and papulacandin B (150). These studies suggest that modified
ribonucleotides in tRNA are components of cellular response pathways.
While the presence of some tRNA modifications confers resistance to specific stresses, it
has also been shown that the level of individual modified nucleotide can alter in responses to
physiological states. An example of this phenomenon involves starvation of different nutrients,
which leads to unique changes in the level of tRNA modifications. In Salmonella typhimurium,
ms 2io A37 is replaced by ms2i6A37 under anaerobic conditions, probably because the
hydroxylation of ms2i6A requires molecular oxygen (151). Interestingly, if the hydroxylase for
this reaction is absent, the cells are not able to use intermediates of the TCA cycle, including
malate, fumarate, and succinate, as sources of energy (152). This suggests that ms2io6A37 plays
a role in regulating metabolic pathways. While the formation of ms2io6 A depends on the
availability of its precursor, this is not always the case. Deficiency in leucine, histidine, or
arginine causes under-modification at several positions in an E. coli phenylalanine tRNA,
including decreases in the levels of acp 3 U47 and Y55, as well as loss of D16 and ms2i6A37 (153,
154). The under-modification occurs even though the growth rate of the cells is not affected,
which suggests that changes in the spectrum of modified ribonucleosides are not caused by lack
of biosynthetic precursors (155).
Besides responding to changes in environment, tRNA modifications also change as a
function of cell cycle. In mammalian cells, one of the leucine tRNAs, tRNALeu(2), is under-
modified in some stages of the cell cyle, with the under-modified tRNA known as tRNA Leu(4)
(156, 157). The level of tRNALeu(4) is high during cell growth in G1 phase, while it decreases
when cell enters S phase and increases again the cell is ready to go to G2 phase (158). For
temperature-sensitive mutant that are trapped in G1 phase during heat-shock or deficiency in
leucine, the level of tRNALeu(4) remains low (156). These studies support a role for tRNA
modifications in control of the cell cycle
There are a number of observations that suggest that tRNA modifications play a role in
cellular responses to stress, though the mechanisms linking the RNA modification and the
response are not well understood. For example, recent studies indicate that a specific
modification in S. cerevisiae is involved in regulation of protein synthesis that somehow confers
resistance to DNA damage. It is known that a tRNA methyltransferase, Trm9, modulates the
toxicity of exposure to alkylating agents and ionizing radiation, with the transcription level of
the trm9 gene elevates in cells exposed to these stresses (159-161). Trm9 catalyzes the last
step of the formation of mcm5U and mcm 5s2U at the anticodon wobble position of tRNAArg(UCU)
and tRNAGlu(CCU), respectively (162, 163). These two modifications enhance the binding of the
tRNA to a specific codon: AGA for tRNA Ar(UCU) and GAA for tRNA Glu(UUC) (164). Several
studies have demonstrated that the levels of Trm9-catalyzed tRNA modifications control the
translation of genes with high usage of the AGA or GAA codons, with most AGA- and GAA-rich
genes are associated with responses to DNA damage (165). In humans, tRNA Arg (UCU) also
contains mcm 5 U34 and its formation is catalyzed by a Trm9 homolog, ABH8 (166), an enzyme
that possesses both a domain homologous to Trm9 and a dioxygenase domain (166). It has
been demonstrated in vitro that ABH8 can catalyze hydroxylation of mcm 5U34 on tRNAArg(UCU),
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with the hydroxyl group added to the a-carbon attached to C5 of uridine to form 5-
methoxycarbonylhydroxymethyluridine (mchm 5U) (167). This hydroxyl group could potentially
activate the release of the side chain from C5 to form uridine (Figure 1-2). These results
suggest that the level of mcm 5U34 is under dynamic control, and, since this modification affects
the translation of specific group of genes, the dynamic control of mcm 5U34 level on
tRNAArg(UCU) may serve to regulate protein expression to adapt to changes in environment.
Methylase domain
of ABH8
SAM
5-carboxymethyluridine (cm5U)
0
HN
ON
Postion 34
Uridine (U)
Postion 34
5-methoxycarbonylmethyluridine (mcmsU)
Dioxygenase domain
of ABH8
Fe2 , a-ketoglutarate
Hypothetical reaction HN I
O10 N O
Postion 34
5-methoxycarbonylhydroxymethyluridine
(mchmsU)
Figure 1-2. Proposed metabolic cycle of 5-methoxycarbonylmethyluridine (mcm5U) in
mammalian tRNA. U34 in tRNAArg(UCU) is modified to 5-carboxymethyluridine (cm5 U) in a
multi-steps reaction. In S. cerevisae, this process involves at least 9 proteins: ELP1-EPL6, KT/11-
KT/13 (168). The methylase domain of ABH8 then catalyzes the methylation of cm5 U to form mcm5U.
The dioxygenase domain of ABH8 catalyzes hydroxylation of mcm5 U to form mchm 5U. The hydroxyl
group activates the release of this side chain from C5 of uridine to from uridine again.
Studying functions of tRNA modifications with systems approach
From the studies discussed above and other studies, there is a clear role for individual
RNA modifications in a variety of cellular responses to chemical exposures and other stimuli.
However, given the presence of 25-35 RNA modifications in any organism, the study of
individual modifications ignores possible relationships between two or more modifications
functioning as a system to control translational efficiency and thus limits our understanding of
how these modifications contribute to cell physiology and cell survival with toxic exposures.
Further, tRNA modifications could have overlapping roles or they can function cooperatively, as
illustrated by the apparent redundancy of modifications that leads to a lack of phenotypic
change with the loss of a modification (99, 135, 136, 169). The larger biological system in
which these modified nucleotides are involved is thus hidden from traditional genetic and
molecular biology approaches. To understand the biological roles of tRNA modifications and
those in other RNA species in cellular responses, we must study the modifications as a systems.
To this end, the research described in this dissertation aims to understand the functions
of RNA modifications at a systems level, in terms of identifying interdependent patterns and
behaviors of some or all of the modifications (170). Systems-type studies involve an initial
identification of the biological parameters, the individual RNA modifications here, followed by
analysis of the behavior of the parameters under different conditions. This requires the
development of a model to explain the network structures of the biological system, with the
structures identified with a bottom-up or a top-down approaches. In a bottom-up approach,
the system is relatively well characterized and the parameters of interest can be determined by
literature search, with subsequent targeted analysis of each parameter. For instance, in studies
with goals of understanding the regulatory relationships between transcription factors and
transcriptional activities, the model for this biological system is that transcription factors
regulate transcription; parameters to be monitored are the abundance levels of the mRNAs and
the levels of the transcription factors. This approach has been used in understanding a wide
range of biosystems, such as studies of embryonic developments of Drosophila (171-174). The
top-down approach mainly relies on collecting large amounts of data to construct networks in a
system. For instance, some studies predict the function of genes based on DNA microarray
data using clustering analysis (175-178). The parameters monitored in systems-level studies
vary widely, including lipids, metabolites, proteins, microRNA, mRNA, and carbohydrates. Data
can also be generated by measurements of the frequency of biological processes, such as
protein-protein interactions and assembly of organelles. Systems biology studies increasingly
involve image-based spatial and time-lapse microscopic observations, including protein
localization and subcellular responses (179, 180). In many cases, specialized tools must be
developed to acquire quantifiable data for subsequent behavior analysis. Generally, the goal is
to analyze the dynamic behaviors of the parameters of the system under various conditions,
such as external perturbations or cell cycle phases. In addition to a systems-level understanding,
these behavior analyses may reveal targets for modulating activities in the biological system,
which can also be targets of medical treatments. Also, with statistical tools and computational
power, the response of biological systems to different situations can be simulated and
predicted. Such simulations can provide the fundamentals for designing new biosystems or
modifying existing systems for various applications.
To understand the roles of tRNA modifications in stress response, the theme of this thesis
is to study modified ribonucleosides as a system of interrelated components. Based upon the
examples mentioned above, we hypothesize that level of modified ribonucleosides in tRNA
changes in response to specific stresses to control the translation of critical stress response
proteins. To test this model, a mass spectrometry-based platform was developed to quantify
modified ribonucleosides in populations of tRNA (Chapter 2). This platform was then used to
assess changes in the spectrum of modified ribonucleosides in tRNA from S. cerevisiae exposed
to toxic agents with various mechanisms of action. Statistical methods, including hierarchical
clustering and principle components analysis, were employed to determine unique patterns of
changes in response to different stresses (Chapter 3). We then examined the mechanism
linking RNA modifications to the stress response. One of the changes noted in response to
exposure to hydrogen peroxide involved trm4, the gene responsible for formation of m5C in
tRNA. It was observed that m5C is mechanistically linked to expression of specific ribosomal
proteins and its presence, along with the altered ribosomal proteins, confers resistance to
hydrogen peroxide toxicity. These studies demonstrate a novel translational regulation
pathway in response to stress (Chapter 4). Furthermore, we developed a data-driven model
from changes in spectrum of S. cerevisiae tRNA modifications for predicting the behavior of
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specific classes of toxicant exposures (Chapter 5). This work is then summarized and discussed
in a larger context in Chapter 6.
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Chapter 2
Development of a Platform for Characterizing and Quantifying the
Spectrum of tRNA Modifications in an Organism
Part of this chapter is published as an article in
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Abstract
There are over 100 tRNA modifications in transfer RNA (tRNA) and ribosomal RNA (rRNA)
across all organisms and many of these modifications are conserved in widely different species.
However, the biological roles of RNA modifications are poorly understood. To further our
understanding, we developed a quantitative systems approach to study the spectrum of tRNA
modifications in any organism, beginning with S. cerevisiae. All species of tRNA were isolated
under conditions that minimize artifacts, such as oxidation and deamination of RNA, and the
tRNA rigorously quantified. The RNA was then hydrolyzed enzymatically to nucleoside level.
Liquid chromatography-coupled mass spectrometric techniques (LC-MS) were then developed
to characterize and quantify the spectrum of tRNA modifications in the hydrolysate. Based on
high mass accuracy MS (QTOF), collision-induced dissocation fragmentation patterns,
comparisons with synthetic standards, and changes in the levels of ribonucleosides in mutants
lacking tRNA modifying enzymes, we identified 23 modified ribonucleosides in S. cerevisiae
tRNA. These modifications include Y, D, m C, m 3C, Cm, ac 4C, Am, m A, t A, i'A, I, m l, m'G, m G,
m 2G, m 2G, Gm, m U, Um, mcm U, mcm s 2U, ncm U, and yW. We then developed a liquid
chromatography-coupled tandem mass spectrometry (LC/MS-MS) method to quantify the
spectrum of S. cerevisiae tRNA modifications. These methods provide tools for comparing
changes in the spectrum of RNA modifications in cells under different stress conditions ans
stimulations.
Introduction
Since the first discovery of RNA modifications more than 50 years ago, over 100 modified
ribonucleosides have been reported in literature (1-3). Many of these modifications are found
in organisms from all three phylogenetic domains; some of them are even conserved at the
same position in tRNA across all organims (4). Although this conservation strongly suggests that
these modifications play important roles in cell physiology, their function of many remains
undefined.
To elucidate the biological function of RNA modifications, it is essential to identify the
modifications and study their changes as a function of cellular states. Classically, one of the
approaches is to enzymatically hydrolyze RNA to nucleosides and post-label them with 32P; the
[5'- 32P]-NMPs are separated with 2-dimension thin-layer chromatography (TLC) and the identity
of modified nucleosides is defined by migration in relation to standards (5, 6). This method can
determine absolute quantity. However, it is not chemically specific due to co-migrations and it
is not applicable to all modified nucleosides as many modification groups significantly affect the
efficiency of enzymatic 32P-labeling (7). Another approach to quantify modifications involves
blocking reverse transcription by the modifications on RNA. Specific modified nucleosides can
be derivatized chemically; for instance, pseudouridine can be modified by N-cyclohexyl-N'-(2-
morpholinoethyl)-carbodiimid-metho-p-toluolsulfonate. These derivatives stop reverse
transcription and thus, provide indicators of the presence of the modifications (8). While the
modification is quantified, this approach also provides information of its location. The major
pitfall of this approach is that the quantification of each modification requires a specific
chemical for derivatization and the modifications themselves alter reverse transcription.
For the purpose of characterizing the full spectrum of tRNA modifications and studying all
modifications with a quantitative systems approach, we developed a liquid chromatography-
coupled mass spectrometric platform (LC-MS). Previous studies demonstrated that a wide
range of modified nucleosides are separable by high-performance liquid chromatography (HPLC)
and in some cases, the resolved nucleosides can even be identified and quantified by
comparing the UV spectrum and retention time relative to synthetic standards (9). With limited
amounts of samples, the sensitivity of detection can be increased using mass spectrometric
techniques. Also, mass spectrometry is able to structurally characterize and identify most
ribonucleosides (10). By using these techniques, we developed a robust and sensitive method
to characterize and quantify these modifications in tRNA from S. cerevisiae.
S. cerevisiae is one of the most studied organisms, in which at least 25 tRNA secondary
modifications (11) and more than 50 enzymes responsible for catalyzing their formation (12)
have been identified. For the convenience of manipulating genetic behaviors and analyzing
changes in cellular compositions, we employed S. cerevisiae as a model to study roles of tRNA
modifications in cellular responses. The spectrum of tRNA modifications was first characterized
using approaches including analysis of collision-induced dissocation (CID) fragmentation
patterns of modified nucleosides with tandem quadrupole (MS/MS) techniques. Nucleosides
were also identified by comparison with synthetic standards. Further, we monitored changes in
the levels of the modified ribonucleosides in mutants lacking the genes for tRNA modifying
enzyme. With 23 tRNA modifications identified, a LC/MS-MS method was developed to
quantify them. This method provides the basis for us to compare changes in the spectrum
under different physiological conditions.
Materials and Methods
Materials. All chemicals and reagents were of the highest purity available and were used
without further purification. Yeast extract and peptone were purchased from Biomed
Diagnostics (White City, OR). PureLink miRNA Isolation Kit was purchased from Invitrogen
(Carlsbad, CA). 2'-O-Methyluridine (Um), pseudouridine (Y), N1-methyladenosine (m'A), N2,N2_
dimethylguanosine (m22G), N,N 6-dimethyladensoine (m62A), and 2'-O-methylguanosine (Gm)
were purchased from Berry and Associates (Dexter, MI). N-threonylcarbamoyladenosine (t6A)
was purchased from Biolog (Bremen, Germany). N6-isopentenyladenosine (i6A) was purchased
from International Laboratory LLC (San Bruno, CA). 2'-O-Methyladenosine (Am), N4-
acetylcytidine (ac4C), 5-methyluridine (m5 U), inosine (1), 2-methylguanosine (m2G), N7-
methylguanosine (m7G), 2'-O-methylcytidine (Cm), 3-methylcytidine (m3C), 5-methylcytidine
(m5C), alkaline phosphatase, lyticase, RNase A, ammonium acetate, geneticine, bovine serum
albumin, deferoxamine mesylate, butylated hydroxytoluene, and glucose were purchased from
Sigma Chemical Co. (St. Louis, MO). Nuclease P1 was purchased from Roche Diagnostic Corp.
(Indianapolis, IN). Phosphodiesterase I was purchased from USB (Cleveland, OH). HPLC-grade
water, acetonitrile, and chloroform were purchased from Mallinckrodt Baker (Phillipsburg, NJ).
All strains of S. cerevisiae BY4741 and were purchased from American Type Culture Collections
(Manassas, VA).
Culturing S. cerevisiae BY4741. Yeast cells were grown in YPD (yeast extract, peptone,
and dextrose) media. To prepare this culture media, 5 gram of yeast extract, 10 gram of
peptone, and 10 gram of dextrose were dissolved in 500 mL of water. The solution was
sterilized by autoclave. Cultures were incubated at 30 *C with shaking at 220 rpm until they
reached mid-log phase (OD660 is in the range of 0.6 to 0.8). Cells were then collected by
centrifugation at 12000x g for 10 min. Cell pellets were snap-frozen with liquid nitrogen and
stored at -80 0C before use.
Isolation of tRNA from S. cerevisiae BY4741. Approximately 5 x 107 cells were
resuspended in ~200 ptL of a buffer containing 5 pg/mL coformycin, 50 Ig/mL tetrahydrouridine,
0.1 mM desferrioxamine, 0.1 mM butylated hydroxytoluene, 10 mM Tris-HCI, and 1mM EDTA,
pH 8.0. This solution was incubated with 10 pg of lyticase at 300C for 10 min to digest the cell
wall of yeast. Yeast cells were then recollected by centrifugation with 12000x g for 5 min. After
removing the supernatant, tRNA was isolated from the pellet by using the PureLink miRNA
Isolation Kit. The yield of tRNA was determined by UV absorbance at 260 nm and using Agilent
bioanalyzer.
Enzymatic hydrolysis of S. cerevisae tRNA. An amount of 6 ptg of tRNA was mixed with 50
pL of a solution at pH 6.8 that contains 30 mM of sodium acetate, 2 mM of ZnCl 2, 0.02 Unit/pL
of nuclease P1, 0.1 Units/pL of RNase A, 5 pg/ml coformycin, 50 mg/ml tetrahydrouridine, 0.1
mM deferoxamine mesylate, and 0.1 mM butylated hydroxytoluene. The solution was
incubated at 37 *C for 3 h before adding an additional 50 ptL of solution at pH 7.8 with 30 mM
sodium acetate, 0.2 Units/pL of alkaline phosphatase, and 0.01 Units/pL of phosphodiesterase 1.
This mixture was incubated at 37 0C overnight to ensure reactions were complete. As
illustrated in previous studies, artifacts of modified ribonucleosides generated during this
process were neglectable (13). Proteins were removed from the nucleosides with a Microcon
YM-10 filter.
Characterizing the modified ribonucleosides from S. cerevisiae tRNA by LC-QTOF.
Modified nucleosides from hydrolyzed tRNA were resolved by a Thermo Scientific Hypersil
GOLD aQ reverse-phase column (150x2.1 mm, 3tm particle size) on a HPLC system with 0.1%
(v/v) acetic acid in water and in acetonitrile as mobile phases. The gradient of organic phase is
as follow: 0-20 min, 0-1%; 20-25 min, 1%; 25-35 min, 7%; 35-50 min, 7%; 50-60 min, 100%; 60-
70 min, 100%. The flow rate was 0.25 mL/min and the temperature of column was 50 0C. The
HPLC column was coupled to an Agilent 6510 quadrupole time-of-flight LC/MS mass
spectrometer with an electrospray ionization source. The mass spectrometer was operated in
the targeted MS/MS mode with the following MS parameters: gas temperature, 350 'C; gas
flow, 10 L/min; nebulizer, 35 psi; fragmentor voltage, 110; and capillary voltage 3500V. For
scanning nucleosides, ions in the range of m/z 100 to m/z 1000 were monitored with an
acquisition rate of 2 spectra/second. [M+H]* ions of modified nucleosides were targeted for
collision-induced-dissociation. The fragmented ions were monitored with an acquisition rate of
2 spectra/second. The retention time, time period for monitoring, m/z of the parent ion, and
collision energy for each modification are as follows: dihydrouridine (D): 2.5 min, 1.75-3.25
min, m/z 247.9246, 5 V; pseudouridine (Y): 2.6 min, 2-3 min, m/z 245.07681, 5 V; 5-
caramoylmethyluridine (ncmsU): 3.0 min, 2-6 min, m/z 302.09828, 10 V; 3-methylcytosine
(m3C): 3.7 min, 3-5 min, m/z 258.10846, 9 V; 5-methylcytosine (m5C), 4.2 min, 3-5 min; m/z
258.10846; 9 V; 1-methyladenosine (m'A): 4.2 min, 4-5 min, m/z 282.11968, 15V; 7-
methylguanosine (m7G): 6.0 min, 4-8 min, m/z 298.11460, 9 V; 2'-O-methylcytosine (Cm), 6.2
min, 6-7 min, m/z 258.10846, 9 V; inosine (1): 6.2 min, 5.2-7.2 min, m/z 269.08805, 10 V; 5-
methyluridine (m5U): 7.0 min, 6-10 min, m/z 259.09246, 7 V; 2'-O-methyluridine (Urn), 8.7 min,
6-10 min, m/z 259.09246, 7 V; 1-methylguanosine (m'G): 12.3 min, 11.5-16.5 min, m/z
298.11460, 9 V; 1-methylinosine (m'l): 12.4 min, 11-14 min, m/z 283.10370, 10 V; 5-
methoxycarbonylmethyluridine (mcm 5 U): 12.7 min, 11.8-13.8 min, m/z 317.09794, 7 V; 2'-0-
methylguanosine (Gm): 13.0 min, 11.5-16.5 min, m/z 298.11460, 9 V; 4-acetylcytosine (ac4C):
14.5 min, 13.5-15.5 min, m/z 286.10336, 6V; N2-methylguanosine (m2G): 15.0 min, 11.5-16.5
min, m/z 298.11460, 9 V; 2'-O-methyladenosine (Am): 17.6 min, 17-19 min, m/z 282.11968, 15
V; N2, N2-dimethylguanosine (m22G): 26.0 min, 24.7-26.7 min, m/z 312.13025, 8 V; 5-
methoxycarbonylmethyl-2-thiouridine (mcm s2U): 26.2 min, 25.5-27.5 min, m/z 333.07510, 7 V;
N6-threonylcarbamoyladenosine (t6A): 41.4 min, 40-42 min, m/z 413.14154, 8 V; wybutosine
(yW): 57.4 min, 56.5-58.5 min, m/z 509.19905, 10 V; and N-isopentenyladenosine (i6A): 58.1
min, 57-59 min, m/z 336.16663, 15 V.
Developing an LC-MS/MS method to quantify the spectrum of S. cerevisiae tRNA
modifications. Samples of ribonucleosides were resolved with a Thermo Scientific Hypersil
GOLD aQ reverse-phase column (150x2.1 mm, 3 pm particle size) eluted with the following
gradient of acetonitrile in 8 mM ammonium acetate at a flow rate of 0.3 mL/min and 360C: 0-
18 min, 1-2%; 18-23 min, 2%; 23-28 min, 2-7%; 28-30 min, 7%; 30-31 min, 7-100%; 31-41
min, 100%. The HPLC column was coupled to an Agilent 6410 triple quadrupole mass
spectrometer with an electrospray ionization source where it was operated in positive ion
mode with the following parameters for voltages and source gas: gas temperature, 350*C; gas
flow, 10 L/min; nebulizer, 20 psi; and capillary voltage, 3500 V. The first and third quadrupoles
(Q1 and Q3) were fixed to unit resolution and the modifications were quantified by pre-
determined molecular transitions. Q1 was set to transmit the parent ribonucleoside ions and
Q3 was set to monitor the deglycosylated product ions, except for Y for which the stable C-C
glycosidic bond led to fragmentation of the ribose ring; we used the m/z 125 ion for
quantification. The dwell time for each ribonucleoside was 200 ms. The retention time, m/z of
the transmitted parent ion, m/z of the monitored product ion, fragmentor voltage, and collision
energy of each modified nucleoside and 15N-labeled internal standard are as follow: D, 1.9 min,
m/z 2474115, 80 V, 5 V; Y, 2.5 min, m/z 245-4125, 80 V, 10 V; m5C, 3.3 min, m/z 2584126, 80
V, 8 V; Cm, 3.6 min, m/z 258-112, 80 V, 8 V; msU, 4.2 min, m/z 2594127, 80 V, 7 V; ncmsU,
4.3 min, m/z 302->170, 90 V, 7 V; ac4C, 4.4 min, m/z 286->154, 80 V, 6 V; m3C, 4.4 min, m/z
258-126, 80 V, 8 V; ncm 5Um, 5.5 min, m/z 3164170, 90 V, 7 V; Um, 5.1 min, m/z 2594113, 80
V, 7 V; m7G, 5.1 min, m/z 2984166, 90 V, 10 V; m'A, 5.7 min, m/z 2824150, 100 V, 16 V;
mcm 5 U, 6.4 min, m/z 3174185, 90 V, 7 V; m' I, 7.3 min, m/z 2834151, 80 V, 10 V; Gm, 8.0 min,
m/z 2984152, 80 V, 7 V; m'G, 8.3 min, m/z 2984166, 90 V, 10 V; m2G, 9.4 min, m/z 2984166,
90 V, 10 V; I, 10.9 min, m/z 269+137, 80 V, 10 V; mcm 5s2U, 14.2 min, m/z 3334201, 90 V, 7 V;
[15 N]5-dA, 14.4 min, m/z 2574141, 90 V, 10 V; m2G, 15.9 min, m/z 312+180, 100 V, 8 V; t'A,
17.2 min, m/z 4134281, 100 V, 8 V; Am, 19 min, m/z 2824136, 100 V, 15 V; yW, 34.2 min, m/z
5094377, 80 V, 5 V, and i6A, 34.4 min, m/z 3364204, 100 V, 17 V. The mass spectrometer
monitored ions with the molecular transitions of D, Y, m5C, and Cm from 1 to 4 min; molecular
transitions of msU, ncmsU, ac4C, m3C, ncm5Um, Um, m7G, m'A, and mcm 5 U from 4 to 7 min;
molecular transitions of m'l, Gm, m1G, and m2G from 7 to 10 min; molecular transitions of 1,
mcm 5s2U, [15N]5-dA, m22G, t A, and Am from 10 to 30 min; molecular transitions of yW and i6A
from 30 to 40 min.
Results
Isolation of tRNA. Obtaining tRNA samples of high quality is one of the key features of
rigorous quantitative comparison of changes in levels of tRNA modifications. Each organism
contains various species of RNA, including tRNA, rRNA, and mRNA, which makes purification of
tRNA a challenging task. As the size of tRNA is about 70 nucleotides and most other species of
RNA are much larger, we decided to purify tRNA with a commercial kit that can isolate RNA
below 200 nucleotides. While most species of RNA in this range of size are tRNA, there is also a
small amount of other species of RNA, including microRNA (~21 nt) and 5S rRNA (~120 nt) (14).
To assess the purity of each sample, we used an Agilent Bioanalyzer (microfluidics-based sizing
and quantification against an internal standard) for quantification of total tRNA species, which
amounted to 85±5% (N = 39) in the mixture of small RNA. Based upon the quantification, an
internal standard ([15Ns]-2'-deoxyriboadenosine) was added before enzymatic hydrolysis to
minimize variation in the levels of the individual ribonucleosides.
Characterization of the spectrum of S. cerevisiae tRNA modifications by LC-QTOF mass
spectrometry. In S. cerevisiae, 25 modified ribonucleosides in tRNA are reported in the
literature (11). To identify these modified ribonucleosides in the hydrolyzed tRNA samples, we
used an LC-QTOF system to obtain high mass accuracy (error < 10 ppm) characterization of the
ionized ribonucleosides. Ions with expected mass were selected for collision-induced
dissociation (CID) to determine the fragmentation patterns of the ribonucleosides. These
fragmentation patterns further confirm the identities of these molecules; they were compared
with the fragmentation patterns of commercially available nucleosides (Y, I, m5 U, Gm, Um, m5C,
m 3C, Cm, m 2G, ac 4C, t A, m G, Am, m 2G, i A, and m'A). For those modified nucleosides with no
available standards (D, ncmsU, mcmU, mi G, mcm s 2U, mil, and yW), they were compared to
the fragmentations reported in the literature (10, 15, 16). Two of the 25 known S. cerevisiae
modifications were not detected (ncm5Um and Ar(p)). The mass spectra of CID fragmentation
for the other 23 modified nucleosides are shown in figure 2-1.
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Figure 2-1. Mass spectra of fragmentized nucleosides by collision-induced dissocation. These
characterizations were performed with LC/QTOF as described in the Materals and Methods. A
total of 23 modifications were analyzed, including m3C, m5C, Cm, m5 U Urn, I, m7G, m'G, Gm,
m 2G, mcm U, miA, ac 4C, Am, m 2G, mcm 5s2U, i A, t A, yW, D, m1l, ncm U, and Y.
............... ........
LC-MS/MS-based quantification of the spectrum of modified nucleosides in S. cerevisiae
tRNA. An LC-MS/MS method was developed to quantify S. cerevisiae tRNA modifications.
Based upon the fragmentation of nucleosides in high mass-accuracy mass spectrometry, the
modifications were quantified by pre-determined molecular transitions during CID. The
transitions monitored for all nucleosides are the dissociation of ribosyl group from the base,
except for pseudouridine that the base is linked to the ribose via a C-C bond. CID of
pseudouridine leads to the formation of a fragment, consisting of the base and the 1'-CH 2' from
ribose, which we chose as product ion for quantification (17). Even though the ncm 5 Um was
not observed with quadrupole time-of-flight mass spectrometer (QTOF), an ion with the
expected molecular transition for this nucleoside was detected by triple quadrupole mass
spectrometer (QQQ). This could be because the sensitivity of QQQ is higher than QTOF. A
chromatogram of nucleosides quantified by this method is shown in Figure 2-2. By analyzing a
series of samples with different quantity of hydrolyzed tRNA (0 pig, 0.05 Ipg, 0.1 pg, 0.2 p1g, 0.4
Ig, 0.8 pg, 1.2 pg, 1.6 pg, and 2.0 pg), we determined that the signal intensities of all modified
nucleosides are linear to the amount of samples in the range of 0.05 pg to 0.8 pg (Figure 2-3).
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Figure 2-2. Total ion chromatogram of S. cerevisiae tRNA modified ribonucleosides from LC-
MS/MS analysis. A total of 23 ribonucleosides were monitored.
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Figure 2-3. Mass spectrometer signal intensities for tRNA ribonucleoside modifications. Small
RNA isolates containing tRNA were enzymatically hydrolyzed and quantities ranging from 0.1 to
2 pg were analyzed by LC-MS/MS. Mass spectrometric signal intensities were determined for 23
of 25 modified ribonucleosides from yeast tRNA and plotted against total tRNA. Data represent
mean ± SD for three analyses of the same sample.
Monitoring levels of modified nucleosides in yeast mutants. With the quantitative method
developed, we further confirmed the identity of modified ribonucleosides by comparing the
levels of specific modifications in a wild-type strain to those in mutant strains each lacking a
corresponding tRNA modifying enzyme. If the identity of the modification is correct, a decrease
in MS signal intensity is expected with loss of its biosynthetic pathway. As shown in Table 2-1,
we used 17 mutants to confirm 15 modifications. Deletion of some tRNA modifying enzyme
genes led to their corresponding modifications to drop below detection limit; these include
trmlA for m22G, trm2A for m5U, trm9A for mcm U and mcm-s 2U, trmllA for m2G, trml2A fro
yW, and tadlA for m11. As formation of some modifications is catalyzed independently by
multiple enzymes, modifications in corresponding mutants did not disappear completely; these
overlaps in gene function include trm3 and trm7 for catalyzing Gm, trm5 and tad1 for m1 \, trm5
and trmlO for m G, and, trm7 and trm13 for Cm. However, for m'C, m G, Um, i A, and ac4C,
even though only one biosynthetic pathway was discovered for each of these modifications,
these modified nucleosides were still observed in the corresponding mutants. These
observations suggest that the formation of these modified nucleosides involves more than one
pathway, or the modified nucleosides were from other speices of RNA, such as 5S rRNA.
Genesied de iModified MS Modified MS
. Modified .. Fold-changeGenes deleted in nucleoside(s) signal intensity signal intensity (mutant:wild-
mutants from the gene in wild-type (Avg in mutant (Avg t type)
± SD) SD)
trm1 m22G 52029 1233 nd 0
trm2 m5U 1419± 15 nd 0
trm3 Gm 25736 1145 24948 ±1261 0.97
trm4 m5C 52457 1254 3883 159 0.07
trm5 mil 5775 ±420 3687 149 0.64
yW 153 ±21 43 ±9 0.28
m1G 148698 13388 90329 ±6727 0.61
trm7 Cm 34402 ±614 16373 ±500 0.48
Gm 25736 1145 19694 ±6660 0.77
trm8 m7G 66810 ±8171 7642 ±160 0.11
trm9 mcm 5U 457 ± 42 nd 0
mcm5s2U 638 ±67 nd 0
trm10 m'G 105441 ±7738 31437 ±1898 0.30
trm11 m 2G 19552 ±835 nd 0
trm12 yW 71± 28 nd 0
trm13 Cm 37912 ±4121 25946 ±568 0.68
trm44 Um 1569± 413 331 ± 31 0.21
trm82 m7G 66810 ±8171 8509 184 0.13
tadi mIl 3941 622 nd 0
mod5 i6A 3115 ±39 39 ±6 0.01
tani ac4C 14277 ±2248 4419 ±237 0.31
Table 2-1. Quantitative assessments of
corresponding enzymes. "nd" indicates
changes in modified nucleosides in mutants with loss of
the modification was not detectable in that mutant.
Discussion
Mass spectrometry-based methods for quantifying spectrum of tRNA modifications in
S. cerevisiae. We developed an LC-MS/MS method capable of quantifying 23 of the 25 known
ribonucleoside modifications in cytoplasmic tRNA in S. cerevisiae. This method begins with
isolation of small RNA species below 200 nt and quantification of the tRNA content with
bianalyzer and UV-vis spectrophotometer. Individual ribonucleosides in enzymatic hydrolysates
of tRNA were resolved by HPLC and determined by their characteristic fragmentation pattern
using mass spectrometry.
As modifications in S. cerevisiae are well-studied, we identified them using high mass-
accuracy mass spectrometry to compare fragmentation patterns with chemical standards and
literature in a highly targeted manner. Each ribonucleoside was subsequently quantified by
pre-determined molecular transitions during CID in the LC-MS/MS system. We were able to
identify and quantify 23 of the 25 tRNA modifications in yeast, with 2'-O-ribosyladenosine
phosphate (Ar(p)) not detected in positive ion mode (18, 19), possibly due to the negatively
charged phosphate, and only tentative identification of ncm5 Um by CID due to weak signal
intensities.
A critical feature of our approach is quantitative rigor given the need for highly precise
measurement of even small changes in the relative quantities of ribonucleosides. To this end,
we used an Agilent Bioanalyzer (microfluidics-based sizing and quantification against an internal
standard) for quantification of total tRNA species in the mixture of small RNA and an internal
standard (['5N5]-2'-deoxyriboadenosine) to minimize variation in the levels of the individual
ribonucleosides.
We monitored specific modified ribonucleosides in mutants with deletion of
corresponding tRNA modifying enzyme genes. As shown in Table 2-1, the abundance of
modifications decreased when the responsible gene was lost. The formation of some
modifications is catalyzed by multiple genes independently, including Gm, m Il, mIG, and Cm,
and these modifications were not completely lost in the mutants. However, for some
modifications (m5C, m7G, Um, i6A, and ac4 C that only one biosynthetic pathway is characterized,
they were still detectable in their corresponding mutants. It is possible that these modifications
were formed via alternative pathways. For instance, m'A and m7G are common adducts that
can be formed chemically (20, 21). One caveat here is low-level contamination (a few percent)
with 5S rRNA that also contains ribonucleoside modifications. We were able to obtain highly
reproducible data for the signal intensity associated with each ribonucleoside (see Figure 2-3
for linearity of signal intensity for the 23 ribonucleosides). Multiple reaction monitoring (MRM)
mode yielded no detectable background signal in the absence of tRNA hydrolysates except for
i6A (9 ± 2%). Analysis of tRNA from wild type cells revealed a three-log range of signal intensity,
with I and ac4C producing the highest intensity and ncm5Um the lowest (Figure 2-2 and Table 2-
2). In general, modifications can be categorized in high (1, ac4C, miA, m22G, Am, Y), medium
(Cm, m C, Gm, m G, tA, m G, m2 G, m3C, i A) and low signal intensities (mlI, D, m U, ncm Um,
mcm U, mcm5 s 2U, Um, yW, ncm5 U), with signal intensity reflecting both the abundance and
mass spectrometric sensitivity for each ribonucleoside. This MS quantification method is used
to study the changes in the spectrum of S. cerevisiae tRNA modifications in response to
exposure to different type of toxic agents (Chapter 3).
0.4 pg of hydrolyzed tRNA
Expt. I Expt. 2 Expt. 3 Average Std. Dev.
D 424088.4 423640.7 427548.5 425092.5 2138.689
Y 2600599 2388005 2463198 2483934 107803.5
ncm5U 10587.98 9967.097 10180.51 10245.2 315.4535
I 41189.76 39247.89 39772.93 40070.19 1004.483
m5U 102418.4 100054.1 100503.1 100991.9 1255.656
ncm"Um 4582.739 4674.049 4448.249 4568.345 113.5859
Gm 223923.7 210210.5 212587.9 215574 7328.098
UM 18719.91 16800.13 17000.06 17506.7 1055.413
m3C 45560.77 42904.79 40723.55 43063.04 2422.486
m5C 424830.2 400425.2 408744.8 411333.4 12406.74
Cm 122686.3 117802.3 114972.7 118487.1 3902.139
mcm5 U 9778.705 9686.143 9617.348 9694.065 80.9694
m7G 306670.2 287031.1 295568.3 296423.2 9847.455
m'G 397554.9 379427.3 384249.4 387077.2 9388.839
m 2G 178295.5 166431.3 174566 173097.6 6066.884
ac4C 77889.31 71419.34 71098.4 73469.01 3831.446
t6A 79569.02 74730.69 77152.04 77150.58 2419.163
mcm 5s2 U 4356.895 4381.075 4653.992 4463.987 164.9921
m 11 17948.28 16791.12 17414.55 17384.65 579.1582
Am 307639.5 288643.2 290306.1 295529.6 10520.39
m22G 350220.4 325874.8 338643.6 338246.2 12177.65
i A 244157.1 227802.4 230786.3 234248.6 8709.734
mIA 535454.3 517797.7 513667.6 522306.5 11572.01
Table 2-2. MS Signal intensities of modified nucleosides from S. cerevisiae tRNA. An amount of
1 pmol of [15N5]-2'-deoxyadenosine was added per pg of tRNA as internal standard. After
enzymatic hydrolysis, 0.4 ptg of nucleosides were analyzed with LC/MS-MS. Quantity of signal
for each nucleoside in the three experiments was normalized by the signal intensity of the
internal standard.
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Chapter 3
A Quantitative systems approach reveals dynamic control of tRNA
modifications during cellular stress
Part of this chapter is published as an article in
PLoS Genetics 2010, 6 (12): e1001247
Abstract
Decades of study have revealed more than 100 ribonucleoside structures incorporated as
post-transcriptional modifications mainly in tRNA and rRNA, yet the functional dynamics of this
conserved system are unclear. To this end, we used a highly precise mass spectrometric
method to quantify tRNA modifications in Saccharomyces cerevisiae. Our approach revealed
several novel biosynthetic pathways for RNA modifications and led to the discovery of signature
changes in the spectrum of tRNA modifications in the damage response to mechanistically
different toxicants. This is illustrated with the RNA modifications Cm, m5C, and m22G, which
increase following hydrogen peroxide exposure but decrease or are unaffected by exposure to
methylmethane sulfonate, arsenite, and hypochlorite. Cytotoxic hypersensitivity to hydrogen
peroxide is conferred by loss of enzymes catalyzing the formation of Cm, m5C, and m22G, which
demonstrates that tRNA modifications are critical features of the cellular stress response. The
results of our study support a general model of dynamic control of tRNA modifications in
cellular response pathways and add to the growing repertoire of mechanisms controlling
translational responses in cells.
Introduction
The complexity of the transfer RNA (tRNA) system confers great potential for its use in
cellular regulatory programs. There are hundreds of tRNA-encoding genes in S. cerevisiae and
human genomes, with extensive post-transcriptional processing that includes enzyme-
mediated ribonucleoside modifications (1). Considering both tRNA and ribosomal RNA (rRNA),
there are more than 100 known ribonucleoside modifications across all organisms in addition to
the canonical adenosine, guanosine, cytidine and uridine (2, 3). In general, tRNA modifications
enhance ribosome binding affinity, reduce misreading and modulate frame-shifting, all of which
affect the rate and fidelity of translation (4-7). However, information about the higher-level
biological function of ribonucleoside modifications has only recently begun to emerge. We
have approached this problem with a systems-level analysis of changes in the spectrum of
ribonucleosides in tRNA as a function of cell stress, which has revealed novel insights into the
biosynthesis of tRNA modifications and their role in cellular responses.
Emerging evidence points to a critical role for tRNA and rRNA modifications in cellular
responses to stimuli, with evidence for a role in tRNA stability, cellular stress responses, and
cell growth (8-13). We recently used high-throughput screens and targeted studies to show
that the tRNA methyltransferase 9 (Trm9) modulates the toxicity of methylmethanesulfonate
(MMS) in S. cerevisiae (11, 14). This is similar to the observed role of Trm9 in modulating the
toxicity of ionizing radiation and of Trm4 in promoting viability after methylation damage (15,
16). Trm9 catalyzes the methyl esterification of the uracil-based cm5 U and cm5s2U to mcm 5 U
and mcm5 s2U, respectively, at the wobble bases of tRNA ucu-ARG and tRNAccu-GLU, among
others (17). These wobble base modifications in the tRNA enhance binding of the anticodon
with specific codons in mixed codon boxes (18). Codon-specific reporter assays and genome-
wide searches revealed that Trm9-catalyzed tRNA modifications enhanced the translation of
AGA- and GAA-rich transcripts that functionally mapped to processes associated with protein
synthesis, metabolism and stress signaling (11). The resulting model proposes that specific
codons will be more efficiently translated by anticodons containing the Trm9-modified
nucleoside and that tRNA modifications can dynamically change in response to stress.
To assess the dynamic nature of tRNA modifications proposed by this model, we
quantified the full set of tRNA modifications in S. cerevisiae with a systems-oriented approach
using liquid chromatography-coupled, tandem quadrupole mass spectrometry (LC-MS/MS) as
described in Chapter 2. Mass spectrometry-based methods have recently emerged as powerful
tools for identifying and quantifying RNA modifications (19, 20). We applied such an approach
to quantify changes in the spectrum of tRNA modifications in yeast exposed to four toxicants:
hydrogen peroxide (H20 2), sodium hypochlorite (NaOCI), sodium arsenite (NaAsO 2), and methyl
methanesulfonate (MMS). H20 2 is an oxidizing agent that can form hydroxyl radical by reacting
with reduced transition metal ions (Fenton reactions) (21). Hydroxyl radical leads to DNA
damages via various mechanisms (22-24). While NaOCI also induces oxidative stress and forms
hydroxyl radical at low pH, it can also from singlet oxygen, molecular chlorine, and chloramines
that are all cytotoxic (24). Arsenite is a carcinogen, as indicated by studies with animal models;
even though its mechanism of action is not understood, evidences suggest that it generates
oxidative stress and leads to adduction in both proteins and DNA (25). MMS is an alkylating
agent that methylates nucleophiles, such as amines, in a wide range of biological
macromolecules (26). These four reagents generate stress with dissimilar mechanisms.
Multivariate statistical analysis of the data reveals dynamic shifts in the population of RNA
modifications as part of the response to damage, with signature changes for each agent and
dose. Further, analysis of yeast mutants lacking specific modification enzymes revealed novel
biosynthetic pathways and compensatory or cooperative shifts in the population of RNA
modifications as part of the response to damage, with signature changes for each agent and
dose. Further, analysis of yeast mutants lacking specific modification enzymes revealed novel
biosynthetic pathways and compensatory or cooperative shifts in the levels of other
modifications.
Materials and Methods
Materials. All chemicals and reagents were of the highest purity available and were
used without further purification. 2'-O-Methyluridine (Um), pseudouridine (Y), N'-
methyladenosine (m'A), N2,N2-dimethylguanosine (m22G), and 2'-O-methylguanosine (Gm)
were purchased from Berry and Associates (Dexter, MI). N6-Threonylcarbamoyladenosine (t6A)
was purchased from Biolog (Bremen, Germany). N-lsopentenyladenosine (i6A) was purchased
from International Laboratory LLC (San Bruno, CA). 2'-O-Methyladenosine (Am), N4-
acetylcytidine (ac4C), 5-methyluridine (m5 U), inosine (I), 2-methylguanosine (m2G), N7-
methylguanosine (m7G), 2'-O-methylcytidine (Cm), 3-methylcytidine (m3C), 5-methylcytidine
(m5C), alkaline phosphatase, lyticase, RNase A, ammonium acetate, geneticine and
desferrioxamine were purchased from Sigma Chemical Co. (St. Louis, MO). Nuclease P1 was
purchased from Roche Diagnostic Corp. (Indianapolis, IN). Phosphodiesterase I was purchased
from USB (Cleveland, OH). PureLink miRNA Isolation Kits were purchased from Invitrogen
(Carlsbad, CA). Acetonitrile and HPLC-grade water were purchased from Mallinckrodt Baker
(Phillipsburg, NJ). All strains of S. cerevisiae BY4741 were purchased from American Type
Culture Collections (Manassas, VA).
Sensitivity assay of S. cerevisiae to toxic agents. All strains of S. cerevisiae BY4741 were
cultured in YPD (yeast extract-peptone-dextrose) media with 200 pig/mL of geneticine at 30 *C
with shaking at 220 rpm. Cultures were grown to mid-log phase (OD660 ~ 0.6 to 0.8) followed
by addition of water, to serve as untreated control, or toxic agents, including hydrogen
peroxide (H202), methyl methanesulfonate (MMS), sodium hypochlorite (NaOCI), or sodium
arsenite (NaAsO 2). After 1 hour, these cultures were diluted 10 4- to 106-fold with YPD media
and then plated to YPD agar plates. Survival rates of exposed cells were determined by
comparing the number of colonies formed from untreated culture with that from each exposed
culture after two days.
Exposure of S. cerevisiae. Cultures of S. cerevisiae BY4741 were grown to mid-log phase
followed by addition of toxicants to the noted final concentrations (cytotoxicity of ~20%, 50%
and 80%): H20 2, 2, 5 or 12 mM; MMS, 6, 12 or 24 mM; NaAsO 2, 20, 40 or 60 mM; NaOCI, 3.2,
4.0 or 4.8 mM. The sensitivity of the following mutant strains to toxicant exposure was also
determined (doses producing ~80% cytotoxicity in wild-type: 12 mM H20 2, 24 mM MMS, 60
mM NaAsO 2, or 4.8 mM NaOCI ): trml, trm2, trm3, trm4, trm7, trm8, trm9, trmlO, trmll, trm12,
trm13, trm44, trm82, tadi, mod5, and tan1. Since trm5 is essential, a diploid strain (GBY1)
lacking one copy of trm5 was used. After a 1 h, cells were collected and viability determined by
plating.
tRNA isolation and quantification of cytoplasmic tRNA modifications. tRNA isolation
and quantification of modified nucleosides are described in details in Chapter 2. This process
involves lyzing cells with lyticase, extracting tRNA from cell lysate by using Invitrogen PureLink
small RNA isolation kit, enzymatically hydrolyzing tRNA to nucleosides, resolving these
nucleosides by HPLC, and monitoring each species based on pre-determined molecular
transitions by mass spectrometer (MS2).
Quantification of m7G in control and MMS-treated yeast. To assess the direct and
indirect effects of MMS on levels of methylated ribonucleosides, the absolute levels of m7G
were quantified in small RNA hydrolysates isolated from MMS-exposed and unexposed mutant
and wild type strains of yeast by the LC-MS/MS method described above. Calibration curves
were generated by mixing variable amounts of m7G (final concentrations of 0, 5, 50, 300, 600,
1000, and 2000 nM) with a fixed concentration of [15 N]5-dA (40 nM). A volume of 10 pl of each
solution was analyzed with the LC-MS/MS system described earlier.
Statistical analysis of changes in the levels of tRNA modifications. Differences in the
levels of ribonucleosides in exposed versus unexposed and in mutant versus wild-type yeast
were analyzed by Student's t-test. Hierarchical clustering analyses were performed using
Cluster 3.0. Data were transformed to log2 ratios of modification levels in treated cells relative
to unexposed controls. Clustering was carried out using the centroid linkage algorithm based
on the distance between each dataset measured using the Pearson correlation, with heat map
representations produced using Java Treeview. Principal component analysis was performed
using XLStat (Addinsoft SARL, Paris, France), with a Pearson correlation matrix consisting of data
that were mean-centered and normalized to the standard deviation. Correlation analysis was
used to assess the degree of covariance among the various sets of fold-change values for each
mutant, with correlation coefficients calculated using Excel (Microsoft).
Results
Cytotoxicity dose-response studies with S. cerevisiae exposed to various toxic agents.
To test the hypothesis that the changes in spectrum of tRNA modifications are unique to
different stress, we decided to expose cells to four different toxic reagents with doses that
cause the same survival rate. The doses for exposures were determined by assessing the
sensitivity of cells to a serial concentration of H202 (1, 2, 5, 7, 9, 11, 12, 13, and 15 mM), MMS
(0, 1.2, 6, 12, 24, 36, and 48 mM), NaOCI (0, 0.16, 0.8, 1.6, 3.2, 4, 4.8, 8, and 16 mM), and
NaAsO 2 (0, 10, 20, 40, 60, 80, and 100 mM). Based on these assays (Figure 3-1), we decided to
quantify spectra of tRNA modifications in cells exposed to 2, 5, and 12 mM of H202, 6, 12, and
24 mM of MMS, 20, 40, and 60 mM of NaAsO2, and 3.2, 4.0, and 4.8 mM of NaOC. The three
doses of each reagent led to cytotoxicity of approximately 20%, 50%, and 80%.
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Figure 3-1. Cytotoxicity dose-response studies with S. cerevisiae exposed to H20 2, MMS,
NaAsO4, and NaOCI. Data represent mean ± SD for three biological replicates. The dotted line
marks the 80% survival level.
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Changes in spectrum of tRNA modifications in response to stress. By using the LC/MS-
MS method described in Chapter 2, we compared the spectrum of tRNA modifications from
cells exposed to the three doses of each of the four reagents as described above. Each
exposure condition was carried out in biological triplicates. Signal intensities from all
nucleosides were normalized by that from the internal standard, [15N5]-labeled 2'-
deoxyadenosine, so that the relative quantity of each modification can be compared across
samples; average of normalized signal intensities was calculated (Table 3-1). Changes in the
spectrum were expressed as fold-change of the levels of nucleosides in treated cells relative to
in untreated cells; statistical significance of these changes were determined by Student's t-test
(Table 3-2). The results demonstrated that levels of m5C, Cm, and m22G increased, and level of
yW and m'G decreased statistically significantly (p<0.1) after exposed to all three doses of H202.
For MMS-exposed cells, levels of 1, Gm, Cm, t A, Am, m 2G, and yW decreased and that of m7G
and m3C increased. Exposures of NaAsO 2 led to a general decreases in the level of all
modifications. Cells treated with NaOCI had a decrease in the level of m1l and an increase in
the levels of Um and Am. Hierarchical clustering analysis and principle components analysis on
this set of fold-change data demonstrate that the spectrum of tRNA modifications changed
specifically in response to each toxic agent (Figure 3-2 and 3-3).
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2 5 12 6 12 24 20 40 60 3.2 4 4.8
D____ 1.17762 1.008073 1.177209 1.138843 0.925642 1.117973 0.921993 1.176083 1.413422 1.367941
Y 1.048207 1.011943 0.906502 0.942232 0.852851 0.891963 0.86479 0.856079 0.783348 1.113707 1.024734 0.996259
ncm'U 1.151324 1.056956 1.094415 1.063012 1.106319 1.166317 0.954578 1.171254 1.033215 1.109587 1.262151 1.383549
1__ 1.026212 0.965643 0.998282 0.924478 0.948808 0.986754 1.143359 1.078319
msU 0.917486 0.853888 0.832692 0.966747 1.011623 10.906295 1.137101 0.944218 0.826607 0.974009 0.881178
Gm 1.078032 0.910225 0.93788 0.913613 0.898294 0.919625 1.237301 1.066641
Um0.947464 1.09091210.8336691 0.91136 |10.891144 0.860356 0.949127 0.959982 1.204729
m C 057 2.148977 1.97494 0.846477 0.845219 10.719437 0.937362 0.848824 0.464038 0.59621 0.735072
m SC 11.00289 11.0686-47 0.9146681M 1.198253 1.056243 0.932754 0.0451.003756 0.919617 0.944877
CM _ 092 9220.882314 0.849917 0.921497 0.914356 0.929981
mcm SU 10.866434 0.84255710.84245811.00879311.155832 11.080345 0.86817 0.921413 1.11455 1.967932 0.993679
m7G 0.903554 1.178655 0.77581 1.778017 1.028016 0.959749 1.0235 0.97289 0.899333
M1G 0.804767 0.935312 10.964822 1.078963 1.022186 0.910449 0.921813 0.881423
maG 0.845636 0.7864 0.76856 0.902425 v1.041745 1.012757 m.8f43i9 0.945365 0.935283 0.885212
acC 11.06273711.031264 1.075229 1.00156 10.942444 1 0.938 0.958734 0.926895 0.6611.07839 1.086729 0.981309
t' 0.921653 g i l 0.893989 0.86578 0.980664 0.955176 0.923151
m msaU 0.892 0.873775 0.86 98 0.9320340.904726 .847081
mte 0.948333 0.863812 0.829329 0.9762771 0.99663 10.85528511.027179 77
Am 0.89334210.9876 = 0.78879 1132
mzaG 0.2261 M1.-013808 0.5920.959165 0.923232 0.863837
i'A 0.756877 0.717579 0.7043371 0.7938741 0.71939 1 0.680728 0.82324 0.868636 0.2750.86 907 1 0875 0.820137
W 0 2 0.8376581 0.815594 0.9716 L .9370848
I mjA 0.887864 1078 1.2162 1.068969 0.99238 1.036885 0M947231 0.8977561
Table 3-2. Fold-change values for S. cerevisiae tRNA modifications in treated cells relative to
untreated controls. Shading color indicates significant difference from control by Student's t-
test: blue, p<0.05; yellow, p<0.1.
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Figure 3-2. Hierarchical cluster analysis of toxicant-induced changes in tRNA modification
spectra in wild-type yeast exposed to concentrations of MMS, H202, NaOCI, and NaAsO2
producing 20%, 50%, and 80% cytotoxicity. Scale of fold-changes is indicated by the color bar
on the top-left of this figure.
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Figure 3-3. Principal component analysis (PCA) of changes in the levels of tRNA modifications
caused by exposure to MMS, H202, NaOCI, and NaAsO2. (A) Scoring plot of PCI vs. PC2; (B)
Loading plot of PC1 vs. PC2; (C) Scoring plot of PC2 vs. PC3; and (D) Loading plot of PC2 vs. PC3.
Sensitivity of tRNA modifying enzyme-deficient mutants to various stresses. To
determine the importance of modified nucleosides in stress responses, we assessed sensitivity
of tRNA modifying enzyme-deficient mutants of S. cerevisiae to the four toxic agents. Each
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mutant had a knock-out of one of the following genes: trml, trm2, trm3, trm4, trm5, trm7,
trm8, trm9, trml, trmll, trm12, trm13, trm44, trm82, tad1, mod5, and tan1. As trm5 is an
essential gene, we used a diploid strain of yeast (S. cerevisiae GBY1) with deletion of one of the
copies of trm5. Besides that, all mutants were originated from the haploid strain S. cerevisiae
BY4741. As shown in figure 3-4, cells were increased in sensitivity to H20 2 in the absence of
trm4 or trm7; also, the genes trml, trm4, trm7, trm9, and trm44 conferred resistance to MMS;
trml, trm4, and trm9 conferred resistance to NaAsO 2; at last, trm4A mutant was sensitivity to
NaOCI.
Changes in spectrum of modified nucleosides in tRNA as a function of deficiency in tRNA
modifying enzymes. Spectra of tRNA modifications from those tRNA modifying enzyme-
deficient mutants of S. cerevisiae were compared to that of wild-type cells. The results shown
in Table 3-3 illustrated that knockout of each tRNA modifying enzyme led to the loss of its
corresponding modification(s): trmlA mutant lost m22G; trm2A lost m5U; trmlOA lost m'G;
tadlA lost m l; trm4A lost m5C; trm8A and trm82A lost m G; mod5A lost i A; tanlA lost ac4C;
trm5A and trml2A lost yW; trmllA lost m2G; and trm9A lost mcm 5 U and mcm 5s2U. However,
as the formations of some modifications are catalyzed by several enzymes, loss of one of these
enzymes did not lead to complete depletion of the modified nucleoside. For instance, both
TRM3 and TRM7 catalyze the formation of Gm; TRM7 and TRM12 catalyze the formation of Cm.
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Figure 3-4. Phenotypic analysis of cytotoxicity induced by H202, MMS, NaOCI, and NaAsO 2 in S.
cerevisiae mutants lacking tRNA methyltransferase and other modification genes. The mutants
were exposed to 12 mM H202, 24 mM MMS, 60 mM NaAsO2, or 4.8 mM NaOCI, which
generated ~80% cytotoxicity. Data represent mean ± SD for three biological replicates.
Asterisks denote values statistically different from unexposed controls by Student's t-test,
p<0.05. Associated RNA modifications are listed below each enzyme.
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Table 3-3. Fold-changes of levels of tRNA modifications in mutant strains relative to in wild
type S. cerevisiae. Underlined: Mutant was determined to be significantly different from wild
type by Student's t-test with P<0.05; Yellow: ratios <0.02 (values of 0.00001 indicate
undetectable ribonucleosides in the mutant strains); Green: ratios <0.6; Red: ratios >1.5.
Discussion
Yeast exposure parameters. To quantify the dynamics of tRNA modifications in cellular
responses, we selected four well studied chemicals that possess distinct mechanisms of toxicity:
MMS, hydrogen peroxide (H20 2), sodium arsenite (NaAsO 2), and sodium hypochlorite (NaOCI,
pKa 7.5 (27)). The behavior of yeast upon exposure to MMS, NaAsO 2 and H20 2 has been
extensively studied in terms of transcriptional response and cytotoxicity phenotyping (11, 12,
28). We also chose NaOCI since it produces an oxidative stress distinct from that of H20 2 and
could thus affect the tRNA modification spectrum differently. We then performed cytotoxicity
dose-response studies in S. cerevisiae exposed to agents (Figure 3-1), choosing concentrations
that produced ~20%, 50% and 80% cytotoxicity to ensure a common phenotypic endpoint for
comparison.
One important issue with the methylating agent, MMS, was the possibility that changes in
methyl-based modifications in tRNA could be due to both enzymatic methylation and direct
chemical methylation. Literature precedent indicates that MMS reacts with DNA to form
adducts mainly at guanine N7 (68%), adenine N1 (18%) and cytosine N3 (10%) (29, 30). To
address the extent of direct methylation of RNA by MMS, control studies were performed and
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revealed that direct alkylation by MMS contributes <25% to the cellular burden of m7G in small
RNA, with the bulk of m7G arising by enzymatic methylation of tRNA (Figure 3-5). No other
agent affected tRNA modifications in this manner, with changes in the relative quantities of the
modifications resulting from alterations in biosynthesis, tRNA gene transcription or tRNA
degradation.
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Figure 3-5. Quantification of absolute level of m7G in different strains of yeast with or without
MMS-exposure. (A) External calibration curve for m7G. (B) Absolute quantities of m7G. Data
represent mean ± SD for three biological replicates.
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Reprogramming tRNA modifications during the stress response. With exposure and
analytical parameters established, we tested the hypothesis that the spectrum of tRNA
modifications would dynamically change as a function of the S. cerevisiae stress response. In
addition, we predicted that these changes would serve as biomarkers of each exposure. Cells
were exposed to three concentrations of each chemical and 23 tRNA modifications were
quantified by LC-MS/MS, with the results shown in Tables 3-1 and 3-2, the latter as the ratio of
treated to control signal intensities. A crude analysis of the data shows fold-changes ranging
from 0.2 to 4, with 25% and 36% of the exposure data significantly different from control values
by Student's t-test at p<0.05 and p<0.1, respectively (Table 3-2). These results point to the non-
random and regulated nature of the exposure-induced changes in the levels of the tRNA
modifications.
Multivariate statistical analyses revealed important patterns or signatures in the toxicant-
induced changes in tRNA modifications. As shown in Figure 3-2, hierarchical clustering
distinguished both agent- and dose-specific changes in the modification spectra, with unique
patterns of increase and decrease apparent in all cases. H202 consistently increased the levels
of m5C, Cm and m22G and, at the highest concentration, t6A, with dose-dependent decreases in
m U, m IG, m 2G, mcm s 2U, i A, yW and m'A. MMS consistently increased the level of m7G, and
decreased Am, m C, Cm, mcm5 s 2U, i6A, and yW. NaAsO 2 caused only decreases in modification
levels at the highest concentration, most notably for mcmsU, m3 C, m G, mcm s 2U, i A, yW, m C,
and Cm. Interestingly, the dose-response for NaOCI showed an inverse correlation between
concentration and increased levels of Am and Um and decreased levels of m5C. Given the
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reproducibility of the data, the changes in tRNA modification spectra can be considered
signature biomarkers of exposure for these four classes of chemical stressor.
Principal component analysis (PCA) creates a model that reduces the complexity of a data
set by identifying hidden correlations (the principal components) comprised of weighted, linear
combinations of the original variables, with the first principal component (P1) accounting for
the largest portion of the variation of the data and so on. The results of PCA of the dataset of
nucleoside fold-change values (Table 3-2) are shown in Figure 3-3. With 88% of the variability
expressed in the first 3 principal components (56%, 22% and 10%, respectively), individual
agents contributed variance to each as shown in Table 3-4, with H202 contributing 74% in P1,
MMS and NaOCI each contributing >40% in P2 and NaAsO2 contributing 53% in P3. The scores
plots (Figure 3-3) clearly distinguish the four agents, with H202-induced changes as the major
determinant of P1 and with MMS, NaOCI and NaAsO2 distinguished best in P2. While H202 and
NaOCI are negatively correlated in P1, they are more closely grouped in P2 and P3, which
suggests that the changes in tRNA modifications reflect both common and unique facets of the
toxic mechanism of each agent. For example, H202 and NaOCI are both oxidizing agents, but
H202 generates hydroxyl radicals by Fenton chemistry while the protonated form of NaOCI
yields hydroxyl radicals, chloramines and singlet oxygen (24, 31-33). Similarly, MMS and
NaAsO 2 are negatively correlated in P3 and more positively correlated in P2, with the latter
consistent with recent evidence for alkylation-like adduction of arsenic to DNA and proteins
following its metabolism (25, 34). This would also explain the negative correlation of NaAsO 2
and H202 in P1, while the recognized oxidative stress caused by arsenite is consistent with a
positive correlation between NaAsO 2 and H202 in P2 (35).
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PCI PC2 PC3
H20 2  74% 6.9% 0.45%
MMS 11% 42% 21%
NaAsO 2  6.2% 2.8% 53%
NaOCI 8.7% 49% 26%
Table 3-4. Contribution of each agent to variance in principal component analysis.
Both PCA (Figure 3-3) and cluster analysis (Figure 3-2) revealed that mC, m2 2G, Cm and
t6A are major features of the H202 response, while m'A, m3C and m7G were associated with
MMS. Increases in Gm, Um, I and Am were responsible for the variance induced by NaOCI,
which is consistent with the inversely related doses and levels for Am and Um observed in
cluster analysis. NaAsO2 was poorly distinguished in P2, with only m2G accounting for variance
only at the highest concentrations (Figure 3-2).
tRNA modification biosynthetic pathways are critical to the stress response. The
observation of toxicant- and dose-dependent changes in the levels of the 23 tRNA modifications
is consistent with a model in which cells respond to toxicant exposure by modifying tRNA
structure to enhance the synthesis of proteins critical to cell survival, as has been proposed in
previous studies with yeast exposure to MMS (11). In these studies, the conversion of cm5 U to
mcm5 U by Trm9 was found to be critical for surviving MMS exposure. To define the roles of
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specific tRNA modifications in the toxicant response, cytotoxicity phenotypic analyses were
performed with yeast mutants lacking each of 13 trm tRNA methyltransferase genes and 3
other types of RNA modification biosynthetic genes. As shown in Figure 4, heightened
sensitivity to H202 was observed in mutants lacking Trm4 and Trm7, which catalyze formation
of two modifications elevated by H20 2 exposure: m5C and Cm, respectively (36, 37). The simple
explanation is that the increase in a specific tRNA modification is needed to promote an
efficient stress response. However, m22G was also elevated by H20 2 (Figure 3-2), yet loss of an
enzyme involved in its biosynthesis, Trml, did not confer H20 2 sensitivity, as shown in Figure 3-
4 (38, 39). This behavior draws a comparison to mRNA, as it has been reported that many of
the transcripts induced in response to a stress are not essential for viability during a challenge
from that stress (40, 41). MMS sensitivity was identified in trml, trm4 and trm9 mutants,
whose corresponding proteins synthesize m2G, m5C and mcm 5U/mcm5s2 U, respectively.
However, these modifications were not strongly associated with MMS exposure in PCA (Figure
3-3). Somewhat surprisingly, loss of Trml, Trm4, Trm7 and Trm9 conferred NaAsO 2 sensitivity.
These methyltransferases are responsible for forming m2G, m5C, m1G and mcmSU/mcm 5s2U,
respectively, of which only m2G was found to vary significantly in PCA (Figure 3-3). For NaOCI,
only trm4 was sensitive to exposure and the m5C product of Trm4 was not associated with
NaOCI exposure (Figure 3-3). Again, this behavior parallels that of mRNA transcripts the levels
of which do not change after exposure but that encode proteins important for viability after
exposure (40, 41).
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Potential mechanisms linking tRNA modifications and the stress response. These results
reveal a complex and dynamic control of tRNA modifications in cellular survival responses and
suggest models for homeostasis of the modifications. One example involves modifications for
which the biosynthetic mutant is sensitive to exposure but the modification level does not
change in wild type cells following exposure (e.g., MMS exposure and trml/m2G, trm4/m 5 C,
trm9/mcm 5U or mcm5s2U). The simplest explanation here is that the modification change
occurs in a single tRNA species and the change is masked by an inverse change in the level of
the modification in the larger population of tRNA molecules; it is known that both m2G and
m5C occurs in mutiple tRNAs (2-4). A second explanation parallels the idea of both pre-existing
mRNA and stressor-induced transcription during a stress response. We have observed stress-
induced increases in the levels of several modifications required for the survival response.
However, other modifications may already exist on tRNA molecules involved in selective
translation of stress response messages. In both cases, the modifications are absolutely
required for survival, but some are already present in unstressed cells and others are induced.
Finally, it is possible that a modification, though its level may not change, is required for the
subsequent synthesis of other modifications that are critical to the survival response. Such
"cooperativity" is suggested by data from mod5-deficient cells, in which i6A decreases by ~75-
fold while D is reduced by ~2-fold. The presence of i6A may signal downstream biosynthetic
events, with deficiencies promoting a general reprogramming of tRNA. Similarly, cells deficient
in Trm82, a subunit of m7G methyltransferase, had a ~7-fold reduction in m7G and a >1.5-fold
increase in m3C, mcmsU, m G, m2 G, t A, mcms2 U and m22G (Table 3-3), which raises the
possibility that Trm82 itself or m7G inhibits other tRNA modifying enzymes. With the caveat of
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possible increases in tRNA copy number, the ~50% increase in these modifications suggests a
pool of unmodified tRNA molecules, an observation supported by increases in m3C after
exposure to MMS, mcm5U after exposure to NaOCI, and both t6A and m22G after exposure to
H202 (Figure 3-2).
Cooperativity could also explain the case in which the level of a modification changes
significantly following exposure yet the mutant strain is not sensitive to the exposure. For
example, loss of trml did not confer sensitivity to H202 but its product, m22G, rose significantly
with H20 2 exposure (Figure 3-2 and Figure 3-4). The stress-induced change in m22G may be a
response to a change occurring with another modification for which the mutant strain might be
sensitive to the exposure. In support of this argument, msC modifications increase along with
m 22G after H202 exposure and deficiencies in the msC-producing methyltransferase Trm4 confer
sensitivity to H202. Some other studies have also demonstrated such cooperativity among RNA
modifications in the observation of the negative regulation of wobble position C-to-U editing by
thiolation of a U at position 33 outside the anticodon in T. brucei (42).
Finally, there is the case in which a modification decreases with exposure to a stressor and
a deficiency in the enzyme responsible for that modification confers sensitivity, as in the case of
m5C, trm4 and NaOCI (Figure 3-2 and Figure 3-4). The population level of m5C may decrease
with NaOCI exposure in spite of a protective increase in the level of m5 C at some critical tRNA
location. This may reflect a decrease in the transcription of tRNA substrates of Trm4 or the
targeted degradation of specific tRNA species. It is important to note that biosynthetic
redundancy, as in the case of Gm with Trm3 and Trm7, could mask any major changes in tRNA
modification levels that are associated with mutational loss of one enzyme (Table 3-3), yet loss
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of one of the redundant enzymes can induce sensitivity, such as the case of H202 and trm7.
These observations lead to many questions that obviously require more mechanistic study to
define the precise role of tRNA modifications in cellular responses to stress.
One consistent feature that arose from our studies of modifications affected by or
protecting against toxicant exposure was the frequent involvement of the wobble position, 34
(Table 1-2 in Chapter 1 and Table 3-2). The correlation between the wobble modification and
the importance of a corresponding enzyme after toxicant exposure is not surprising in light of
recent observations of the critical role played by these modifications and anticodon loop
ribonucleosides in translational fidelity and efficiency (4). Controlled alteration of
ribonucleoside structure at position 34, and that at the conserved purine at position 37, is
proposed to allow reading of degenerate codons by modulating the structure of the anticodon
domain to facilitate correct codon binding. As the most frequently modified ribonucleosides,
positions 34 and 37 also have the largest variety of modifications, so it is reasonable that they
would be extensively involved in translational control of the survival response (43, 44). This is
also consistent with previous studies that mcm 5 U at the wobble position was critical to the
translation of a specific group of genes related to DNA damage response (11).
Perhaps more interesting is a potential role for putative non-anticodon loop
ribonucleoside modifications in the survival response. For example, Trm44 is the 2'-0-
methyltransferase in yeast responsible for formation of 2'-O-methyl-U (Um), which occurs only
at position 44 in yeast tRNA (45, 46). Loss of Trm44 conferred sensitivity to NaAsO 2 exposure.
This observation suggests three possibilities: (1) that Trm44 synthesizes or influences the
synthesis of modifications at other positions in tRNA; (2) that Um occurs in positions other than
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44 (e.g., anticodon loop); or (3) that Um(44) plays a role in modulating translation in response
to NaAsO2 exposure. Another example involves Trml and m22G at position 26. Current
evidence suggests that m2 2G occurs only at position 26 in yeast tRNA and that Trml is the
methyltransferase responsible for its formation (39, 45). The fact that loss of Trm1 conferred
sensitivity to MMS and NaAsO 2 exposure and that H202 exposure increased the level of m22G
again suggest the three possibilities analogous to those for Trm44 and Um. Similar arguments
can be made for Trm3 and Gm at position 18 with NaOCI exposure, for Trmll and m2 G at
position 10 with NaOCI and NaAsO2 exposure, and for Trm8/82 and m7G at position 46 with
MMS exposure.
All of these observations point to participation of wobble and non-wobble RNA
modifications in a complex and dynamic network of translational mechanisms in cellular
responses. This expands the repertoire of translational control mechanisms, which includes
recent discoveries about the effect of ribonucleoside modifications on tRNA stability (8, 9). In
this model, cell stress leads to rapid degradation of specific tRNAs and subsequent effects on
translational efficiency. Another similar stress response involves cleavage of cytoplasmic
transfer RNAs by ribonucleases released during the stress [10]. One consequence of these
degradation pathways would be to decrease the amount of modified ribonucleoside detected
in our assay, which may explain some of our observations with the toxicant stresses. Our
approach to quantifying tRNA modifications provides information only about population-level
changes, so the observed changes could result from modification of existing tRNA molecules or
changes in the number of tRNA copies. Of particular importance here is the observation by
Phizicky and coworkers that loss of m7G at position 46 leads to degradation of specific tRNAs [9],
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which suggests that our observation of changes in the levels of RNA modifications could be
amplified by both reduction in the activity of modifying enzymes and by tRNA degradation. On
the other hand, one argument against large increases in tRNA copy number arises from recent
observations of repressed tRNA transcription during S-phase and, of direct relevance to the
present studies, during replication stress induced by MMS, hydroxyurea and likely other
toxicants (47). Finally, our findings may also parallel recent work on tRNA charging. Reactive
oxygen species have been implicated as a methionine misacylation trigger and modification
status could help promote these programmed changes to the genetic code (12). As we are
beginning to appreciate the precision and coordinated nature by which cells mount a regulated
stress-response, it is most likely the observed changes in tRNA modification levels promote
multiple biological responses.
Novel biosynthetic pathways for tRNA modifications. As recognized by several groups,
the LC-MS/MS platform facilitates definition of biosynthetic pathways for RNA modifications
(19, 20). This is illustrated in Table 3-3, which contains ratios of the basal levels of tRNA
modifications in yeast mutants lacking various tRNA modification enzymes compared to wild
type yeast. These data corroborate known substrate/enzyme pairs and further demonstrate
the highly quantitative nature of our approach (45). For example, the level of m'l drops to
nearly undetectable levels with loss of Tad1, the adenosine deaminase producing the inosine
precursor to m'l (48). That a diploid heterozygous mutant of trm5, the product of which
catalyzes N-methylation of I [47], caused a ~40% reduction in total m'l attests to the accuracy
of our assay and demonstrate that gene dosage effects alter the level of tRNA modification (49).
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A similar ~50% reduction in yW occurred in the trm5 mutant due to the absence of the m'G37
precursor to yW, while complete loss of Trm12, which methylates the 4-demethylwyosine
precursor of yW, made yW undetectable. Other pathways critical to yW are apparent in the
smaller decreases in yW (0.3- to 0.5-fold) occurred in cells deficient in other enzymes (Trm8,
Trm82, Tad1, Mod5, Tan1, Trmll, Trm5).
The data in Table 3-3 also reveal several novel observations. It has been observed that
Trm7 catalyzes 2'-O-methylation of G and C nucleosides at positions 32 and 34, but they could
not detect the ncm 5Um product of 2'-0-methylation of ncm 5 U (37). While we could only
tentatively identify ncm5Um, we observed a quantifiable signal for a species with the correct
molecular transition for ncm 5Um and observed that loss of Trm7 led to a lowering of putative
ncmsUm to undetectable levels. This supports their prediction that Trm7 catalyzes formation of
ncmsUm in yeast.
Another example involves the formation of Um. While Trm44 catalyzes synthesis of Um at
position 44 in tRNA(ser) (46), analysis of trm mutants as shown in Table 3-3 suggests a
redundancy in methyltransferase activity capable of 2'-O-methylation of U(44), including Trm7,
which methylates U at positions 32 and 34 (37), and Trm13 methylation of C and A at position 4
in several yeast tRNAs. Cells lacking Trm44, Trm7 or Trm13 have 53%, 50% and 76% of wild
type levels of Um, respectively.
In summary, a quantitative bioanalytical approach to the study of tRNA modifications has
revealed several novel biosynthetic pathways for RNA modifications and has led to the
discovery of signature changes in the spectrum of tRNA modifications in the damage response
to different toxicant exposures. The results support a general model of dynamic control of
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tRNA modifications in cellular response pathways and add to the growing repertoire of
mechanisms controlling translational responses in cells (9, 10, 13, 50). Further, these cellular
response mechanisms almost certainly involve parallel changes in spectrum of ribonucleoside
modifications in rRNA and perhaps other RNA species.
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Chapter 4
Changes in composition of ribosome caused by trm4-deletion and by
exposure to hydrogen peroxide
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Abstract
As noted in Chapter 3, the relative level of 5-methylcytosine (m5 C) in the yeast S.
cerevisiae tRNA increases after the cells are exposed to hydrogen peroxide and loss of tRNA
m5C-methyltransferase Trm4 reduces the survivability of cells under this stress. While m5C is
found in many species of tRNA, only a leucine tRNA for coding the codon UUG comprises this
modification at the wobble position which may affect the translation efficiency of UUG.
Intriguingly, S. cerevisiae contains many duplicated ribosomal genes with significant difference
in usage of UUG. Through quantitative studies of homologous ribosomal proteins with liquid
chromatogarpahy-coupled time-of-flight mass spectrometiry (LC-QTOF), we demonstrate that
in relative to its homologue, the protein expression of a UUG-enriched gene rp/22a decreases in
the absence of Trm4 and increases in H202-exposed cells. Moreover, exposing H202 to trm4
mutant does not lead to changes in relative level of Rp122a. Also, only the gene rp/22a confers
resistance to H202 but not rp/22b. These results support a model of which Trm4 and m5C are
involved in regulating the expression of homologous ribosomal proteins by modulating the
translation efficiency of UUG.
Introduction
Modifications in tRNA are known to confer resistance to specific stresses but the
underlying mechanisms are not well-studied (1, 2). Recently, Begley and coworkers have
shown that a S. cerevisiae tRNA methyltransferase Trm9 confers resistance to DNA damage by
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promoting the translation of a specific set of genes (3). The enzyme Trm9 catalyzes the last
step of the formation of mcm 5U and mcm5s2U at the wobble position of tRNAArg(MCM5UCU) and
tRNAGlu(mcm 5S2 UUC) respectively (4, 5). These two modifications modulate the efficiency of
these two species of tRNA in translating their corresponding codon, AGA for tRNAArg(mcm5UCU)
and GAA for tRNAGlu(MCM5S2UUC) (6). Through this mechanism, Trm9-catalyzed modifications
on tRNA control the translation level of genes with high usage of AGA or GAA while many of
them are associated with DNA damage responses (3). The studies suggest that modifications at
wobble position of tRNA can affect the efficiency of translating specific codons and thus, they
can be used as mechanisms of translational regulation in response to stress.
In chapter 3, differential patterns of changes in the spectrum of tRNA modifications are
observed in the yeast S. cerevisiae exposed to four mechanistically distinct toxic agents,
hydrogen peroxide, methyl methanesulfonate, sodium hypochlorite, and sodium arsenite,
which suggests that responses to different stress involve different subsets of modifications.
After exposing to H202, the levels of several modifications, including 5-methylcytosine (m5 C),
increase and also, tRNA m5C-methyltransferse Trm4 protects cells against this toxic agent;
these observations strongly suggest that m5C is involved in stress response to H202. In addition,
this modification may be involved in a broad range of cellular responses as trm4A mutant is also
sensitive to heat-shock, killer toxins, and various chemicals (7-10).
The modification m5C is reported in at least 34 different species of tRNA and is located at
position 34, 40, 48, and 49 (11). However, only a leucine tRNA for translating UUG on mRNA
contains m5C at the wobble position. As m5C at wobble position has previously been
demonstrated to promote the efficiency of translation (12), we then hypothesized that Trm4
127
modulates the translation of UUG by regulating the level of m5C. To test this, we searched for
DNA transcripts enriched in this specific codon, UUG, and found that many of them are
encoding for ribosomal proteins while the others are mostly related to energy metabolism
(Table 1).
Yeast ribosomes comprise 78 proteins in which 59 of them have two duplicated genomic
copies. Even though the amino acid sequences of homologous ribosomal proteins are very
similar, UUG codon usage patterns of the two proteins can be significantly different (Table 4-2).
Homologous ribosomal genes were arose from a whole genome duplication; while most
duplicated genes were eliminated as they were redundant, some of them were retained by
evolving to new functions (13). Indeed, evidence supports that ribosomal homologues play
specific biological roles; for instances, the lack of specific ribosomal homologue leads to defects
in ribosomal assembly (14), sporulation (15), actin organization (16), and bud-site selection (17).
Komili and coworkers have provided insights in mechanistic roles of ribosomal homologous
proteins by demonstrating that a specific subset of ribosomal homologues is necessary for the
translation of localized ASH1 mRNA during bud tip formation (18). These observations led us to
hypothesize that Trm4 regulates the protein composition of ribosome for adapting changes in
cellular conditions.
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Systematic Freq. of Protein Functions
Name #UUG UUG
YLR029C 13 1 Protein component of the large (60S) ribosomal subunit
YJL189W 2 1 Protein component of the large (60S) ribosomal subunit
YLR110C 9 1 Cell wall mannoprotein
2P 1fso
YPR143W 3 1 Protein component of the large (60S) ribosomal subunit
YLR185W 2__ 1 Protein component of the large (605) ribosomal subunit
YOLO40C 9 1 Protein component of the small (40S) ribosomal subunit
YHR072W-A 5 1 Constituent of small nucleolar ribonucleoprotein particles
YFL014W 3 1 Plasma membrane localized protein
YJR009C 20 0.95 Glyceraldehyde-3-phosphate dehydrogenase, isozyme 2
YHL033C 19 0.95 Ribosomal protein L4 of the large (60S) ribosomal subunit
ck TMTtQ ( AM
YPLO90C 19 0.95 Protein component of the small (40S) ribosomal subunit
YBR031W 26 0.93 Protein component of the large (60S) ribosomal subunit
YDR064W 13 0.93 Protein component of the small (40S) ribosomal subunit
YHR174W 35 0.92 Enolase 11
YALO38W 32 0.91 Pyruvate kinase
YLRO44C 49 0.91 Major of three pyruvate decarboxylase isozymes
YLLO45C 19 0.90 Ribosomal protein L4 of the large (60S) ribosomal subunit
Y c o ftl (o
YKL189W 9 0.90 Protein component of the large (60S) ribosomal subunit
YBR189W 18 0.90 Protein component of the small (405) ribosomnal subunit
YGLI47C * T 7" "
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Table 4-1. List of S. cerevisiae genes with transcripts with highest usage frequency of UUG.
This table includes the systematic name, the number of UUG, the UUG usage frequency, and a
description of the function of gene product. UUG usage frequency is the number of UUG codon
in a transript divided by the total number of leucine that its protein is comprised of. Only genes
with UUG usage frequency above 0.9 are listed.
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Gene TTG Different Difference Gene TTG Different Difference
Name #TTG frequency In #TTG in TG Name #TTG frequency In #TTG u TRPL1A 22.8 frequency . frequency Name 5.
RPL1A 22 0.88 RPL23A 5 0.56
RPL1 B 22 0.88 RPL23B 4 0.44 ____
RPL2A 13 0.81 3 0.19 RPL24A 6 0.86 0 0.00
RPL2B 10 0.63 RPL24B 6 0.86
RPL3 18 0.86 -- -- RPL25 9 0.82 -- --
RPL4A 26 0.93 RPL26A 9 0.640 0.00 0 0.00
RPL4B 26 0.93 RPL26B 9 0.64
RPL5 17 0.74 -- -- RPL27A 5 0.71 0 0.12
RPL6A 13 0.68 2 0.07 RPL27B 5 0.83
RPL6B 15 0.75 RPL28 9 1.00 -- --
RPL7A 17 0.85 0 0.00 RPL29 2 0.67 -- --
RPL7B 17 0.85 RPL30 11 0.85 -- --
RPL8A 19 0.95 0 0.05 RPL31A 6 0.55 0 0.00
RPL8B 19 0.90 RPL31B 6 0.55
RPL9A 9 0.90 RPL32 7 0.78 -- --
RPL9B 8 0.89 RPL33A 5 0.83 1 0.17
RPL1O 16 0.94 -- -- RPL33B 4 0.67
RPL11A 8 0.73 1 0.09 RPL34A 4 0.80 0 0.00
RPL11B 7 0.64 RPL34B 4 0.80
RPL12A 6 0.55 4 0.36 RPL35A 11 0.85 1 0.08
RPL12B 10 0.91 RPL35B 10 0.77
RPL13A 5 0.45 4 0.36 RPL36A 4 0.67 2 0.33
RPL13B 9 0.82 RPL36B 6 1.00
RPL14A 7 0.64 RPL37A 2 1.00
RPL14B 7 0.64 RPL37B 2 1.00 0_0.00
RPL15A 13 1.00 RPL38 8 0.89 -- --
RPL15B 8 0.62 5 0.38 RPL39 2 1.00 -- --
RPL16A 9 0.50 RPL40A 12 0.86
RP1B 1 .2 5 0.32 2 0.14RPL16B 14 0.82 RPL41B 10 0.71 0_0.00
RPL17A 9 0.90 RPL41A 0 0.00
RPL1 7B 9 0.90 0 .0 RPL41 B 0 0.00 0___ 0.00___
RPL18A 11 0.73 RPL42A 7 1.00
RPL18B 10 0.67 RPL42B 6 0.86
RPL19A 9 0.56 1 0.06 RPL43A 3 1.00 2 0.67
RPL19B 10 0.63 RPL43B 1 0.33
RPL20A 8 0.89 RPPO 21 0.84 -- --2 0.29
RPL20B 6 0.60 RPP1A 9 0.82 5 0.32
RPL21A 4 0.50 2 0.36 RPP1B 4 0.50
RPL21B 6 0.86 RPP2A 5 0.50
RPL22A 7 1.00 4 0.63 RPP2B 5 0.56 0 0.06
RPL22B 3 0.38 1 1 1 1 _ _ _ _
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Gene TTG Different Difference Gene TTG Different Difference
Name #TTG frequency in #TTG in TTG ame #TTG frequency in #TTG In TTG
frequency frequency
RPSOA 9 0.47 RPS17A 13 0.87
RPSOB 14 0.70 5 0.23 RPS17B 13 0.87 0 0.00
RPS1A 16 0.73 RPS18A 11 0.73
RPS1B 19 0.83 3 0.10 RPS18B 10 0.67 1 0.07
RPS2 19 0.90 -- -- RPS19A 6 0.75
RPS3 12 0.63 -- -- RPS19B 7 0.88 1 
0.13
RPS4A 16 0.64 RPS20 5 0.83 -- -
RPS4B.2 0.08 RPS21A 4 0.57
RPS5 13 0.93 -- -- RPS21B 5 0.71 1 _0.14
RPS6A 19 0.95 RPS22A 8 0.80
RPS6B 19 0.95 RPS22B 6 0.55 2 0.25
RPS7A 18 0.86 RPS23A 10 0.77
RPS7B 14 0.67 RPS23B 10 0.77 0 0.00
RPS8A 5 0.50 RPS24A 3 0.18
RPS8B 5 0.50 0 0.00 RPS24B 6 0.67 3 0.49
RPS9A 12 0.60 RPS25A 4 0.446 0.30 2 0.22
RPS9B 18 0.90 RPS25B 6 0.67
RPS10A 7 0.78 RPS26A 2 0.50
RPS1OB 9 1.00 RPS26B 4 1.00
RPS1 1A 3 0.60 RPS27A 3 0.33
RPS1 1 B 3 0.60 0 0.00 RPS27B 5 0.56 2 0.22
RPS12 11 0.73 -- -- RPS28A 3 0.50
RPS13 13 0.93 -- -- RPS28B 4 0.67 1 
0.17
RPS14A 4 0.67 0 0.10 RPS29A 1 0.50 0 0.00RPS14B 4 0.57 RPS29B 1 0.50
RPS15 9 1.00 -- -- RPS30A 2 0.50
RPS16A 7 0.64 RPS30B 2 0.50 0 0.00
RPS16B 8 0.73 1 RPS31 11 0.79 - --
Table 4-2. Usage of TTG of S. cerevisiae ribosomal protein genes for proteins in (A) large
subunit and in (B) small subunit. The number of TTG used for coding leucine (#TTG) and the
proportion of leucine coded by TTG (TTG frequency) are included in this table. For the genes
having a homologue, the differences in #TTG and in TTG frequency are also listed.
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In the following studies, we sought to determine whether Trm4 is involved in regulating
the levels of homologous proteins in ribosomes. We showed that the translation level of
ribosomal protein Rpl22a decreases relative to its homologue Rpl22b in the trm4 knockout, the
rp/22a gene has a higher usage frequency of TTG. Also, rp/22a confers resistance to hydrogen
peroxide toxicity but rpl22b does not. Further, we showed that the relative level of Rpl22a
protein to Rpl22b protein increases after cellular exposure to hydrogen peroxide only when
Trm4 is present. These results are consistent with the hypothesis that Trm4 confers resistance
to stress by regulating the translation of homologous ribosomal proteins, which is a novel
pathway of stress response.
Materials and Methods
Materials. All chemicals and reagents were of the highest purity available and were used
without further purification. Hydrogen peroxide, trypsin, ammonium chloride, magnesium
chloride, potassium chloride, magnesium acetate, ammonium acetate, dithiothreitol, and
glucose were purchased from Sigma Chemical Co. (St. Louis, MO). Yeast extract and peptone
were purchased from Biomed Diagnostics, Inc. (White City, OR). Tris-acetate was purchased
from USB Corp. (Cleveland, OH). HEPES was purchased from EM Science (Darmstadt, Germany).
Micron YM10 filters were purchased from PALL Corp. (Port Washington, NY). HPLC-grade water
and acetonitrile were purchased from Mallinckrodt Baker (Phillipsburg, NJ). Biorad Protein
Assay was purchased from Biorad laboratories (Hercules, CA). All strains of S. cerevisiae BY4741
were purchased from American Type Culture Collections (Manassas, VA).
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Exposure of S. cerevisiae. Cultures of wild-type, rpl16aA, rpl16bA, rpI22ad, and rpI22bA
strains of S. cerevisiae BY4741 were grown to mid-log phase. A final concentration of 2 mM
hydrogen peroxide was then added into each culture and cells were harvested after 3 hours by
centrifugation at 8000x g for 15 minutes. The H202 sensitivity of these strains of yeast was also
assessed by exposing each mid-log phase culture to 5 mM of hydrogen peroxide; after 1 hr,
cells were plated on YPD agar plate to determine the viability.
Isolation of ribosome. Approximately 1010 cells were resuspended in 10 mL of the lysis
buffer with 50 mM Tris-acetate, 50 mM ammonium chloride, 12 mM magnesium chloride, and
1 mM dithiothreitol, pH 7.0. Cells were then lyzed mechanically by bead-beating. Lysate was
centrifuged at 10000x g for 10 minutes and the supernatant was collected to repeat the
centrifugation two more times to remove all particulates. The supernatant was layered over
2.5 mL of a solution with 1 M sucrose, 20 mM HEPES, 500 mM KCI, 2.5 mM magnesium acetate,
and 2 mM dithiothreitol, pH 7.4 and centrifuged for 110 minutes at 60000 rpm in a Beckman 70
Ti rotor. Supernatant was removed and the pellet of ribosomes was resuspended in 1.5 mL of a
digestion buffer with 100 mM ammonium acetate, pH 8.5. The samples were concentrated by
centrifuging on a YM10 filter and re-diluted with the digestion buffer for 5 times to remove the
remaining salts. Approximately 300 ig of ribosome was obtained based on the results of
Biorad Protein Assay.
Identification of ribosomal proteins. An amount of 1 pg of proteomics-grade trypsin was
added into 50 ptg of ribosome in 200 pL of the digestion buffer (100 mM ammonium acetate
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solution, pH 8.5). Samples were incubated at 37 0C for 12 hours before dried by lyophilization
and resuspended in 100 pL of a 0.1% formic acid solution. Roughly 2.5 pg (5 PL) of peptide
products from tryptic digestion were resolved with an Agilent ZORBAX 300SB-C18 column (100
x 0.3 mm, 3p particle size) eluted with the following gradient of acetonitrile in 0.1% formic acid
at a flow rate of 20 pL/min and 45 *C: 0-25 min, 1-30%; 25-30 min, 30-60%; 30-31 min, 60-95%;
31-36 min, 95%. The HPLC column was coupled to an Agilent 6510 QTOF LC/MS Mass
spectrometer with an electrospray ionization source. The mass spectrometer was operated in
positive ion mode to scan for ions within the range of m/z 100 to m/z 1700 at an acquisition
rate of 1.4 spectrum/second with the following parameters for voltages and source gas:
fragmentor voltage, 110 V; gas temperature: 300 *C; gas flow: 5 L/min; nebulizer: 20 psi; and
capillary voltage: 3500 V. Compounds detected by the mass spectrometer were identified using
the molecular feature extraction function in the Agilent MassHunter Workstation Software with
the following filter parameters: minimum peak height: 300 counts; and maximum charge state:
2. The lists of compounds were then analyzed with the Agilent Spectrum Mill mass
spectrometric data analysis software to identify proteins based upon peptide mass fingerprints.
A search was performed against the NCBlnr protein database for Sacchromyces cerevisiae with
no protein modifications and missed cleavage considered. The search parameters were set
with a mass tolerance of 20 ppm and protein coverage of at least 25%.
Identification of peptides. Samples of tryptic-digested peptides were resolved with the
same HPLC method as described in the above section. The HPLC column was coupled to the
same mass spectrometer that was operating in positive ion, targeted MS/MS mode with a
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constant collision energy of 15 V to monitor ions within the range of m/z 100 to m/z 3000; the
acquisition rates for MS scan and MS/MS scan were both 1.4 spectrum/second and all the
parameters for voltages and source gas are the same as in the LC/MS analysis for characterizing
ribosomal proteins. The peptides monitored in MS/MS analysis are described in Figure 4-5.
Transcription level assay. Total RNA was isolated from S. cerevisiae BY4741 using the
Qiagen RNeasy Mini kit. An amount of 100 ng of total RNA was used to perform real-time
quantitative PCR with Applied Biosystems Power SYBR Green RNA-to-CT kit and an Applied
Biosystems 7900HT Fast Real-Time PCR System to determine the relative transcription levels of
ribosomal protein genes rp/l6a, rp/l6b, rp/22a, and rp/22b with act1 chosen as a housekeeping
gene for normalization. Primer sequences are listed in Table 4-3. The A£CT method was used
to compare the transcription levels in different samples (19).
Gene Forward (5' to 3') Reverse (5' to 3')
acti GAAAAGATCTGGCATCATACCTTC AAAACGGCTTGGATGGAAAC
rp/l6a AGGTCGTTTAGCTTCCGTTGTTGCT GCGGCCTTACCACGAGCAGT
rp/l6b GTTGGGTCGTTTGGCCTCCACTA GCCTTACCACGGGCGGTCTT
rp/22a AGATTGCCAAGACCTTTACCGTCGA CCATCTTCAGTGACAGTGACAGCGT
rp/22b AAACGGAGTCTTCGATCCGGCTT GTCAGCATCTTCAGGGGTGACTTGA
Table 4-3. Sequence of primers for RT-qPCR.
136
Results
Identification of ribosomal proteins. As the mass of ribosomal complex is significantly
larger than any other biological macromolecules, ultracentrifugation can isolate ribosomes
from cell lysate to high purity (20). Ribosomes were digested by trypsin to peptide fragments
before analyzed with a liquid chromatographic-mass spectrometric approach. Compounds
detected by high mass accuracy mass spectrometry were compared to theoretical tryptic
fragments from proteins in the yeast protein database. From this analysis, a total of 39
proteins were identified consistently in three biological replicates (Table 4-4). Either because
the two homologous proteins have identical amino acid sequence or the detected tryptic
peptides did not cover the regions with difference, we could not distinguish the proteins from 9
pairs of homologous genes. These proteins include Rpl9a/b, Rpllla/b, Rpl22a/b, Rpsla/b,
Rps4a/b, Rps9a/b, Rpsl7a/b, Rps25a/b, and Rps28a/b. Also, we were able to identify Rpl2b,
Rpll5a, Rpl18b, Rpll9b, Rpl20a, Rpl23a, Rpl27a, Rpl35a, Rpsl9b, Rps24a, and Rps26b but not
their homologues. Some ribosomal proteins with no homologues were also identified,
including Rpl32, Rps2, Rps3, and Rps13. For proteins that both homologues were identified,
there were Rpl6a and Rpl6b, Rpl7a and Rpl7b, Rpl16a and Rpll6b, Rpl22a and Rpl22b, Rpl33a
and Rpl33b, Rpl36a and RpI36b, and Rps7a and Rps7b. These 7 pairs of homologous ribosomal
proteins served as the basis for studying the changes in ratios of homologues.
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Protein Coverage (%) Mass Error Mean (Std. Dev.) (ppm)
Proteins Expt. 1 Expt. 2 Expt. 3 Expt. 1 Expt. 2 Expt. 3
RPL2B 46 38 40 -5.5 (5.8) -5.3 (6.4) -6.1 (6.3)
RPL6A 37 40 32 1.2 (6.1) -3.3 (6.6) -2.7 (7.3)
RPL6B 48 44 36 -5.9 (5.9) -3.1 (4.7) -2.1 (7.0)
RPL7A 40 35 40 1.1 (6.5) -1.8 (4.5) -2.5 (7.0)
RPL7B 40 35 40 0.8 (6.6) -2.0 (4.6) -2.8 (7.1)
RPL9A/B 50 41 41 -2.1 (8.2) -3.3 (8.3) -3.1 (10.7)
RPL11A/B 28 31 25 1.5 (3.2) -0.9 (4.4) -1.8 (2.6)
RPL15A 31 33 33 0.3 (2.3) 2.3 (6.5) -0.3 (8.6)
RPL16A 44 37 44 -2.6 (8.7) -2.5 (8.4) -2.1 (7.6)
RPL16B 45 42 39 -1.8 (8.5) -3.9 (8.3) -3.8 (8.6)
RPL18B 41 38 46 -1.3 (8.2) -2.5 (8.3) -2.4 (7.0)
RPL19B 29 32 63 -4.3 (6.3) -2.7 (9.3) -4.4 (7.3)
RPL20A 51 47 48 1.8 (7.3) 1.9 (7.3) -0.6 (5.1)
RPL21A/B 46 46 46 -3.7 (4.8) -3.2 (6.1) -2.4 (5.5)
RPL22A 35 68 54 1.7 (12.3) 0.2 (6.6) 3.3 (9.4)
RPL22B 49 50 50 0.2 (5.8) 1.1 (6.2) 1.8 (10.8)
RPL23A 55 48 55 -0.4 (6.6) -0.5 (9.4) -1.1 (8.0)
RPL27A 46 46 43 -0.4 (9.4) -2.6 (8.7) -4.4 (6.5)
RPL32 46 56 53 0.1 (4.2) 0.5 (6.2) -1.2 (1.2)
RPL33A 49 44 49 0.7 (8.8) -5.3 (10.2) -0.8 (8.5)
RPL33B 49 44 49 0.7 (8.8) -5.3 (10.2) -0.8 (8.5)
RPL35A 30 37 37 -0.3 (6.2) -4.8 (5.0) -4.2 (5.5)
RPL36A 52 52 39 -5.3 (5.7) -2.4 (8.3) -0.1 (1.9)
RPL36B 52 52 52 -4.8 (6.1) -2.0 (8.4) -4.8 (6.1)
RPS1A/B 45 36 36 1.4 (7.5) -4.0 (5.6) -0.9 (5.9)
RPS2 38 38 36 -0.4 (10) -4.7 (4.5) -1.6 (8.7)
RPS3 48 56 56 -2.7 (4.7) -3.5 (4.8) -4.0 (4.5)
RPS4A/B 59 57 63 -1.5 (8.3) -2.1 (8.2) -3.7 (9.3)
RPS7A 64 64 66 -0.5 (5.8) -1.5 (7.0) -2.5 (7.1)
RPS7B 68 64 66 -2.3 (6.6) -5.1 (6.6) -5.6 (6.6)
RPS9A/B 54 54 54 -0.5 (7.5) -1.4 (7.2) -1.8 (6.9)
RPS13 68 62 58 -2.1 (4.0) -2.8 (5.8) -3.5 (3.7)
RPS17A/B 62 52 52 -0.6 (10.3) -2.3 (7.4) -5.5 (8.6)
RPS19B 59 67 63 -4.2 (6.9) -3.8 (6.9) -4.4 (7.3)
RPS20 52 52 52 -0.6 (7.1) -3.5 (4.3) -2.0 (5.4)
RPS24A 36 36 36 0.4 (1.4) -0.8 (1.6) -1.2 (1.4)
RPS25A/B 52 52 52 -1.0 (5.0) -1.1 (6.4) -1.3 (7.3)
RPS26A 49 42 50 2.3 (5.9) -1.8 (7.3) -4.6 (5.1)
RPS28A/B 70 58 64 -2.3 (11.7) -3.6 (7.6) -3.4 (5.6)
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Table 4-4. List of ribosomal proteins identified from LC/MS analysis of tryptic peptides. Data
was obtained from three biological replicates. The table contains the percent of amino acid
residues covered by the detected peptides and the average mass difference between the MS
detections and theoretical values for all detected peptides of each protein.
Characterization of unique peptides from ribosomal proteins. Amino acid sequences of
homologous ribosomal proteins are nearly identical. Thus, most tryptic fragments from the two
ribosomal homologues are the same. Therefore, instead of monitoring all peptides from each
ribosomal protein, the quantification of each ribosomal protein was based on mass
spectrometric signal intensities from a unique peptide. These peptides are listed in Table 4-5.
Even though the mass values detected by mass spectrometer were highly accurate (error < 10
ppm), identity of peptides can still be mis-assigned as peptides with different amino acid
sequence and even different amino acid composition can have the same mass. For
confirmation, these unique peptides were subjected to targeted MS-MS analysis to determine
their amino acid sequence based upon the detection of b- and y- ions formed in collision-
induced dissociation (CID). CID mass spectra of the 14 unique peptides, each from one protein
of the 7 pairs of ribosomal homologues, are shown in Figure 4-1.
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VFreuecy UG Protein Sequence (location of the peptide) Thortc2 /zo
0.85 17 RLA TAEQVAAER (22 to 30) 1487.7433
17 RPL7B TAEQIAAER (22 to 30) 494.751
1.00 7 RPL22A LAFYQVTPEEDEEEDEE (105 to 121) 1036.4233
0.38 3 RPL22B LVFYQVTPEDADEEEDDE (105 to 121) 1071.9418
0.67 4 RPL36A VTSMTPARK (17 to 25) 466.2443
1.00 6 RPL36B VTQMTPARK (17 to 25) 486.7573
Table 4-5. The list of peptides selected for quantification.
frequency of each gene transcript, the number of UUG, the
is originated, the sequence of the peptides, the position of
the ion of these peptides.
This table contains the UUG usage
name of protein that each peptide
the peptide, and the m/z value of
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12 1271.627 - 1352.6B5
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15 1604.796 - 1637.817
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Figure 4-1. Collision-induced dissociation mass spectra of peptides. Each peptide is unique to
one of the 14 proteins in the 7 pairs of homologues: (A) Rpl6a; (B) Rpl6b; (C) Rpl7a; (D) Rpl7b;
(E) RpIl16a; (F) RpIl16b; (G) Rpl22a; (H) Rpl22b; (1) Rpl33a; (J) Rpl33b; (K) Rp136a; (L) Rp136b; (M)
Rps7a; and (N) Rps7b. The table in each figure lists the m/z values of expected b- and y-ions
and the m/z values of detected ions.
Changes in composition of ribosome at various cellular conditions. With the seven
pairs of ribosomal homologues identified, we first determined the relative level of each pair of
homologues in wild-type and trm4A strains of cells (Table 4-6 and 4-7); relative level was
defined as ratio of the level of homologue with high usage of UUG to that with low usage. As
shown in Table 4-5, the difference of UUG codon usage frequency between the two genes,
rp/22a and rp/22b is about 0.6, which is the largest within the 7 pairs of homologous proteins.
Absence of Trm4 caused a statistically significant decrease in the relative level of Rpl22a to
Rp122b; the relative level decreased 40% in trm4A mutant with p < 0.01 in student's t-test.
Similarly, as the pair of homologues with the second largest difference in UUG usage frequency
(the difference is about 0.3), relative level of Rpl6a to Rp116b also decreased in trm4A mutant
by 10% (p < 0.05). Relative levels of the other 5 pairs of homologues had no statistically
significant changes in trm4A mutant.
We then assessed changes in relative levels of these 7 pairs of homologues in response to
H202-exposure (Table 4-5 and 4-6). In wild-type cells, exposure of H202 led to a 30%-increase in
the relative level of Rpl22a and Rpl22b. However, in the absence of Trm4, the relative level
between these two homologous ribosomal proteins did not change in response to H202.
Changes in relative level of Rpl16a to Rp116b also followed the same trend but with a smaller
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amplitude. Relative levels of the other 5 pairs of homologues were not affected by H20 2 in
either wild-type or trm4A cells.
Table 4-6. Relative quantification of ribosomal homologues in S. cerevisiae under various
cellular conditions. Ribosomes were isolated from three biological replicates of untreated wild-
type cells, H202-exposed wild-type cells, untreated trm4A mutant cells, and H202-exposed
trm4A mutant cells and were digested to peptide fragments as described in Materials and
Method section. Numerical values unshaded: MS signals detected from the unique peptide of
each ribosomal homologue; numerical values shaded in grey: ratio of MS signals from the
homologue with high TTG usage to that from the homologue with low TTG usage.
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Untreated wild type H202-exposed wild type Untreated trm4A Hz0 2-exposed trm4A
Expt. 1 Expt. 2 Expt. 3 Expt. 1 Expt. 2 Expt. 3 Expt. 1 Expt. 2 Expt.3 Expt.3 Expt.2 1 t. 3 2
RPL6A (Low TTG) 37202 34838 32168 29167 35729 36437 34839 33189 45467 34448 37473 36774
RPL6B (High TTG) 37772 34787 35296 32688 37779 42100 35890 31606 45913 35444 35900 38462
RPL7A (High rTG) 52125 58358 63886 74369 82757 83302 62527 54725 68598 57060 44969 48997
RPL7B(Low TrG) 17710 19592 17632 23190 27501 25342 16287 12382 22589 12710 15531 14762
RPL16A (Low 1TG) 26441 25322 26059 30370 32684 32427 24239 21581 29295 23720 22763 25216
RPL16B (High 1TG) 47808 48619 45449 61319 65143 64909 40599 34275 49250 35821 37258 41661
RPL22A (High TTG) 82104 78812 79959 100923 113122 104331 68494 62884 91551 65753 72045 75433
RPL22B (Low TTG) 5135 4540 4855 5003 5433 4238 6567 5868 7976 6229 7390 6490
RPL36A (Low TrG) 19685 21034 20425 24329 25429 23785 22614 15387 23366 22005 18688 18690
RPL36B (High TTG) 66330 64554 59024 71843 80215 78331 56138 51568 68440 49292 52990 58109
RPL33A (High TTG) 98668 93021 100545 118034 139000 129200 92192 81121 113781 85621 91965 100247
RPL33B(Low TTG) 38656 36228 38861 41246 53358 46685 37164 31947 41556 32080 37467 36725
RPS7A (High TTG) 114436 112016 117772 134724 165935 149546 99232 96376 149868 118242 132693 131115
RPS7B(LowTTG) 33420 33119 32254 38212 46501 40892 30173 26912 45140 36514 38219 38574
Exp 1
I
H20rexpoed WT:untreated WT tn4 A mutant: WT H20rtreatad tm4A:untreated trm44
Ratio____________ Fold change t-Test Fold change t-Test Fold change t-Test
Ratio (RPL6A:RPL6B) 1.07 0.15 0.96 0.36 1.01 0.72
Ratio (RPL7A:RPL7B) 1.00 0.96 1.18 0.27 0.95 0.77
Ratio (RPL16B:RPL16A) 1.10 0.03 0.90 0.04 0.97 0.42
Ratio (RPL22A:RPL22B) 1.32 0.02 0.65 0.00 0.98 0.73
Ratio (RPL36B:RPL36A) 1.01 0.89 0.94 0.55 0.93 0.62
Ratio (RPL33A:RPL33B) 1.07 0.08 1.01 0.84 1.01 0.79
Ratio (RPL7A:RPL7B) 1.03 0.35 0.97 0.51 0.99 0.83
Table 4-7. Fold-change of relative levels of ribosomal proteins in various cellular conditions.
Results in this table were based on calculation on data in Table 4-6. These include changes in
H202-exposed wild-type cells relative to unexposed wild-type cells, changes in unexposed
trm4A mutant relative to in unexposed wild-type, and changes in H202-exposed trm4A mutant
relative to unexposed trm4A mutant. Statistically significant changes (p < 0.05) are highlighted
in red.
Sensitivity of mutants lacking ribosomal protein genes to hydrogen peroxide toxicity. As
described above, hydrogen peroxide treatment led to increases in the protein levels of RPL16B
and RPL22A relative to their homologues. To assess the importance of these changes in stress
responses, we assayed the H202 sensitivity of rpl16aA, rpl16bA, rpl22a, and rpl22bA mutants.
As shown in Figure 4-2, rpI22aA mutant was more sensitive to H202 than the wild-type strain.
However, the loss of any other ribosomal proteins (Rp116a, Rpll6b, and Rpl22b) did not result
in changes in phenotype toward H202.
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Figure 4-2. Sensitivity of ribosomal protein-deleted mutants to hydrogen peroxide toxicity. The
cytotoxicity assay was performed as described in the Materials and Methods section. Survival
rate for each strain of cells was represented by the ratio of number of colonies formed from the
H202-exposed culture to that from the unexposed culture.
Transcription levels of ribosomal protein genes. To understand the underlying
mechanism of regulation of ribosomal homologous proteins expressions, we compare the
transcript levels of rp/l6a, rp/l6b, rpI22a, and rp/22b as a function of Trm4 availability and of
H202-exposure by using RT-qPCR. Results as shown in Table 4-8 illustrates that expressions of
mRNA for these four genes were statistically the same in all conditions.
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uniueLMeu w I
WT with H20 2
Untreated trm4A
Trm4A with H20 2
13.U3 2 U.o IL.W zU.Z u.u4Ut U.z U ±U./2 1 (U.6-1.7)
13.05 ±0.24 13.12±0.26 -0.08 ± 0.35 -0.11 ±0.35 1.1 (0.8-1.4)
12.63 ±0.28 13.27 ± 0.24 -0.64 ± 0.37 -0.68 ±0.37 1.6 (1.2-2.1)
12.58 ±0.55 13.09 ±0.14 -0.51 ±0.57 -0.55 ±0.57 1.5 (1.0-2.2)
B
Untreated WT 13.43 ±0.60 12.99 ± 0.23 0.44 ±0.64 0 ±0.64 1(0.6-1.6)
WT with H20 2  13.36 ± 0.20 13.12 ± 0.26 0.23 ±0.33 -0.21 ±0.33 1.2 (0.9-1.5)
Untreated trm4A 13.24 ±0.38 13.27 ± 0.24 -0.02 ±0.45 -0.46±0.45 1.4 (1.0-1.9)
Trm4A with H20 2  12.76 ± 0.17 13.09 ± 0.14 -0.33 ± 0.22 -0.77 ±0.14 17 (1.4-2.0)
C
A* T A * SD AC* SDD
CT* SD
Untreated WT 14.20 ±0.26 12.99 ±0.23 1.21 ±0.35 0 ±0.35 1(0.8-1.3)
WT with H20 2  14.57 ± 0.67 13.12 ±0.26 1.44 ±0.72 0.24 ±0.72 0.8 (0.5-1.4)
Untreated trm4A 14.18 ±0.11 13.27 ±0.24 0.92 ±0.27 -0.29 ± 0.27 1.2 (1-1.5)
Trm4A with H202 14.22±0.65 13.09 ±0.14 1.13 ±0.67 -0.09 ± 0.67 1.1 (0.7-1.7)
D
Averag A A""a ACr*SD ASDSO af
Cr*SD Cr*SD relft to ACn
Untreated WT 16.65 ± 0.32 12.99 ±0.23 3.66 ± 0.40 0 ±0.40 1(0.8-1.3)
WT with H20 2  16.83 ±0.16 13.12 ±0.26 3.70 ± 0.30 0.04 0.30 1(0.8-1.2)
Untreated trm4A 16.54 ±0.15 13.27 ± 0.24 3.28 ± 0.28 -0.39 ±0.28 1.3 (1.1-1.6)
Trm4A with H2O2 16.44 ± 0.22 13.09 ±0.14 3.35 ±0.26 -0.31 ±0.26 1.2 (1.0-1.5)
Table 4-8. Relative transcript levels of ribosomal protein genes in cells under various cellular
conditions. These genes include: (A) rp/l6a; (B) rpl16b; (C) rpI22a; and (D) rpI22b. Experiments
and analyses were performed as described in Materials and Methods section.
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Discussion
Characterization of ribosomal proteins. Our goal of characterizing ribosomal proteins is
to define a sample set for testing the hypothesis that tRNA mSC-methyltransferase Trm4
regulates the selection of homologous proteins for ribosome assembly based upon the
difference in UUG codon usage frequency between the two homologues. Thus, we aimed to
identify homologous pairs with a coverage of a wide range of difference in UUG codon usage
frequency. A proteomics approach was used to serve this purpose which involves isolation of
ribosomes from cell lysate by ultracentrifugation, cleavage of proteins to peptide fragments
with trypsin, resolution of peptides with HPLC, and monitoring of these peptides by mass
spectrometric techniques. By comparing the mass of peptides determined by mass
spectrometry with the peptide mass fingerprints of proteins in S. cerevisae database, we
identified 39 ribosomal proteins reproducibly in three biological replicates (Table 4-4). These
proteins include 7 pairs of ribosomal homologues, Rpl6a and Rpl6b, Rpl7a and Rpl7b, Rp116a
and Rpll6b, Rpl22a and Rpl22b, Rpl33a and Rpl33b, Rpl36a and Rp136b, and Rps7a and Rpl7b;
the difference in UUG codon usage frequency between the two homologues of these pairs
cover the range from 0 to 0.62 (Table 4-5). The transcripts of rp/22a and rp/22b, with a value of
0.62, have the largest difference in UUG codon usage frequency among all ribosomal
homologue pairs in S. cerevisiae. These 7 pairs cover the whole range of difference in UUG
codon usage frequency and thus, are adequate to serve as the testing targets for our studies.
As the sequences of the two homologues of each ribosomal protein pair are only different
by a few amino acids, most tryptic fragments from the two proteins are identical. Thus, instead
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of including all peptides from each protein for quantification, we only selected one specific
peptide (Table 4-3) which is unique in the whole S. cerevisiae protein database. To avoid
mistakes in assigning peptides, as peptides with different amino acid sequences or different
amino acid compositions can have the same mass, each peptide was analyzed with MS-MS
studies to determine its amino aicd sequece based on b- and y-ions formed in collision-induced
dissociation (Figure 4-1).
In S. cerevisiae, each ribosome is composed by 78 proteins with 59 of them preserve two
homologues in the genome, while the homologues of 22 of these proteins are identical (these
identical proteins include RPS4A/B, RPS6A/B, RPS8A/B, RPS11A/B, RPS16A/B, RPS17A/B,
RPS18A/B, RPS23A/B, RPS24A/B, RPS30A/B, RPL2A/B, RPL1A/B, RPL12A/B, RPL18A/B, RPL20A/B,
RPL19A/B, RPL23A/B, RPL35A/B, RPL42A/B, RPL43A/B, RPL40A/B, and RPL41A/B) (21). Thus, S.
cerevisiae ribosomes potentially comprise 115 sequence-specific proteins. While we only
identified 39 of them, the detection can be improved with at least two ways. First, the
sensitivity of detection can be improved by purifying each protein before MS analysis. Carroll
and coworkers studied ribosomal proteins in Arabidopsis by resolving each protein with SDS-
PAGE gels before enzymatic digestions and LC/MS analysis (22). With this approach, they were
able to identified 87 ribosomal proteins. Second, coverage of peptides identified can be
improved by including peptides with modifications in database search. In protein identification,
we only considered peptide with no post-translational modifications. Even though no post-
translation modifications are found on the 14 peptides that we have identified, it has been
shown that a number of modifications are present in ribosomal proteins, including
phosphorylation, lysine N-methylation, N-terminal acetylation, and N-terminal methylation (22,
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23). Including these modifications in database search and validating these modified peptides
with MS-MS analyses may increase the number of proteins identified.
As a conclusion on this method, it is sufficient for understanding the correlations between
expression level of proteins with different UUG codon usage and level of m5C on tRNA.
However, the method can be improved to include a larger number of proteins for quantification.
tRNA m5C-methyltransferase Trm4 regulates the relative level of Rpl22a and Rpl22b in
ribosome. The 7 pairs of ribosomal homologues identified in proteomics analysis were used to
investigate the relationship between UUG usages and protein expression levels as a function of
activities of tRNA m5C-methyltransferase Trm4. Strobel and Abelson found that an amber
suppressor tRNA, tRNA SUPs, comprises an m5C at the wobble position, in which the lack of this
modification reduces the efficiency of suppressor activity (12). This study has demonstrated
that m5C at wobble position of tRNA can affect translation of the corresponding codon. In S.
cerevisale, m5C is located at the wobble position of a leucine tRNA for coding the codon UUG in
mRNA. Thus, the translation of UUG may be regulated by the activity of tRNA m5C-
methyltransferase.
To test this hypothesis, we quantified the relative protein levels of the 7 pairs of
ribosomal homologues in wild-type and trm4-deleted strains of cells. These homologous pairs
are an ideal system for testing the hypothesis because amino acid sequences between the two
homologues in each pair are very similar but the UUG usage frequency varies from 0 to 0.62. As
shown in Table 4-6 and 4-7, the relative level of RPL22A/B and RPL16A/B are affected, in which
the absence of trm4 led to decreases in protein levels of the genes with high usage of UUG
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relative to that of their homologous gene with low usage of UUG in both cases. Differences in
the usage frequency of UUG and in the number of UUG between rp/22a and rp/22b are 0.62
and 4 respectively; the relative protein level of RPL22A decreased 1.5-fold in trm4A mutant (p <
0.01 from Student's t-test). Those between rp/l6a and rp/l6b are 0.32 (UUG usage frequency)
and 5 (number of UUG) and the relative level of RRPL16B decreased only 1.1-fold in the
absence of Trm4 (p < 0.05). For rp/36a and rpI36b, while the difference in UUG frequency is
0.33, the difference in number of UUG is only 2, the lack of Trm4 did not affect the relative
protein expression level of this homologous pair. These observations suggest that the activity
of Trm4 affect the protein expression levels based upon both the UUG codon usage frequency
and the number of UUG codon.
Changes in the relative protein. level between Rpl22a and Rpl22b in response to
hydrogen peroxide. As described in Chapter 3, level of m5C in S. cerevisiae tRNA increases after
exposing to hydrogen peroxide and Trm4 confers resistance to this toxic agent which indicates
that m C and Trm4 are important for stress responses. To investigate the cellular response
pathways that Trm4 is involved, we compared the relative levels of ribosomal homologous pairs
in H20 2-exposed and unexposed cells. For the proteins Rp122a and Rpl22b in wild-type cells,
relative level of homologue with high usage of UUG in H202-exposed cells increases 1.3 folds
compared to that in unexposed cells. However, exposure of H202 to trm4A mutant does not
cause any statistically significant changes in the relative expression level of this pair of
homologues. Similarly, the relative level of Rpl16a and Rpl16b increases 1.1 folds in wild-type
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cells exposed to H202 but that in trm4A mutant does not change after the same treatment.
These results suggest that Trm4 is involved in regulating the composition of ribosome.
Rpl22a and Rpl22b may perform different biological roles. The changes in ribosome
composition in response to hydrogen peroxide exposure led us to the question that whether
these changes contribute to improvement in survival rate under the stressful condition. We
assessed the sensitivity of S. cerevisiae mutants with rpl16aA, rpl16bA, rpl22aA, or rpI22bA to
hydrogen peroxide relative to wild-type strain of cells and determined that only Rpl22a confers
resistance to H202 within these four genes. Prior studies have suggested that ribosomal
homologue-specific defects are simply due to differences between expression levels of the two
homologues (24-28). Indeed, based on the CT values from RT-qPCR (Table 4-7) and MS signal
intensities (Table 4-6), expression of Rp122a was significantly higher than that of Rpl22b in both
transcription level and translation level. However, Komili and coworkers have illustrated that
translation of ASH1 requires a specific subset of ribosomal homologues, which suggests that
ribosome composed by different homologues are specialized for differential cellular functions
(18). Applying this model to our case, ribosome with Rpl22a may responsible for the translation
of genes that are important for responding to H20 2.
Correlations between H202-sensitivity of trm4A and rpI22aA strains. In chapter 3, we
have observed that H20 2 cytotoxicity increased in cells lacking Trm4. As described above, the
lack of Trm4 leads to a decrease in the relative level of ribosomal protein Rpl22a to Rpl22b, in
which Rpl22a also confers resistance to hydrogen peroxide. The ribosomal protein expression
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level pattern in trm4 knockout and the role of Rpl22a can then be correlated to the fact that
Trm4 also confers resistance to H20 2 toxicity. However, this may not be the only related
pathway that Trm4 is involved. As illustrated in Table 4-1, genes encoding many ribosomal
proteins and metabolic enzymes are also enriched in UUG which may also participate in critical
processes for stress responses.
tRNA modifying enzymes as components of translational regulation pathways. Our data
is consistent with a model in which Trm4 modulates the translation of UUG by catalyzing the
formation of m5C at wobble position of the tRNA for coding UUG and this leads to selection in
protein expression between UUG-enriched genes and UUG-depleted genes. In 66 species of S.
cerevisiae tRNA that were completely sequenced, 28 of them have modifications in the
anticodon region, including Y, Gm, Cm, I, m5C, ncm 5 U, ncm 5 Um, mcm 5U, and mcm's 2U (11), and
these modifications have high potential to be utilized in regulating translation of genes
enriched in different codons. Indeed, as described above, Trm9, which is responsible for the
formation of mcm 5 U, modulates the translation of a group of AGA-enriched genes (3).
Our studies have specifically demonstrated that the relative level of two ribosomal
homologues is modulated by Trm4 to improve survivability during H202 exposure. This level of
regulation may be extendable to other homologous protein pairs. Kellis and coworkers
proposed that whole genome duplication occurred in an ancestor of S. cerevisiae and about
90% of these redundant copies were lost during evolution while the last 10% of duplicated
genes retained because they have evolved to serve new functions (13). Interestingly, codon
usage patterns of some duplicated genes diverged significantly; one example is the two
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pyruvate kinase genes, cdc19 and pyk2, which pyk2 is expressed preferentially during
conditions of low glycolytic flux (29). In cdc19, 32 of 35 leucines are coded by UUG (frequency
= 0.91) while in pyk2, only 15 of 45 leucines are coded by UUG (frequency = 0.33). Thus, Trm4
may also involve in translational regulation of these two genes.
In conclusion, our studies support the hypothesis that Trm4 is involved in translational
regulation by selectively affecting translation of genes enriched in UUG. As a specific example,
we demonstrated that Trm4 promotes the relative level of Rpl22a comparing to it homologue
Rpl22b in response to H202-exposure, for which Rp122a confers resistance to H20 2. Similar
pathways may be applied generally to genes with high usage of UUG, which provide a new level
of regulation in gene expression.
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Chapter 5
Spectrum of tRNA modifications as a source of biomarkers
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Abstract
In previous studies, we observed unique patterns in the spectrum of tRNA modifications
from cells exposed to mechanistically distinct toxicants, which lead us to hypothesize that the
spectrum can serve as index of cellular conditions. To test this hypothesis, we characterized
changes in the spectrum from cells exposed to four oxidizing agents, hydrogen peroxide, tert-
butyl hydroperoxide, peroxynitrite, and gamma-radiation, and five alkylating agents, methyl
methanesulfonate, ethyl methanesulfonate, isopropyl methanesulfonate, N-methyl-N'-nitro-N-
nitrosoguanidine, and N-nitroso-N-methylurea. Multivariate statistical analysis on these data
indicates class-specific features for both oxidizing agents and alkylating agents, involving 14
modifications, Am, m 2G, mcm5U, mcm5s2U, m3C, m G, yW, Gm, m C, ncmsU, m22G, i6A, and Cm.
These features were used to develop a data-driven model that can accurately predict the class
of toxic agents. These results demonstrate that spectrum of tRNA modifications is a potential
source of biomarkers, which may be abe to provide a new level of information for development
of diagnostic and prognostic tools.
Introduction
Each organism is a complex biological system that comprises proteins, DNA, RNA, lipids,
and various types of metabolites. In such complex systems, the expressions of all components
are correlated and so, small deviations in physiological conditions may lead to significant
changes in different parts of the system and vice versa, changes in a specific set of biological,
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biochemical, or chemical features or characteristics can be used as index of health, disease, or
response to a therapeutic intervention. Indeed, with advances in DNA sequencing, microarray
technologies, mass spectrometry and many other quantitative techniques in recent years, many
biomarker signatures of exposures and diseases were determined. For instance, C-reactive
protein is identified as a biomarker of health risk and inflammation, as this protein increases
several orders of magnitude during states of systemic inflammation and is directly and
positively correlated with the risk of cardiovascular diseases (1-3). Another well-studied
biomarker is a DNA adduct, aflatoxin-B1-N7-guanine, which is used to indicate food poisoning
as it is found in urine from patients ingested the fungal toxin, aflatoxin (4, 5). In the systems
level, signature patterns for exposure to toxicants and for disease states were discovered in
profiles of transcripts, proteins, and metabolites (6, 7).
tRNA secondary modifications are also a part of complex biological systems. Using S.
cerevisiae for illustration, there are more than 50 genes encoding tRNA modifying enzymes, 280
genes encoding tRNA, and at least 25 tRNA modifications (8, 9). A combination of changes from
so many factors can potentially serve as highly specific biomarkers with a large dynamic range.
In chapter 3, we have shown that the spectrum of tRNA modifications changes specifically
when cells are exposed to 4 mechanistically distinct toxic agents, which implies that the
patterns of changes can reflect cellular conditions of the cells. Expanding along this line, in this
study we tested whether toxic agents with similar mechanisms of action can lead to common
features in the spectrum of tRNA modifications.
By using a liquid chromatography-triple quadrupole mass spectrometric method, we
characterized the changes in spectra from cells exposed to oxidizing agents and alkylating
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agents relative to spectrum of unexposed cells. Multivariate statistical analysis on the data
revealed that spectra from cells exposed to the same class of toxicants share common features
that are unique from the other class. Based upon these class-specific features, we developed a
data-driven model that can identify alkylating agent-exposed cells, oxidizing agent-exposed
cells, and unexposed cells with high accuracy.
Materials and Methods
Materials. All chemicals and reagents were of the highest purity available and were used
without further purification. Methyl methanesulfonate, ethyl methane sulfonate, N-nitroso-N-
methylurea, hydrogen peroxide, RNase A, alkaline phosphatase, and tert-butyl hydroperoxide
were purchased from Sigma Chemical Co. (St. Louis, MO). Isopropyl methanesulfonate was
purchased from Pfaltz & Bauer, Inc. (Waterbury, CT). N-methyl-N'-nitro-N-nitrosoguanidine
was purchased from TCI America (Portland, OR). Sodium peroxynitrite was purchased from
Cayman Chemical Co. (Ann Arbor, MI). Nuclease P1 was purchased from Roche Diagnostic Corp.
(Indianapolis, IN). Phosphodiesterase I was purchased from USB (Cleveland, OH). Yeast extract
and peptone were purchased from Biomed Diagnostics, Inc. (White City, OR). Micron YM10
filters were purchased from PALL Corp. (Port Washington, NY). HPLC-grade water and
acetonitrile were purchased from Mallinckrodt Baker (Phillipsburg, NJ). S. cerevisiae BY4741
cells were purchased from American Type Culture Collections (Manassas, VA).
167
Sensitivity assay of S. cerevisiae to toxic agents. S. cerevisiae BY4741 was cultured in YPD
(yeast extract-peptone-dextrose) media with 200 pg/mL of geneticine at 30 'C with shaking at
220 rpm. Each culture was grown to mid-log phase (OD660 ~ 0.6 to 0.8) followed by exposing
to one of the following chemical in one of the dosages: hydrogen peroxide (H20 2; 0, 2, 3.5, 5, 10,
15, and 20 mM); tert-butyl hydroperoxide (TBHP; 0, 0.7, 2, 4, 7, 14, 22, 25, and 29 mM); sodium
peroxynitrite (ONOO~; 0, 0.3, 0.5, 0.8, 1.0, 1.5, and 2.0 mM); y-radiation (0, 21.3, 168, 327, 513,
and 606 G); methyl methanesulfonate (MMS; 0, 1.2, 6, 12, 24, 36, and 48 mM), ethyl
methanesulfonate (EMS; 0, 0.19, 0.29, 0.39, 0.49, and 0.58 M); isopropyl methanesulfonate
(IMS; 0, 8, 17, 33, 50, and 66 mM); N-methyl-N'-nitro-N-nitrosoguanidine (MNNG; 0, 41, 61, 82,
102, and 136 mM); and N-nitro-N-methylurea (NMU; 0, 1.3, 2.3, 3.2, and 4.2 mM). After 1 hour,
these cultures were diluted 104 folds with YPD culture media and 50 PL of the diluted culture
was plated to YPD agar plates. Survival rates of exposed cells were determined by comparing
the number of colonies formed from untreated culture with that from each exposed culture
after two days.
Exposure of S. cerevisiae. Cultures of S. cerevisiae at mid-log phase (OD660 ~0.6) was
exposed to 5 mM H202, 25 mM TBHP, 0.8 mM ONOO~, 500 G y-radiation, 24 mM MMS, 190 mM
EMS, 50 mM IMS, 82 mM MNNG, or 3.2 mM NMU for 1 h, in which each of these exposures
produced approximately 80% cytotoxicity (Figure 1). Three unexposed cultures were also
prepared to serve as control. Approximately 2 x 107 cells from each culture were then pelleted
by centrifugation. The whole set of experiments was replicated five times.
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Isolation of tRNA from S. cerevisiae. Pellets of cells were resuspended in TRIZOL reagent
with the addition of antioxidants (0.1 mM desferrioxamine and 0.1 mM butylated
hydroxytoluene) and deaminase inhibitors (5 pg/mL coformycin and 50 ig/mL
tetrahydrouridine). Cells in this solution were lyzed by mechanical disruption. The solution was
mixed with chloroform and this mixture was centrifuged to separate the aqueous phase and
the organic phase. The aqueous phase, which contained all species of RNA, was collected and
tRNA in this solution was isolated by using PureLink miRNA Isolation Kit, following
manufacturer's instructions. Approximately 6 pg of tRNA was isolated from 2 x 107 cells based
on quantification with UV-vis spectrophotometer and bioanalyzer.
Enzymatic hydrolysis of S. cerevisiae tRNA. The procedure has already been described in
Chapter 2. An amount of 6 pg of tRNA was mixed with 50 pL of a solution at pH 6.8 that
contains 30 mM of sodium acetate, 2 mM of ZnC12, 0.02 Unit/pL of nuclease P1, 0.1 Units/pL of
RNase A, 5 pg/ml coformycin, 50 mg/ml tetrahydrouridine, 0.1 mM deferoxamine mesylate,
and 0.1 mM butylated hydroxytoluene. Also, 6 pmol of ['5N]5-labeled 2'-deoxyadenosine
([15 N]5-dA) was added to serve as internal standard. The solution was incubated at 37 *C for 3
hours before adding an additional 50 ptL of solution at pH 7.8 with 30 mM sodium acetate, 0.2
Units/pL of alkaline phosphatase, and 0.01 Units/lpL of phosphodiesterase 1. This mixture was
incubated at 37 0C overnight to ensure reactions were completed. Proteins were removed from
the nucleosides with a Microcon YM-10 filter.
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Method to quantify spectrum of S. cerevisiae tRNA modifications with LC/QQQ. An
amount of 0.4 ptg of ribnucleosides were resolved with a Thermo Scientific Hypersil GOLD aQ
reverse-phase column (150x2.1 mm, 3 pam particle size) eluted with the following gradient of
acetonitrile in 8 mM ammonium acetate at a flow rate of 0.3 mL/min and 360C: 0-18 min, 0%;
18-23 min, 0-1%; 23-28 min, 1-6%; 28-30 min, 6%; 30-40 min, 6-100%; 40-50 min, 100%. The
HPLC column was coupled to an Agilent 6410 Triple Quadrupole LC/MS mass spectrometer with
an electrospray ionization source where it was operated in positive ion mode with the following
parameters for voltages and source gas: gas temperature, 350*C; gas flow, 10 L/min; nebulizer,
20 psi; and capillary voltage, 3500 V. The first and third quadrupoles (Q1 and Q3) were fixed to
unit resolution and the modifications were quantified by pre-determined molecular transitions.
Q1 was set to transmit the parent ribonucleoside ions and Q3 was set to monitor the
deglycosylated product ions, except for Y for which the stable C-C glycosidic bond led to
fragmentation of the ribose ring; we used the m/z 125 ion for quantification. The dwell time for
each ribonucleoside was 200 ms. The retention time, m/z of the transmitted parent ion, m/z of
the monitored product ion, fragmentor voltage, and collision energy of each modified
nucleoside and i5 N-labeled internal standard are as follow: D, 2.2 min, m/z 2474115, 80 V, 5 V;
Y, 2.3 min, m/z 2454125, 80 V, 10 V; m5C, 5.4 min, m/z 2584126, 80 V, 8 V; Cm, 6.4 min, m/z
2584112, 80 V, 8 V; m5U, 7.9 min, m/z 2594127, 90 V, 7 V; ncm5 U, 8.7 min, m/z 302-4170, 90
V, 7 V; ac4 C, 19.7 min, m/z 2864154, 80 V, 6 V; m3C, 5.0 min, m/z 2584126, 80 V, 8 V; Um,
10.7 min, m/z 2594 113, 90 V, 7 V; m7G, 8.5 min, m/z 2984166, 90 V, 10 V; m'A, 6.9 min, m/z
282+150, 100 V, 16 V; mcm 5U, 15.5 min, m/z 3174185, 90 V, 7 V; m'l, 16.9 min, m/z 2834151,
80 V, 10 V; Gm, 18.2 min, m/z 2984152, 80 V, 7 V; m'G, 18.8 min, m/z 2984166, 90 V, 10 V;
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m2G, 22.2 min, m/z 298->166, 90 V, 10 V; I, 7.8 min, m/z 2694137, 80 V, 10 V; mcm5s2 U, 31.3
min, m/z 3334201, 90 V, 7 V; ['5N]s-dA, 31.0 min, m/z 2574141, 90 V, 10 V; m2G, 31.7 min,
m/z 3124180, 100 V, 8 V; t A, 32.8 min, m/z 413->281, 100 V, 8 V; Am, 33.1 min, m/z 282->136,
100 V, 15 V; yW, 37.1 min, m/z 509+377, 120 V, 10 V, and i6A, 37.9 min, m/z 3364204, 120 V,
17 V. The mass spectrometer monitored ions with the molecular transitions of D, Y, m3C and
m5C from 1 to 4.4 min; molecular transitions of mcmsU, ncm5U, m7G, m I, m'A, I, m5U, m3C,
msC, and Cm from 4.4 to 6.5 min; molecular transitions of mcm 5U, ncm5 U, m1G, Gm, ac4C, m' I,
m1A, I, m5U, Um m5C, and Cm from 6.5 to 9 min; molecular transitions of mcm 5U, ncm 5 U, m2G,
Gm, ac4C, m I, m1A, I, m5U, Um, and [15N1s-dA from 9 to 13 min; molecular transitions of t6A,
mcm s 2U, mcm U, m 2G, m 2G, Gm, ac 4C, m I, Am, m U, Um, and [15 N]s-dA from 13 to 24 min.
The signals from each modified nucleoside were normalized with the signals from [15 N]5-dA for
the purpose of comparison between samples.
Hierarchical clustering analysis. To eliminate batch-to-batch variations between the five
sets of replicates, the MS signal intensity of each ribonucleoside in each sample was divided by
the averaged MS signal intensity of the same nucleoside in three controls (unexposed cells) in
the same batch. This ratio is considered as the fold-change in the level of modification in
response to the exposure. These fold-change data were transformed to log 2 ratios before being
used to perform hierarchical clustering analysis with the centroid linkage algorithm in the
software Cluster 3.0, based on the distance between each dataset measured using the Pearson
correlation, with heat map representations produced using Java Treeview.
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Classification of toxic agents associated with tRNA modifications. All data from five
batches are combined together with exposure labels. There were three classes of exposures: CT
(unexposed), AA (alkylating agent-exposed) and OX (oxidizing agent-exposed). K-nearest
neighbor (KNN) classification method was used to establish the classification model; from each
class of exposures, changes of each ribonucleoside were compared to those in the other classes
by using multiple t-test with bonferroni correction and those with p values < 0.01 were assigned
as unique features of that exposure group. All these unique features were set as parameters to
construct a data-driven model by using the programming software R, in which all data were
randomly assigned into 2 groups; one group was used as a training set to build the model and
the other group was used as a testing set to evaluate the prediction accuracy of this model. For
this evaluation, the confusion matrix method was used to determine prediction sensitivity and
prediction specificity with one of these matrices shown in Table 5-1 for illustration. These
experiments were performed in collaboration with Dr. Fugen Li.
Predicted classes
AA CT OX Total
actual AA 8 0 0 8
classes CT 0 6 1 7
OX 2 0 7 9
Total 10 6 8 24
Table 5-1. Confusion matrix for evaluation of prediction accuracy. Our model is to predict the
classes of samples: alkylating agent-exposed (AA), unexposed (CT), and oxidizing agent-exposed
(OX). In this matrix, each column represents a predicted class and each row represents an
actual class. This exercise used 8 samples of AA, 7 samples of CT, and 9 samples of OX, as
shown on the last column and the number of samples predicted as each of the classes is shown
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on the last row. For AA, all 8 samples in this actual class were predicted correctly and thus the
prediction sensitivity was 100% (8 out of 8). However, two other samples actually from OX
were also classified into the AA predicted class and so, the prediction specificity was only 80%
(8 out of 10). Similarly, for CT, prediction sensitivity was 86% (6 out of 7) and prediction
specificity was 100% (6 out of 6), and for OX, prediction sensitivity was 78% (7 out of 9) and
prediction specificity was 86% (7 out of 8). The exercise was repeated 20 times with randomly
selected samples.
Results
Cytotoxicity dose-response studies of S. cerevisiae to various toxic agents. The dosage
of toxic agents may affect which cellular response pathways to be activated. We thus decided
to expose cells to nine toxic agents in which each with a dosage that causes a cytotoxicity of
80%. These nine toxic agents includes five alkylating agents: methyl methanesulfonate (MMS),
ethyl methanesulfonate (EMS), isopropyl methanesulfonate (IMS), N-methyl-N'-nitro-N-
nitrosoguanidine (MNNG), and N-nitro-N-methylurea (NMU), and four oxidizing agents:
hydrogen peroxide (H202), tert-butyl hydroperoxide (TBHP), gamma-radiation (y-radiation), and
sodium peroxynitrite (ONOO~). To determine the LD80 of these reagents, we assessed the
sensitivity of cells to a serial concentration of each of the reagents. As shown in Figure 5-1, the
survival rates of S. cerevisiae to different dosages of these nine reagents were determined and
based upon these results, we exposed cells to 5 mM H202, 25 mM TBHP, 0.8 mM ONOO~, 510 G
y-radiation, 24 mM MMS, 190 mM EMS, 50 mM IMS, 82 mM MNNG, and 3 mM NMU.
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Figure 5-1. Cytotoxicity dose-response studies with S. cerevisiae exposed to H202, TBHP, ONOO~,
y-radiation, MMS, EMS, IMS, MNNG, and NMU. Data represents mean ± SD for three biological
replicates.
Characterization of changes in the spectrum of tRNA modifications in response to
different toxic agents. With the exposure conditions determined, a liquid chromatography-
triple quadrupole mass spectrometric (LC/QQQ) method was used to relatively quantify the
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spectrum of 23 tRNA modifications from cells exposed to each of the toxic agent. Identification
of modified nucleosides and validation of this LC/QQQ method was described in Chapter 2. The
method was used to characterize nine samples from cells exposed to different toxic agents (5
mM H202, 25 mM TBHP, 0.8 mM ONOO, 510 G y-radiation, 24 mM MMS, 190 mM EMS, 50 mM
IMS, 82 mM MNNG, and 3 mM NMU) and three samples from unexposed cells (a total of 12
samples). From the three samples of unexposed cells, mass spectrometric signal intensities of
each modification were averaged and this average was used as the basal level to determine the
fold-change of modification levels in each of the 12 samples. This set of experiments was
replicated 5 times to increase statistical power for distinguishing differences between spectra
(Table 5-2) and the results reveal that in overall, about 40% of modified nucleosides changed
statistically significantly (p values are less than 0.05 in Student's t-test) in response to these
nine toxic agents. The mean values of data points from these 5 sets of data and the nucleosides
with significant changes are shown in Table 5-3.
176
Set 1
Nucleosides Ctril_1 Ctrl1_2 Ctrl1_3 EMS1 y-rad_1 H2 02.1 IMS_1 MMS_1 MNNG_1 NMU_1 ONOO_1 TBHP 1
D 1.023 1.003 0.973 1.298 1.098 1.048 1.103 0.996 1.030 1.071 1.073 1.092
Y 1.011 1.001 0.988 1.225 1.092 1.035 1.079 0.972 1.024 1.054 1.085 1.082
ncm'U 1.034 1.055 0.911 1.354 1.557 1.412 1.018 0.927 1.075 0.987 1.365 1.481
1 1.042 0.942 1.015 0.842 1.018 0.965 1.091 0.985 1.012 1.074 1.002 1.022
msU 1.054 0.959 0.988 1.158 1.043 1.007 1.078 0.989 1.029 1.028 1.040 1.032
Gm 0.964 1.000 1.036 0.803 1.031 1.009 1.556 1.136 1.285 1.120 1.026 1.055
Um 1.012 0.977 1.011 1.278 1.025 0.891 1.262 0.977 1.104 1.188 1.604 1.257
m'C 1.034 0.971 0.995 1.112 1.243 1.282 1.094 1.021 1.045 1.055 1.313 1.294
m3C 1.019 1.004 0.976 1.703 1.105 1.043 1.190 1.515 1.088 1.157 1.074 1.083
Cm 1.028 0.950 1.022 0.828 1.048 1.207 1.099 0.993 0.996 1.063 1.073 1.319
mcm5U 1.026 0.968 1.006 1.125 1.068 1.083 1.158 1.052 1.074 1.164 1.043 1.128
m1G 0.974 1.008 1.018 0.853 1.059 1.020 1.095 1.074 0.969 1.040 1.041 1.075
m2G 0.962 0.992 1.046 0.718 1.035 1.012 1.183 1.098 1.074 1.159 0.994 1.044
ac4C 1.022 0.991 0.988 1.312 1.085 1.024 1.061 0.956 0.973 0.969 1.113 1.086
t'A 0.970 1.016 1.014 0.929 1.044 1.171 1.164 1.056 1.075 1.138 1.000 1.064
mcm's 2U 1.008 1.005 0.987 1.053 1.045 1.043 1.054 1.031 1.051 1.043 1.014 1.094
mG 1.065 0.985 0.949 1.214 1.105 1.034 1.098 1.433 0.900 1.289 1.106 1.087
mil 0.958 1.003 1.039 0.670 1.065 0.791 0.988 0.902 0.838 0.882 1.027 1.075
Am 1.008 0.991 1.001 0.989 1.063 0.972 1.666 0.982 1.526 1.604 1.619 1.065
m22G 0.961 1.003 1.035 0.708 1.349 1.440 1.159 1.005 1.047 1.126 0.997 1.042
16A 1.044 0.991 0.966 1.429 1.125 1.059 1.122 1.012 1.010 1.053 1.130 1.145
yW 1.456 0.712 0.832 1.005 0.743 0.715 1.313 0.612 1.429 1.244 1.624 0.720
m1A 1.013 1.007 0.979 1.106 1.086 1.046 1.103 1.002 0.998 1.072 1.071 1.082
Set 2
Nudeosides Ctrl2_1 Ctrl2_2 Ctrl2_3 EMS_ y-rad_2 H202_2 IMS_2 MMS_2 MNNG_2 NMU_2 ONOO_2 TBHP_2
D 1.016 1.065 0.918 1.065 1.128 1.093 1.249 1.131 1.023 1.031 1.016 1.011
Y 1.098 1.006 0.895 0.941 1.074 1.082 1.133 1.083 0.953 0.953 1.063 0.987
ncm5U 0.982 0.897 1.121 0.765 1.071 1.274 0.990 0.949 0.836 1.057 1.250 1.112
1 1.111 0.972 0.917 0.994 1.034 1.002 1.186 1.052 0.899 0.947 1.006 0.932
m5U 1.089 0.997 0.914 1.049 1.129 1.072 1.241 1.097 0.995 1.041 1.052 1.099
Gm 0.945 1.063 0.992 1.184 1.037 1.062 1.768 1.149 1.250 1.029 0.922 0.981
Um 1.089 0.988 0.924 0.814 0.704 1.129 0.985 0.823 0.868 0.997 1.142 0.834
m5C 1.029 1.033 0.937 0.933 1.319 1.366 1.121 0.958 0.870 0.942 1.226 1.224
m3 C 0.993 1.052 0.954 1.608 1.028 1.056 1.375 1.763 1.141 1.194 0.962 1.015
Cm 1.052 1.028 0.920 0.915 1.015 1.218 1.182 1.027 0.850 0.894 0.910 1.227
mcmSU 0.969 1.051 0.979 1.207 1.113 1.043 0.986 1.103 0.973 1.320 0.985 0.960
miG 0.971 1.079 0.950 1.045 1.084 1.067 1.206 1.092 0.958 0.995 0.972 1.014
m2G 0.960 1.063 0.977 1.081 1.085 1.070 1.347 1.211 1.063 1.107 0.914 1.017
ac4C 1.013 1.050 0.936 1.000 1.068 1.040 1.160 1.059 0.929 0.988 0.984 0.979
t'A 0.996 1.036 0.968 1.132 1.040 1.910 1.296 1.215 1.001 1.129 0.955 1.031
mcm5s2U 0.986 1.079 0.935 1.102 1.005 1.448 1.701 1.259 0.946 1.053 1.175 1.166
m7G 1.004 1.050 0.946 1.487 1.073 1.076 1.285 1.802 0.999 1.461 0.979 1.021
mil 0.958 1.151 0.891 0.787 0.988 0.676 0.949 1.022 0.717 0.934 0.916 0.827
Am 0.934 1.076 0.990 1.056 1.045 1.036 1.526 1.157 1.618 1.611 1.530 0.980
m22G 0.960 1.052 0.988 1.114 1.581 1.757 1.294 1.157 1.044 1.085 0.948 1.035
16A 0.914 1.104 0.982 1.157 1.067 1.250 1.349 1.151 1.036 1.155 1.008 1.029
yW 1.037 0.988 0.975 0.802 1.026 1.170 0.738 0.378 0.627 0.674 1.214 0.929
m1A 0.984 1.084 0.931 1.084 1.096 1.092 1.318 1.163 1.010 1.070 0.986 1.022
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Set 3
Nucleosides Ctrl3_1 Ctrl3_2 Ctr3_3 EMS_3 y-rad_3 H202_3 IMS_3 MMS_3 MNNG_3 NMU_3 ONOO_3 TBHP_3
D 1.069 0.975 0.956 1.026 0.898 0.963 1.084 0.998 1.072 1.040 0.841 0.875
Y 1.084 0.943 0.974 1.044 0.892 0.930 1.069 0.976 1.134 1.012 0.888 0.880
ncm5U 0.982 1.112 0.905 1.165 1.086 0.951 1.095 1.014 1.118 1.138 0.817 1.035
1 1.062 0.940 0.998 0.989 0.877 0.971 0.996 0.925 1.034 0.941 0.885 0.802
m5U 0.989 1.015 0.996 1.007 0.935 0.976 1.154 1.058 1.125 0.999 0.994 0.994
Gm 0.965 1.043 0.991 1.268 0.991 0.994 1.681 0.950 1.307 1.039 0.955 0.960
Um 1.085 0.816 1.100 0.675 1.494 0.642 1.288 0.812 1.110 1.114 1.524 1.097
m5C 0.982 1.029 0.989 1.069 1.257 1.310 1.095 1.064 1.122 1.038 1.268 1.229
m3C 0.962 1.041 0.997 1.752 0.970 0.984 1.300 1.493 1.218 1.142 0.948 0.963
Cm 1.011 0.986 1.003 0.967 0.933 1.103 1.009 0.923 0.992 0.944 0.883 1.138
mcm5 U 0.798 1.164 1.038 1.529 1.211 1.348 1.408 1.284 1.480 1.241 1.188 1.247
m1G 1.000 1.028 0.972 0.988 0.957 0.952 1.033 0.962 1.045 0.972 0.874 0.908
m2G 1.001 1.011 0.988 1.179 0.992 0.991 1.176 1.064 1.209 1.141 0.961 0.974
ac4C 1.069 1.025 0.906 1.066 0.961 0.946 1.071 0.970 1.043 1.016 1.016 0.888
t'A 0.956 1.029 1.015 1.180 0.998 1.586 1.165 1.115 1.164 1.113 1.022 0.990
mcm5s2U 0.840 1.059 1.100 1.267 1.209 1.341 1.392 1.462 1.550 1.065 1.249 1.155
m'G 1.006 1.011 0.983 1.454 0.909 0.940 1.116 1.812 1.190 1.505 0.872 0.893
m11 1.103 0.972 0.925 0.885 0.861 0.813 0.764 0.679 0.852 0.777 0.879 0.669
Am 0.992 1.025 0.983 1.103 0.995 0.991 1.640 1.005 1.725 1.663 1.396 0.956
m2 2G 0.976 1.044 0.980 1.143 1.445 1.449 1.168 1.061 1.162 1.066 0.987 0.991
16A 0.957 1.061 0.981 1.258 1.339 1.181 1.291 1.091 1.092 1.042 1.172 1.117
yW 1.103 1.002 0.894 0.506 0.977 0.912 0.558 0.512 0.631 0.588 0.829 0.772
mIA 0.999 1.035 0.967 1.113 1.003 0.995 1.140 1.051 1.217 1.092 0.997 0.950
Set 4
Nucleosides Ctrl4_1 Ctrl4_2 Ctr43 EMS_4 y-rad4 H202-4 IMS_4 MMS-4 MNNG_4 NMU_4 ONOO_4 TBHP_4
D 0.976 1.011 1.013 1.092 1.038 1.176 1.230 1.104 1.074 1.095 1.056 1.165
Y 0.973 1.016 1.011 1.117 1.033 1.273 1.259 1.063 1.097 1.084 1.089 1.166
ncm5U 1.050 0.995 0.954 1.032 1.042 1.440 1.100 0.898 0.939 1.128 1.187 1.198
1 0.995 1.055 0.950 1.176 1.098 1.267 1.197 1.085 1.051 1.187 1.145 1.223
m5U 0.686 1.362 0.952 0.918 0.732 0.891 1.036 0.976 1.052 1.124 1.474 0.909
Gm 0.993 1.008 0.999 1.237 1.036 1.069 1.519 1.072 1.264 1.121 1.047 1.091
Um 0.960 1.032 1.007 1.190 1.106 0.958 1.290 1.052 1.265 1.275 1.572 1.412
m5C 0.984 0.998 1.017 1.101 1.169 1.614 1.172 1.031 1.074 1.206 1.360 1.391
m
3C 0.948 1.027 1.025 1.546 0.993 1.002 1.252 1.657 1.188 1.223 0.995 1.071
Cm 0.959 0.982 1.059 1.043 0.954 1.386 1.137 1.028 1.099 1.164 1.082 1.384
mcmsU 0.914 1.034 1.052 1.204 1.093 1.061 1.224 1.217 1.132 1.200 1.039 1.130
m G 0.979 1.006 1.015 1.029 1.085 1.127 1.059 1.006 1.023 1.062 1.058 1.158
m2G 0.990 1.012 0.998 1.080 1.048 1.141 1.167 1.046 1.086 1.138 1.063 1.114
ac4C 0.972 1.015 1.013 1.072 1.044 1.351 1.133 0.985 1.026 1.184 1.163 1.166
t'A 1.395 0.845 0.760 0.803 0.936 1.377 0.819 0.814 0.933 0.819 0.952 0.682
mcm s2U 0.954 1.027 1.020 1.014 0.959 0.822 1.023 0.999 1.085 1.208 0.878 0.825
m7G 0.896 1.027 1.077 1.454 0.888 1.084 1.189 1.720 1.141 1.635 0.987 1.082
m11 0.967 1.003 1.030 0.935 1.022 0.775 0.951 0.955 0.913 0.911 0.982 0.926
Am 1.095 0.979 0.926 0.977 1.017 0.941 1.380 0.992 1.640 1.550 1.612 0.926
m22G 1.143 0.957 0.900 0.977 1.364 1.516 1.019 0.924 1.012 1.009 1.117 0.925
16A 1.442 0.794 0.765 0.870 1.024 1.601 0.914 0.720 0.784 0.991 1.544 1.205
yW 1.056 1.038 0.906 0.764 1.103 1.268 0.622 0.644 0.604 0.599 1.158 1.088
m1A 0.968 1.022 1.009 1.119 1.040 1.053 1.174 1.116 1.078 1.156 1.011 1.090
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Set 5
Nucleosides Ctrl5_1 CtrlS_2 Ctrl5_3 EMS_5 y-rad_5 H202.5 IMS_5 MMSS MNNG 5 NMU_5 ONOOS TBHP_5
D 1.156 0.948 0.896 0.994 0.946 1.065 1.077 0.945 0.929 0.950 1.008 1.008
Y 1.171 0.939 0.890 1.005 0.993 1.160 1.071 0.938 0.938 0.938 1.084 1.090
ncm5U 0.992 0.995 1.013 1.018 1.056 1.377 1.109 0.947 1.050 1.138 1.178 1.089
1 1.248 0.885 0.868 0.977 0.979 1.200 1.078 0.897 1.028 1.049 1.159 1.094
m5U 1.016 0.976 1.008 1.487 0.968 1.148 1.144 1.044 1.044 1.095 0.975 1.056
Gm 1.102 0.953 0.945 1.108 0.960 0.969 1.415 0.968 1.153 0.987 0.952 0.962
UM 0.868 0.998 1.134 1.083 0.945 0.902 1.377 1.020 1.264 1.197 0.682 1.196
m5C 1.117 0.934 0.948 1.028 1.081 1.474 1.098 0.935 0.997 1.072 1.278 1.229
m3C 1.115 0.946 0.939 1.358 0.956 1.025 1.118 1.482 1.009 1.046 0.954 0.926
Cm 1.080 0.956 0.964 0.980 0.966 1.230 1.049 0.949 0.969 1.004 0.999 1.248
mcmsU 0.912 1.011 1.077 1.057 0.927 0.970 1.152 1.130 1.221 1.107 0.857 0.932
mIG 1.085 0.963 0.952 0.927 0.993 1.044 0.963 0.901 0.881 0.901 0.989 0.999
m2G 1.089 0.955 0.957 1.017 0.974 1.030 1.079 0.989 1.023 1.036 0.968 0.992
ac'C 1.092 0.955 0.953 0.912 0.941 0.895 0.985 0.937 0.926 0.922 0.920 0.941
t'A 1.101 0.944 0.955 0.811 0.982 0.827 0.814 0.823 0.789 0.777 0.944 0.879
mcm 5s2U 0.526 1.167 1.306 1.234 0.929 0.748 1.245 1.112 1.406 1.309 0.846 1.035
m'G 1.048 0.991 0.961 1.364 0.991 1.058 1.058 1.479 0.949 1.368 0.987 1.016
m11 1.102 0.944 0.954 0.835 0.947 0.696 0.851 0.820 0.806 0.799 0.921 0.803
Am 1.034 0.978 0.989 1.004 0.977 0.961 1.451 1.002 1.638 1.593 1.557 0.959
m2 2G 0.985 0.992 1.023 1.058 1.341 1.616 1.105 1.003 1.105 1.136 1.140 1.112
16A 0.946 1.001 1.053 1.097 1.109 1.695 1.183 0.965 1.112 1.244 1.581 1.207
yW 1.102 0.932 0.965 0.662 1.046 1.121 0.598 0.629 0.590 0.586 1.057 0.995
m1A 0.894 1.071 1.035 1.005 1.075 1.016 0.986 0.978 0.996 1.035 1.021 0.965
Table 5-2. Fold-change of levels of nucleosides in 5 biological replicates. In the 5 sets of data,
each set contains 12 samples, including 3 samples from unexposed cells and 9 samples from
cells which each one was exposed to a different toxic agent. Levels of each nucleoside from the
three replicates of unexposed cells were averaged; fold-change of the nucleoside in each
sample was relative to this mean value.
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Table 5-3. Mean values of fold-change data. In the 5 biological replicates of each exposure as
shown in Table 5-1, the fold-change of abundance of each modification was averaged and then
presented in this table. The changes that are statistically significant (p < 0.05) are highlighted.
Patterns of tRNA modifications spectrum in response to toxic agents are class-specific.
Relative quantification of modified nucleosides with statistical analysis has illustrated that the
spectrum alters in response to a group of alkylating agents and of oxidizing agents. These
results provide us the information to test the hypothesis that patterns of changes in tRNA
modification spectrum share common features in cells exposed to toxic agents with similar
mechanisms of action. Our first step was to use hierarchical clustering to analyze the data in
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Oxidizing agents Alkylating agents
Nucleosides TBHP y-rad H202 ON00 MMS MNNG NMU IMS EMS
D 1.030 1.021 1.069 0.999 1.035 1.026 1.037 1.149 1.095
Y 1.041 1.017 1.096 1.042 1.007 1.029 1.008 1.122 1.066
ncm'U 1.183 1.162 1.291 1.159 0.947 1.004 1.090 1.062 1.067
I 1.015 1.001 1.081 1.039 0.989 1.005 1.039 1.110 0.996
m5U 1.018 0.961 1.019 1.107 1.033 1.049 1.057 1.131 1.124
Gm 1.010 1.011 1.021 0.981 1.055 1.252 1.059 1.588 1.120
Urn 1.159 1.055 0.905 1.305 0.937 1.122 1.154 1.240 1.008
m5c 1.273 1.214 1.409 1.289 1.002 1.021 1.063 1.116 1.049
m' c 1.012 1.010 1.022 0.987 1.582 1.129 1.152 1.247 1.593
Cm 1.263 0.983 1.229 0.989 0.984 0.981 1.014 1.095 0.947
mcm'U 1.079 1.082 1.101 1.022 1.157 1.176 1.207 1.185 1.224
m G 1.031 1.036 1.042 0.987 1.007 0.975 0.994 1.071 0.969
m2G 1.028 1.027 1.049 0.980 1.081 1.091 1.116 1.191 1.015
acc 1.012 1.020 1.051 1.039 0.981 0.979 1.016 1.082 1.072
t'A 0.929 1.000 1.374 0.975 1.005 0.992 0.995 1.051 0.971
mcm's 2U 1.055 1.029 1.080 1.032 1.173 1.208 1.135 1.283 1.134
m'G 1.020 0.993 1.038 0.986 1.649 1.036 1.452 1.149 1.395
mil 0.860 0.977 0.750 0.945 0.876 0.825 0.860 0.901 0.822
Am 0.977 1.019 0.980 1.543 1.027 1.629 1.604 1.533 1.026
ma2G 1.021 1.416 1.556 1.038 1.030 1.074 1.084 1.149 1.000
16A 1.140 1.133 1.357 1.287 0.988 1.007 1.097 1.172 1.162
yW 0.901 0.979 1.037 1.176 0.555 0.776 0.738 0.766 0.748
m1A 1.022 1.060 1.040 1.017 1.062 1.060 1.085 1.144 1.085
. .... .. .......  .......
Table 5-3, which the spectrum from each exposure condition is the average of 5 biological
replicates. As shown in Figure 5-2, samples from alkylating agent-exposed cells clustered into
one group and those from oxidizing agent-exposed cells clustered into another group, which
implies that the patterns of changes in the spectra caused by the same class of toxic agents are
more similar than those caused by the other class.
Ribonucleosides responsible for defining the unique patterns can be indicated from the
heat map (Figure 5-2). The relative levels of yW and m'l decreased in all alkylating agent-
exposed cells but the changes in oxidizing agent-exposed cells were not significant. Also, all
alkylating agents caused an elevation in the levels of Um, m2G, mcm5 s2U, mcm 5U, and mIA,
while these modifications responded to oxidizing agents mildly. In contrast, the levels ncm5 U,
m5C, and i6A did not change in all alkylating agent-exposed cells but they increased significantly
in response to all oxidizing agents.
Subclass signatures were also observed among the alkylating agent group. Modifications
spectra from cells exposed to MMS and EMS were clustered to form one group while IMS,
MNNG, and NMU were clustered to form another group; the formation of subgroups suggests
that the responses to different reagents of the same class may be different. Indeed, the
relative levels of m3C and m7G increased in MMS- and EMS-exposed cells but their responses to
IMS, MNNG, and NMU were weaker. Another group of subclass signatures was the rise of Um
and Am levels in cells exposed to IMS, MNNG, and NMU while the levels of these modifications
in MMS- and EMS-exposed cells did not increase.
181
m5U
I
D
y
acCC
Gm
m 2G
mcmes 2U
mcm 5u
MIA
m3C
m7 G
Urn
Am
Cm
MIG
ncm5U
m5C
1GA
m2 2G
tGA
mil
yW
w2-zzq c~fb'p
D
182
Figure 5-2. Hierarchical clustering analysis of averaged tRNA modifications spectra from cells
exposed to different alkylating agents and oxidizing agents. The fold-change data was
originated from the average of five biological replicates as presented in Table 5-2 and
hierarchical clustering analysis was performed in log space (log base 2). Color code of the heat
map was shown on the left-top corner.
Hierarchical clustering analysis of the averaged tRNA modification spectra from the five
data sets indicates clearly the presence of class-specific patterns of changes in responses to
toxic agents. However, when hierarchical clustering analysis was carried out with the data from
raw spectra (the five data sets in Table 5-2), signatures for the two groups of toxic agents were
less clear (Figure 5-3). In Figure 5-3, most spectra from alkylating agent-exposed cells were
grouped together with exceptions of those spectra from EMS-, IMS-, NMU-, and MNNG-
exposed cells in data set 1. For the 15 spectra from unexposed cells (3 spectra from each data
set), 13 of them were clustered into one subgroup while the other two were mixed with spectra
from oxidizing agent-exposed cells. Spectra from cells treated with oxidizing agents were
divided into two groups. One group mainly comprised ONOO~- and TBHP-exposed samples, and
this group shared more common features with the unexposed samples than with the H20 2- and
y-rad-exposed samples in the other cluster group. Further, two spectra from y-rad-exposed
cells were clustered into the unexposed group.
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Figure 5-3. Hierarchical clustering analysis of individual tRNA modifications spectra from
unexposed, alkylating agent-exposed, and oxidizing agents-exposed cells. The fold-change data
for this analysis was presented in the 5 data sets in Table 5-1. Hierarchical clustering analysis
was performed in log space (log base 2) and color code for the heat map was shown on the left-
top corner. Clusters of samples that exposed to the same class of reagents are boxed with the
following color code; oxidizing agent-exposed: yellow; alkylating agent-exposed: blue; and
unexposed: grey.
Data-driven model to describe biomarker signatures for distinguishing alkylating agent-
exposed and oxidizing agent-exposed cells. Hierarchical clustering analysis of tRNA
modifications levels in cells exposed to alkylating agents and oxidizing agents demonstrates
that the patterns of changes in the spectrum are specific to these two classes of reagents
(Figure 5-2). These results led us to ask if these changes can be used to identify biological
statuses and what changes in the spectrum are important for classifying cells from different
exposure groups. To this end, we developed a data-driven model with the K-nearest neighbor
method (KNN) to describe differences in changes in tRNA modifications spectrum as responses
to the two classes of stimuli (alkylating agents and oxidizing agents). Following 20 training and
test cycles of supervised learning by using the programming software R, a stable model has
been established. The overall confusion matrix demonstrates prediction sensitivities for the
alkylating agent-exposed group (AA) is 95%, for oxidizing agent-exposed group (OX) is 94%, and
for unexposed group (CT) is 78%, and prediction specificities for AA is 95%, OX is 76%, and CT is
98% (Figure 5-4). Based upon this model, the modified ribonucleosides that contributed in
identifying exposures to alkylating agents include m3C, m7G, yW, mcm5 U, Am, Gm, m1A, m5C,
m 2G, mcm5s2 U, and m'l, and those for identifying oxidizing agent-exposures are mSC, m 3C, m G,
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Gm, ncmsU, m22G, i A, yW, and Cm. These features match with those in the hierarchical
clustering analysis (Figure 5-2). With high prediction sensitivity and specificity for akylating
agents, this class of chemicals is significantly different from the others. The prediction
specificity of OX is relatively low (76%) due to high variation of the controls, which causes
misclassification of controls into the oxidation agent group.
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Figure 5-4. Prediction (A) sensitivity and (B) specificity of the data-driven model. A total of 20
training and test cycles have been performed for the combined data to determine the average
prediction sensitivity and specificity. The data driven model is stable due to low standard error
with less than 2%.
186
Discussion
Experimental design for assessing changes in tRNA modifications spectrum. One of our
goals of this study is to compare the spectra of tRNA modifications from cells exposed to two
classes of toxicants, oxidizing agents and alkylating agents, in which we hypothesized that
exposures to reagents of the same class lead to common features of changes. We first isolated
tRNA from cell lysates and quantified tRNA in each samples. An isotope-labeled nucleoside was
added in proportion to the quantity of tRNA and the samples were hydrolyzed enzymatically to
nucleosides. In each sample, the spectrum of modified ribonucleosides was monitored with a
LC/MS method. The level of each modified nucleoside was normalized by MS signal intensity of
the isotopic standard. In each sample of cells, changes in tRNA modifications spectrum was
defined by the fold-change of nucleoside levels relative to that in the unexposed cells.
Hierarchical clustering analysis was then used to identify spectra with common features for
which we expected spectra from cells exposed to the same class of toxicants to cluster.
However, as shown in Figure 5-3, samples from cells with no exposures and with exposures to
oxidizing agents and alkylating agents did not distinctly characterized into three groups and
these observations suggest that the pattern of changes in each tRNA modifications spectrum
contains noises, which can be originated from measurement errors. For instance, spectra from
cells exposed to EMS, IMS, NMU, and MNNG in data set 1 were clustered into the oxidizing
agent-exposed group while all the other alkylating agent-exposed samples clustered to form
another group; these observations strongly suggests that systematic errors occurred in
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experiments for data set 1. Besides, fluctuations in levels of modifications can be caused by
deviations in environment, such as temperature, aeration, and nutrients supply.
To solve this problem, we reduced the noises in our data by replicating the experiments.
As all spectra were compared to the spectrum of unexposed cells, fluctuations in this spectrum
would affect the fold-change data of all samples. Thus, we triplicated the quantification of
tRNA modifications from unexposed cells and used the average for data analysis. Also, the
whole set of experiments was repeated with 5 biological replicates. Mean values of the 5 data
sets were analyze with hierarchical clustering to generate Figure 5-2, which have shown class-
specific signatures as responses to the two mechanistically different groups of toxic agents.
Correlations between subclass signatures and mechanisms of action among alkylating
agents. Results of hierarchical clustering analysis as shown in Figure 5-2 illustrate that patterns
of changes induced by the 5 alkylating agents were also classified into two subgroups, where
changes induced by MMS and EMS were more similar to each other and so as those by IMS,
MNNG, and NMU. For instances, the relative levels of m7G and m5C in MMS- and EMS-exposed
cells increased more significantly than in IMS-, MNNG-, and NMU-exposed cells. In contrast,
the levels of Am and Um did not change in response to MMS and EMS but they were elevated
when cells were treated with the other three alkylating agents. These results suggest that
depending on chemical properties of the alkylating agents, a unique set of cellular response
pathways was activated. It has been shown that alkylating agents can react with various
biological molecules, including proteins and DNA (10-12), in which DNA adducts caused by
these reagents were studied extensively (Table 5-4). As listed in Table 5-3, MMS and EMS can
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alkylate DNA via a SN2 mechanism while IMS, MNNG, and NMU only via SN1 - The difference in
reaction mechanisms affects the alkylation reactivity at different sites. For instance, in in vitro
reactions, less than 0.5% of DNA adducts are formed at 06 of guanine when DNA reacts with
MMS or EMS but 7.0% to 23.7% of adducts formed by IMS, MNNG or NMU are at this position
(Table 5-4). DNA adducts are generally repaired by either direct transfer of the modifying alkyl
group to a transferase, or removal of the modified base by a glycosylase, followed by excision
of the apurinic or apyrimidinic site (13). In cases that the structure of DNA helix was distorted,
nucleotide excision repair may be employed (14). Each transferase and glycosylase is
responsible for repairing a specific set of adducts. For 0 6-alkylguanines that mentioned above,
these adducts are exclusively repaired by O-alkylguanine-DNA alkyltransferase in both rat and
E. coli (13, 15-17) and a homologue of this enzyme was also found in S. cerevisiae. Thus, in
response to each alkylating agent, the translation machinery may be reprogrammed to favor
the expression of enzymes responsible for repairing the specific group of adducts, and these
changes may be reflected as subclass signatures in tRNA modifications spectrum for SN1 and
SN2 alkylating agents.
For the four oxidizing agents, we used one reactive nitrogen species (RNS), ONOO~, one
species of strong ionizing radiation, y-rad, and two reactive oxygen species (ROS), H202 and
TBHP. Potentially, reactive oxygen species and reactive nitrogen species can induce different
response pathways as they generate widely different species of adducts (18-20). Hierarchical
clustering analysis (Figure 5-2) indicates that spectrum of ONOO contains unique features from
spectra of other oxidizing agents. For instance, Am increased in ONOO-exposed cells but not in
other oxidizing agent samples. Experiments with more species of oxidants are necessary to
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define subclass signatures between ROS and RNS. Interestingly, among spectra of the other
three oxidizing agent, H202 is more similar to y-rad than to TBHP. Both H202 and y-rad generate
hydroxyl radical that leads to DNA strand breaks, and formations of abasic sites and a broad
spectrum of adducts. Thus, the cellular responses for both reagents may be very similar.
Sit of MMS EMS IMS MNNG NMU
Alkylation
Adenine
N1  3.8 1.7 -- 1.0 1.3
N3  11.3 4.9 0.4 12.0 9.0
N 7  1.8 1.9 -- -- 2.0
Cytosine
N3  <1.0 0.6 -- 2.0 0.6
Guanine
N3 0.6 0.9 -- -- 1.9
O 0.3 0.2 23.7 7.0 8.2
N7  83.0 65.0 47.4 67 70
Thymidine
02 nd nd 4.3 0.3 --
N 0.1 nd 0.4 0.3 --
04 nd nd 4.3 0.7 --
Mechanisms SN2 SN1/N2 SN1 SN1 SN1
Table 5-3. In vitro alkylation patterns of DNA by MMS, EMS, IMS, MNNG, and NMU. Adducts
formed at different sites are expressed as percent of total adducts. 'nd' indicates the adduct is
not detectable and '--' indicates information is not found. The proposed mechanism (SN1 or SN2)
for each alkylating agent is also listed at the last row of this table. Information was collected
from several studies (21-27).
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tRNA modifications spectrum as a source of biomarkers. Given that the spectra of
tRNA modifications formed class-specific patterns, we developed a data-driven model to
predict the type of stress that cells were exposed to, based upon the unique features induced
by each class of stimuli. The purposes of this exercise are to gain insight in the biological
functions of tRNA modifications in stress responses, and also, to explore the utilities of tRNA
modifications spectra as biomarkers. Based on our model, 14 tRNA modifications were
involved in defining unique patterns and they are listed in Table 5-4. As shown in this table,
some modifications are located at more than one position and at multiple species of tRNA,
which complicated the scenario as our method cannot assess their quantitative distribution.
Interestingly, 10 of these 14 model-defining modifications are found at anticodon region, which
suggests that they can be involved in interacting with codons and in recognizing aminoacyl-
tRNA synthetases (28). For instance, level of m5C increased in response to oxidizing agent and
it is located at the wobble position of the tRNA for coding the codon UUG; in Chapter 3 and 4,
we gained evidence to support our hypothesis that m5C confers resistance to H202 by regulating
translation of H202-resisting genes that are enriched in TTG. Further studies are necessary to
test if other modifications are involved in similar regulatory pathways. In contrast, some
model-defining modifications are only located at a single species of tRNA, which allow us to
study their biological roles directly by altering their biosynthetic pathways. These modifications
include, mcm U, mcms2U, m3 C, Am, yW, and mIl. The increases in relative level of mcm-U and
mcm s 2U are consistent with the results of a study by Begley and coworkers, using trm9-
knockout to demonstrate that mcm 5 U confers resistance to MMS by promoting the expression
of a specific group of DNA damage-response genes (29). For Am and m3C, the same approach
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cannot be used to study their functions as genes responsible for the formation of these two
modifications are not identified (30). Also, gene-knockout experiments cannot be used to study
yW and m'l as formation of both modifications require an essential gene, trm5. Niu and
coworkers suggested that trm5 is involved in regulation of cell cycle (31) and thus, the
decreases in both yW and m'l levels may be indicating that cells were not ready for
differentiation under stress from alkylating agents.
To validate the predictive power of our data-driven model, we used it to distinguish
spectra from cells with the three classes of exposures (alkylating agents, oxidizing agents, and
no exposure) and results showed that both sensitivity and specificity for predicting the three
classes are all above 75%. Previously, numerous studies used transcriptomes, proteomes, and
metabolomes to indicate disease-states and toxicant-exposures (6, 7, 32, 33). However, to our
awareness, this is the first time that spectrum of tRNA modifications was demonstrated to be a
potential source of biomarkers. tRNA of each organism comprises 20-30 modifications, which
combination of changes can potentially result as a wide range of patterns that can be used for
identifying subtly different physiological conditions. This is supported by the presence of
subclass signatures for SN1 and SN2 alkylating agents.
In conclusion, we employed mass spectrometric-based quantitative techniques and
computational statistical tools to demonstrate that the patterns of changes in tRNA
modifications spectrum are specific to classes of toxicants. To serve as a proof of principle, we
developed a predictive model to show that unique features from the spectra can be used as
toxicant class-specific identifier of cellular exposures. We expected that tRNA modifications in
other organisms also change dynamically as a function of cellular conditions, and this may
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provide a new level of information to develop diagnostic and prognostic biomarkers for various
diseases.
tRNA
modification
Increased in
alkylating agents
m3C
m7G
mcm 5 U
mcm 5s2 U
Am
Gm
m2G
Decreased in
alkylating agents
yW
mil
Increased in
oxidizing agents
m5C
ncm 5U
m22G
i6A
Cm
Position of modification
32 of tRNAThr(IGU)
46 of multiple tRNAs
34 of tRNA Arg(MCMSUCU)
34 of tRNAGI(mcms 2UUC)
4 of tRNAHiS(GUG)
18 of multiple tRNAs
34 of tRNAPhe(GmAA)
10 of multiple tRNAs
26 of tRNAVaI(CAC)
37 of tRNAPhe(GmAA)
37 of tRNAAla(IGC)
34 of tRNALeu(mCAA)
40 of tRNAPhe(GmAA)
48 and 49 of multiple tRNAs
34 of tRN Val(ncmsUAC)
26 of multiple tRNAs
37 of multiple tRNAs
32 of multiple tRNAs
34 of tRNATrp(CmCA)
4 of multiple tRNAs
Genes responsible for
modification
Unknown
TRM8, TRM82
TRM9, ELP1-ELP6, KTl11-KT113
TRM9, NFS1, ELP1-EPL6, KTI11-
Unknown
TRM3
TRM7
TRM11
Unknown
TRM5
TAD1, TRM5
TRM4
TRM4
TRM4
ELP1-EPL6,
TRM1
MOD5
TRM7
TRM7
Unknown
KTI11-KTI13
Table 5-4. tRNA modifications for defining class-specific patterns of changes in response to
alkylating agents and oxidizing agents. The modifications are organized into three groups,
depending on whether their levels increased or decreased in response to the two classes of
stimuli. The species of tRNA are only mentioned if the modification is only located in that single
species of tRNA. For tRNA modifying genes, 'unknown' indicates that no genes were identified
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to our awareness. Information was collected from Modomics Database (9) and Sacchromyces
Genome Database (34).
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Chapter 6
Conclusions and Future Directions
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Goals of this thesis
The purpose of studies described in this thesis is to advance our understanding on the
biological functions of tRNA secondary modifications in cellular response to toxic agents. Prior
studies have demonstrated the sensitivities of levels of tRNA modifications to metabolic stress
conditions and developmental stages and the functional roles of many modifications in
conferring resistance to specific stress (1-3). These evidences strongly suggest that tRNA
modifications are involved in cellular responses. However, the complex nature of tRNA and
function redundancy of modification has limited our knowledge on cellular functions of these
modifications.
A platform for characterizing and quantifying the spectrum of tRNA modifications.
To achieve our goals, a quantitative systems approach was used to study the spectrum of
tRNA modifications in S. cerevisiae under different stress. The first step was to characterize the
ribonucleosides from enzymatically hydrolyzed tRNAs with the following three approaches.
First, liqud chromatography-mass spectrometry (LC-MS) was used to determine the mass and
collision-induced dissocation (CID) patterns of ribonucleoside candidates with high mass
accuracy. Second, these candidates were compared to synthetic standards in retention time,
mass, and fragmentation patterns. Third, changes in abundance of tRNA modifications in
mutants lacking tRNA modifying genes were monitored to further confirm the identities of
these modified ribonucleosides. Based upon the characterization, we have developed a
sensitive and robust LC-MS/MS method to quantify 23 modified ribonucleosides. However, this
method cannot provide information on the positions of these modifications while some
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modified nucleosides are located at various locations and species of tRNA (4). As a future
direction, we can use cleavage site-specific endonucleases to generate oligonucleotide
fragments and monitor them with mass spectrometry (5). Location of modifications can then
be derived from the sequence of nucleotides.
Changes in spectrum of tRNA modifications in response to mechanistically distinct toxicants
Quantification of modified ribonucleosides from yeast tRNAs reveals agent-specific and
dose-specific patterns in the spectrum of tRNA modifications in response to exposures to
mechanistically distinct toxic agents, including hydrogen peroxide, methyl methanesulfonate,
hypochlorite, and arsenite. Specifically, the modifications Cm, m5 C, and m22G increase
following hydrogen peroxide-exposures but decrease or do not change in response to methyl
methanesulfonate, arsenite, and hypochlorite. Moreover, sensitivity to hydrogen peroxide
increases in cells lacking specific enzymes that catalyze the formation of Cm or m5C on tRNAs,
which demonstrates critical roles of tRNA modifications in cellular stress responses. The results
of our study support a general model of dynamic control of tRNA modifications in cellular
response pathways. Besides, characterizing changes in the spectrum of tRNA modifications of
cells lacking specific tRNA modifying enzymes reveal several potential biosynthetic pathways of
tRNA modifications.
Potential roles of tRNA modifications in translational regulation
As observed in quantification of tRNA modifications, m5C increases after exposure to
hydrogen peroxide and loss of tRNA m5C-methyltransferase Trm4 reduces the survivability of
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cells under this stress. It is known that m5C is found in many species of tRNA but only a leucine
tRNA translating the codon UUG comprises this modification at the wobble position. Thus, m5C
may affect the translation of UUG as previous studies have suggested that m5C at wobble
position can be involved in codon-anticodon interactions (6). S. cerevisiae contains many
duplicated genes encoding ribosomal proteins with differences between the UUG usages of
these homologues.
These observations led us to hypothesize that trm4 and m5C are involved in regulating the
expression of ribosomal protein homologues. Through studies of ribosomal protein
homologues with a quantitative proteomics approach, we demonstrate that the protein level of
a UUG-enriched gene, rpI22a, decreases in the absence of Trm4 and increases in H202-exposed
cells relative to its homologue, rp/22b. In contrast, exposing H202 to trm4A mutant does not
lead to changes in relative level of this pair of homologues. These data indicate involvements
of Trm4 in modulating expression of ribosomal proteins under stress. Moreover, only the
rp/22aA mutant is sensitive to H202 but not the rp/22bA mutant which indicates distinct
functional roles of ribosomal homologues in stress responses. Together, these results support a
model that tRNA m5C-methyltransferase Trm4 regulates translation of rp/22a to confer
resistance to specific stress.
Besides understanding the biological role of m5C, this study opens up the opportunity to
investigate the functions of ribosomal homologues in stress response with a quantitative
approach. Within 115 sequence-specific ribosomal proteins, our LC/MS method can only
monitor 39 of them. The next step is to optimize this method to cover the full spectrum of
ribosomal proteins and use it to assess changes as a function of cell states.
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Spectrum of tRNA modifications as a potential source of biomarkers of class-specific
exposures
The observations of unique signatures in spectrum of tRNA modifications for exposures to
mechanistically distinct toxicants led us to ask whether the patterns of changes are common
among stimuli with similar mechanisms of action. We characterized changes in the spectrum
from cells exposed to four oxidizing agents, hydrogen peroxide, tert-butyl hydroperoxide,
peroxynitrite, and gamma-radiation, and five alkylating agents, methyl methanesulfonate, ethyl
methanesulfonate, isopropyl methanesulfonate, N-methyl-N'-nitro-N-nitrosoguanidine, and N-
nitroso-N-methylurea. Multivariate statistical analysis on these data indicates class-specific
features for both oxidizing agents and alkylating agents, involving 14 modifications, Am, m2G,
mcm U, mcm s 2U, m 3C, m G, yW, Gm, m C, ncm U, m 2G, i A, and Cm. Further, signatures
specific to SNi and SN2 alkylating agents were observed, which suggests that the spectrum can
potentially serve as an identifier of cellular conditions with subtle differences. These features
were used to develop a data-driven model with predictive power on the class of toxic agents,
which demonstrates that the spectrum of tRNA modifications is a potential source of
biomarkers of exposures. To explore the utilities of profiles of tRNA modifications as index of
diseases and pharmaceutical exposures, this study has to be translated to models of human
cells and animals.
Overall, we demonstrate that tRNA modifications are involved in cellular response to
stress. To investigate a specific response pathway, we have shown that the modification mSC
regulates the expression of a H20 2-resistance-conferring gene based on codon usage. On the
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application side, the spectrum of tRNA modifications has potential to be used as biomarkers of
exposures. Further studies with other classes of stimuli may reveal more biological pathways
that tRNA modifications are involved.
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Appendix A
Preliminary characterization of tRNA modifications in M. bovis BCG
In October 2009 to April 2010, I worked in the Infectious Disease IRG (ID-IRG) of
Singapore-MIT Alliance in Research and Technology in Singapore to set up a new research
group and to explore the possibilities of new projects. Projects in this recently established
center have to be related to infectious diseases, which gave me unique opportunities to
experience different fields of sciences. The work I accomplished in ID-IRG is presented in this
Appendix because the studies are not directly related to the story of my thesis. However, these
experiences are also an important part of my Ph.D. education and training.
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Abstract
The observations of specific tRNA modifications conferring resistance to different
toxic stimuli suggest that the biosynthetic pathways of this family of molecules are
potential targets of antimicrobial agents. To understand the biological roles of tRNA
modifications in Mycobacterium and to explore the utility of these modifications in drug
development, we have characterized the spectrum of tRNA modifications in
Mycobacterium bovis BCG by various mass spectrometric techniques. With our methods,
26 candidates of nucleoside-like species are observed in tRNA; the structure of 12 of them
was identified while one of them, N , N-dimethyladenosine, was previously only observed
in ribosomal RNAs.
Introduction
Tuberculosis (TB) is a disease caused by Mycobacterium, such as M. tuberculosis and M.
bovis, with an estimation of about 10 millions new TB patients in 2010 (1). The high prevalence
of TB is partly due to increases in drug resistance of pathogens and lack of new medications;
the last drug with a novel mechanism of action for curing TB was discovered in 1963 (2). A
major obstacle for development of anti-mycobacterial agents is the lack of understanding on
cellular processes of Mycobacterium.
tRNA modifications in the Mycobacterium family have not been characterized
systematically. However, modified nucleosides in tRNA of many organisms have been studied
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extensively. About 20 to 30 of these modifications are present in each organism studied with a
total of more than 100 distinct structures (3). It is clear that these modifications must be of
high importance or else this complexity would not have evolved. In recent years, some
derivatives of canonical nucleosides have been demonstrated to have anti-mycobacterial
properties, including 2-methyladenosine (4, 5). It is possible that these ribonucleosides disrupt
the formation of essential RNA modifications. To modify these candidates for discoveries of
new TB drugs, advances in the understanding on modifications of RNA in Mycobacterium are
necessary. To this end, we initiate the characterization of spectrum of tRNA modifications in
Mycobacterium Bovis BCG with mass spectrometric techniques.
M. bovis BCG is used as vaccine for TB and more than 90% of its genome is identical to the
infectious M. tuberculosis (6). Thus M. bovis BCG is frequently used as a model organism to
understand TB. By using a mass spectrometry-based approach, we identified 26 candidates of
tRNA modifications; the identities of 12 of them are determined, including Y, m5C, m3C, m1A, I,
m G, Cm, m U, Gm, m 2G, t A, and m62A, in which m 62A was previously only observed in rRNA.
Besides providing the knowledge on Mycobacterium, the strategy we developed can also be
used as a tool for characterizing spectra of modified nucleosides in any organisms.
Materials and Methods
Materials. All chemicals and reagents were of the highest purity available and were used
without further purification. OADC solution, 7H9 culture media powder, and 7H11 agar powder
were purchased from Biomed Diagnostics (White City, OR). TRIZOL reagent and PureLink
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miRNA Isolation Kit was purchased from Invitrogen (Carlsbad, CA). 2'-O-Methyluridine (Urn),
pseudouridine (Y), N1-methyladenosine (m'A), N2,N2-dimethylguanosine (m22G), N6,N6 -
dimethyladensoine (m62A), and 2'-O-methylguanosine (Gm) were purchased from Berry and
Associates (Dexter, MI). N-threonylcarbamoyladenosine (t6A) was purchased from Biolog
(Bremen, Germany). N-isopentenyladenosine (i6A) was purchased from International
Laboratory LLC (San Bruno, CA). 2'-O-Methyladenosine (Am), N4-acetylcytidine (ac4C), 5-
methyluridine (m5U), inosine (1), 2-methylguanosine (m2G), N-methylguanosine (m7G), 2'-0-
methylcytidine (Cm), 3-methylcytidine (m3C), 5-methylcytidine (m5C), alkaline phosphatase,
RNase A, ammonium acetate, geneticine, bovine serum albumin, deferoxamine mesylate,
butylated hydroxytoluene, glucose, sodium chloride, nuclease P1, formic acid, and 20%
Tween80 solution were purchased from Sigma Chemical Co. (St. Louis, MO). Glycerol was
purchased from SinoChem Corp. (Beijing, China). Phosphodiesterase I was purchased from USB
(Cleveland, OH). Ambion RNA structure buffer, RNase A, RNase V1 and RNase T1 were
purchased from Ambion Inc. (Austin, TX). HPLC-grade water, acetonitrile, and chloroform were
purchased from Mallinckrodt Baker (Phillipsburg, NJ). M. bovis BCG was purchased from
American Type Culture Collections (Manassas, VA).
Culturing M. bovis BCG. M. bovis BCG cells were grown in 7H9 culture media at 37 *C in
an incubator with 5 % CO2. After the culture reached an optical density of OD600 ~0.6, at which
the concentration of cells was ~3 x107 /mL, the cells were harvested by centrifugation at
12000x g for 10 min at 4 0C. Cell pellets were snap-frozen with liquid nitrogen and stored at -80
0C.
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For glycerol stocks, the post-centrifugation cell pellet was resuspended in 1 mL of 7H9
culture media with 25% glycerol. The solution was then further diluted to a final concentration
with OD600 1 and the stocks stored at -80 *C. To determine the quantity of living cells in a
glycerol stock or a culture, the cell culture was serially diluted and 100 pL of each dilution was
plated onto a 7H11 agar plate. The plates were incubated at 37 *C with 5% CO2 and resulting
colonies were counted.
The 7H9 media were prepared by mixing 4.9 g of 7H9 powder, 10 mL of 50% glycerol, 2.5
mL of 20% TWEEN 80, 900 mL of double-deionized water, and 100 mL of ADS solution. The ADS
solution was prepared by mixing 50 g of BSA, 20 g of glucose, and 8.1 g of sodium chloride in
950 mL of double-deionized water. The 7H11 agar plates were prepared by mixing 4.2 g of
7H11 agar powder, 2 mL of 50% glycerol, 180 mL of double-deionized water, and 20 mL of
OADC solution. The solution was then heated in a microwave oven until a clear solution was
achieved and the solution was transferred to petri dishes. The agar plates were cooled and
solidified at ambient temperature.
Isolation of tRNA. tRNA was isolated from several organisms, including BCG (~109 cells),
S. cerevisiae (5x10 7 cells), human B lymphoblastoid TK6 cells (3x10 7 cells), and rat liver (~150
mg). Cells or tissues were suspended in 1.5 mL of Trizol reagent with 5 mg/mL coformycin, 50
tg/mL tetrahydrouridine, 0.1 mM deferoxamine mesylate, and 0.5 mM butylated
hydroxytoluene to prevent ribonucleoside modification artifacts (7, 8). BCG and S. cerevisiae
cells were lyzed by 3 cycles of bead beating in a Thermo FP120 Bead Beater set at 6.5 m/s for
each 20 s cycle, with 1 min of cooling on ice between cycles. The TK6 cells and rat liver tissues
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were lyzed with a Qiagen TissueRuptor. Following cell or tissue disruption, all lysates were
warmed to ambient temperature for 5 min and extracted with 0.3 mL volume of chloroform,
with subsequent incubation at ambient temperature for 3 min. The solutions were centrifuged
at 12000x g for 15 min at 4 0C and the aqueous phase was collected. Absolute ethanol was
added to the aqueous phase to reach a final concentration of 35% (v/v) and tRNA was then
isolated using the PureLink miRNA Isolation Kit according to manufacturer's instructions. The
quality and concentration of the resulting small RNA mixture was assessed by Bioanalyzer
analysis, with tRNA comprising >95% of the small RNA species present in the mixture (Figure 2).
There was no detectable 5S rRNA present in the samples, as illustrated in Figure 2.
Enzymatic hydrolysis of tRNA. Samples of purified small RNA (6 pg) were lyophilized
and redissolved in 100 pL of a solution with 10 ng/pL RNase A, 0.01 units/pL RNase T1, 0.001
units/piL RNase V1, 0.15 units/pL nuclease P1, 2.5 mM deferoxamine mesylate, 10 pig/mL
coformycin, 50 ptg/mL tetrahydrouridine, 0.5 mM butylated hydroxytoluene, and 1xRNA
Structure Buffer from Ambion (provided with RNases T1, V1 and A). The solution was incubated
at 37 *C for 3 h, after which alkaline phosphatase was added to a final concentration of 0.1
Units/mL. The sample was incubated at 37 *C overnight, followed by removal of proteins by
filtration (YM10 filter). The resulting filtrate was used directly for mass spectrometric analysis.
Identification of ribonucleosides in BCG small RNA. The samples of ribonucleosides were
resolved with a Thermo Hypersil aQ column (100 x 2.1 mm, 1.9 p) with acetonitrile in 0.1% (v/v)
formic acid in water as mobile phase. The flow rate was 0.3 mL/min. The gradient of
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acetonitrile was as follow: 0-12 min, 0%; 12-15.3 min, 0-1%; 15.3-18.7 min, 1-6%; 18.7-20 min,
6%; 20-24 min, 6-100%. The HPLC column was directly connected to a triple quadrupole mass
spectrometer (LC-MS/MS) in positive ion, neutral loss mode for loss of m/z 132 and 146 in the
range of m/z 200-700. The voltages and source gas parameters were as follow: gas
temperature, 300 *C; gas flow, 6 L/min; nebulizer, 15 psi; and capillary voltage, 4000 V. The
ions that were detected in the neutral loss scan were selected for identification with the LC-
MS/MS system in MRM mode using the same HPLC method and mass spectrometer parameters.
The retention times, m/z of the transmitted parent ions, and m/z of the monitored product ions
for ribonucleoside-like species are listed in Table A-1.
Structural characterization of N, N-dimethyladenosine in BCG small RNA. The
ribonucleoside-like species eluting at 20.1 min and possessing an [M+H] ion with m/z of 296.13
was subjected to structural characterization by collision-induced dissociation (CID) using both
MS2 and pseudo-MS3 (i.e., in-source fragmentation) performed on the LC-QTOF system using a
Thermo Hypersil aQ column (100 x 1 mm, 3 ptm particle size) at a flow rate of 90 pL/min using
the same mobile phase described earlier, with a gradient of organic phase as follow: 0-9 min,
0%; 9-18 min, 0-7%; 18-22 min, 7%; and 22-30 min, 7-100%. The mass spectrometer was
operated in positive ion mode with the following voltages and source gas parameters: gas
temperature, 325 *C; drying gas, 8 L/min; nebulizer, 30 psi; capillary voltage, 3500 V. The m/z
detection range for parent ions was 100 to 800 and that for product ions was 50 to 800. For
MS2 analysis, the fragmentor voltage was 85 V and the target ion for the unknown was m/z
296.1, while the fragmentor voltage was increased to 250 V for MS3 analysis, which caused an
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in-source fragmentation of m/z 296.13 to give m/z 164.1 for further CID analysis. The m/z
164.1 ion was fragmented with collision energies of 0 V, 20 V, 30 V, and 60V.
Absolute quantification of m62A in tRNA from BCG and other organisms. For tRNA
samples from each organism (BCG, S.cerevisiae, TK6, and Rat liver tissue), 4 pmol of [15N]s-2-
deoxyadenosine ([15N]5-dA) internal standard was added to 4 pg of tRNA and the samples were
subjected to enzymatic hydrolysis as described above. Following volume adjustment to achieve
final concentrations of ~40 nM [15N]-dA and ~40 ng/pL ribonucleosides, 10 p1L of sample was
analyzed by LC-MS/MS. Ribonucleosides were resolved on a Thermo Hypersil aQ column (100 x
2.1 mm, 1.9 pm particle size) with acetonitrile in 0.1% (v/v) formic acid as mobile phase and a
flow rate of 0.3 mL/min. The gradient for acetonitrile in 0.1% formic acid was as follow: 0-10
min, 5%; 10-12 min, 30%; 12 min, 95%. The HPLC column was coupled to a triple quadrupole
mass spectrometer with electrospray ionization operated in positive ion mode with the
following parameters for voltages and source gas: gas temperature, 350*C; gas flow, 10 L/min;
nebulizer, 20 psi; and capillary voltage, 3500 V. The mass spectrometer was operated in
multiple reaction monitoring mode (MRM) to quantify two ribonucleosides with the following
parameters (retention time, m/z of the transmitted parent ion, m/z of the monitored product
ion, fragmentor voltage, collision energy): [i5N]-dA, 3.0 min, m/z 2574141, 90 V, 10 V; and
m 62A, 11.1 min, m/z 2964164, 90 V, 15 V. The dwell time for each ribonucleoside was 200 ms
and these two ions were monitored throughout the whole HPLC run. Linear calibration curves
were obtained using a fixed concentration (40 nM) of [i5N]-dA and varying concentrations of
m 62A (5, 10, 50, 100, 500 nM).
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Results
Growth rate of BCG and yield of BCG tRNA. As the spectrum of modified nucleosides
may differ significantly according to the growth conditions, it was essential to standardize the
culturing procedures. The OD600 of M. bovis BCG culture was measured each day in the first
eight days after inoculation from a glycerol stock. Results were summarized in Figure A-1. At
day 7, OD600 of the culture was approximately 0.6. Cells were harvested at this point for all
experiments. Based upon the quantification by using bioanalyzer and UV-vis
spectrophotometer, approximately 4 pig of tRNA can be isolated from 109 BCG cells.
Characterization of the tRNA samples by bioanalyzer (Figure A-2) determined that the average
size of tRNA in M. bovis BCG was about 65 nt.
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Figure A-1. Growth curve of M. bovis BCG. The population of cells was determined by
absorbance at 600 nm as described in Materials and Methods. The data points were obtained
from a single experiment.
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Figure A-2. Bioanalyzer chromatograph of BCG tRNA.
Survey of ribonucleosides in BCG. Ribonucleosides from enzymatic hydrolysis of BCG
tRNA were characterized by using reverse phase HPLC-coupled triple quadrupole mass
spectrometer (LC/QQQ). Most nucleosides share a characteristic neutral loss of 132 Da during
collision-induced dissociation (CID) with low collision energy. This loss corresponds to the
dissociation of the ribose from the base. For nucleosides that are methylated at 2'-0 or other
positions of the ribose, they have a loss of 146 Da instead of 132 Da. Based on this property of
nucleosides, we screened for modified nucleosides by searching for molecules with either one
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of these two neutral losses. As a control experiment, a sample of double-deionized water was
used for tRNA isolation, enzymatic hydrolysis, and neutral loss scan; results of neutral loss
screening of the water sample was compared to that of the tRNA samples. After removing the
artifacts that were also present in the control, there were 26 candidates of modified
nucleosides in the hydrolyzed tRNA. Based upon the retention time and m/z value of these
candidates, the hydrolyzed tRNA samples were analyzed in MRM mode. By comparing with
synthetic chemical standards, we determined that these 26 candidates include Y, m5C, m3C,
miA, m G, I, Cm, Gm, m U, t A and m2G (Table A-1).
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RT Precursor Product Quantity Identification
1.3 255.1 123.1 11100 ?
1.43 245.1 125.1 110 Y
2.15 258.1 126.1 70 m C
2.45 258.1 126.1 279 m3C
2.47 282.1 150.1 500000 mIA
3.85 298.1 166.1 500000 m7G
3.97 320 188 3000 ?
4.21 280 133.9 7000 ?
4.22 258.1 112.1 2500 Cm
4.4 269.1 137.1 80000 1
5.16 352 220 16000 io6A??
5.16 368 236 17000 ?
5.18 285.1 153.1 40000 ?
5.27 322 190 24000 imG-14??
8.22 259.1 127.1 30 m U
8.6 282.1 150.1 7000 mA??
10.69 298.1 166.1 3500 mG??
10.7 320 188 40000 ?
11.4 298.1 152.1 450 Gm
12.9 282.1 150.1 17000 mA??
13.8 320 188 1800 ?
13.91 298.1 166.1 600 m2 G
17.6 416.2 270.1 700 ?
20.1 296.1 164.1 25000 dimethylA??
21.08 307.4 161.3 1000 ?
21.88 413.1 281.1 2500 t A
Table A-1. List of candidates of modified ribonucleosides identified by neutral loss scan using
LC/QQQ. The quantity of each species is the approximate raw counts obtained by mass
spectrometer. In the column of identification, nucleosides with '??' are not certain due to the
lack of standards for comparisons; they are assigned based on m/z values of the ions. The
nucleosides that are not assigned (with a '?') have no known modifications with same mass (9,
10).
Structural characterization of unknown with m/z 296.13. To gain information of
chemical structure of these candidates of modified nucleoside, LC/QTOF was used to obtain
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exact mass (error < 10 ppm). An ion with m/z value of 296.1350 ± 0.0011 (this value is the
average ± SD of all mass spectra of the chromatographic peak) was observed (Figure A-3).
Based upon this m/z value, this ion was most likely to have a chemical formula of C12Hi8NsO4*
(m/z 296.1359). This formula corresponded to an adenosine with 2 methyl group or 1 ethyl
group.
296.13
100 120 140 160 180 200 220 240 260 280 300 320 340 360
Counts vs. Mass-to-Charge (m/z)
21.5 22 22.5 23 23.5 24 24.5 25 25.5 26 26.5 27 27,5 28 28.5 29 29.5 30 30.5 31 31.5 32 32.5 33
Counts vs. Acquisition Time (min)
Figure A-3. Extracted ion chromatogram and mass spectrum of [M+H]* ion of m62A. The peak
in the small graph (black) represents the m/z of all ions observed between time = 31 to 31.5
minutes. The large graph (red) represents MS signal intensity of ions with m/z 296.1359 (error
< 10 ppm) in HPLC eluent.
217
We carried out MS2 and pseudo MS3 analysis on the unknown ion m/z 296.13 to gain
structural information for identification. In MS2 analysis, the unknown was fragmentized to
form an ion m/z 164.09, which the loss of mass was corresponded to a ribose (Figure A-4). The
free base was likely to have a chemical formula of an adenine with a C2 H4 (m/z 164.0936).
Pseudo MS3 analysis was used to gain structural information on this adenine derivative. The
ribosyl group was detached from the base by in-source fragmentation which produced an ion
m/z 164.09. This ion was then selected for collision-induced dissociation to generate the mass
spectrum on Figure A-5(A). The mechanism of collision-induced dissociation of adenosine was
studied previously (11); based upon that dissociation model and the fragmentation pattern, we
derived that the structure of the m/z 296.13 ion was N,N-dimethyladenosine (m62A). This
conclusion was confirmed by the retention time and MS2 and pseudo MS3 fragmentation
patterns of synthetic m62A (Figure A-5(B)).
164.09
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Figure A-4. MS2 mass spectrum of m62A. This CID mass spectrum was obtained with by
LC/QTOF as described in the Materials and Methods section.
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Figure A-5. (A) Pseudo-MS3 spectrum of m62A from tRNA hydrolysate. (B) Pseudo-MS3
spectrum of synthetic m62A. The nucleoside was fragmentized to form the free base by high
ionization energy at ion source (fragmentor voltage = 250V). The free base (m/z 164.09) was
selected to pass through the first quadrupole (Q1) and fragmentized in the second quadrupole
(Q2) by collision-induced dissociation with collision energy of 30 V. Proposed structure of
fragmented ions with m/z 108.06, 119.04, 121.05, 123.07, 148.06, and 164.09 are presented in
(A).
Absolute quantification of m62A. We quantify m62A in BCG small RNA samples by using
external calibration (Figure A-6). In M. bovis BCG, the level of m62A was 0.88 pmol per 1 pg of
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tRNA (Table A-2). Based upon the results from bioanalyzer, the average size of tRNA in M. bovis
BCG is 65 nt (Figure A-2). Assuming that each nucleotide is 340 Da, there was approximately
one molecule of m62A in every 51 tRNA molecules. It is known that m62A is present in ribosomal
RNA of yeast, rat and human (12). However, it was not observed in tRNA previously (13-17). To
illustrate the m62A observed in M. bovis BCG tRNA samples were not from contaminating rRNA,
we employed the same method to isolate tRNA from yeast, rat liver tissues and human TK6
cells and quantify m6 2A in these samples. The amount of m62A in these samples is below
quantification limit (Table A-2).
0 1
y = 13.061x + 0.9682
R2 = 0.9973
2 3 4
Amount of m62A (pmol)
Figure A-6. External calibration curve
Methods section.
for quantifying m62A as described in Materials and
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tRNA samples
M. bovis BCG Human TK6 Rat liver Yeast
Normalized MS signals (0.4 pg 5.8 0.9 0.0054 ± 0.0056 ± 0.0054±
tRNA) 5. ± 0.0002 0.0002 0.0004
Amount of m62A (pmol/pg 0.88 ± 0.14 < 0 < 0 < 0
tRNA)
Table A-2. Quantification of m62A in tRNA from M. bovis BCG, human TK6 cells and rat liver
tissue. Quantity of MS signals is converted to molarity of m62A by fitting into the external
calibration curve in Figure A-6.
Discussion
Spectrum of M. bovis BCG tRNA modifications. We developed a general approach to
characterize spectra of modified ribonucleosides. This method begins with isolation of small
RNA species below 200 nucleotides and quantification of the tRNA content with bianalyzer and
UV-vis spectrophotometer. Individual ribonucleosides in enzymatic hydrolysates of tRNA were
resolved by HPLC and determined by their characteristic fragmentation pattern using mass
spectrometry. In samples of M. bovis BCG small RNA, we obtained 26 candidates of modified
nucleosides and identified 12 of them. They include Y, m5C, m3C, m1A, m7G, Cm, I, m5U, Gm,
m 2G, t6A, and m62A. Besides m'A, the presence of these modifications in Mycobacterium is not
reported in the literature to our awareness (18, 19). All these modifications are found in tRNA
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of other organisms except m6 2A (9, 10) and they have important biological functions.
Pseudouridine (Y) is the most abundant modifications in tRNA; it is found in at least 15 positions.
While most Y on tRNA are non-essential, loss of Y38, Y39, or Y40 leads to a decrease in growth
rate in both E. coli, S. typhimurium, and S. cerevisiae (20-22). 5-methylcytosine (m5C) is also
located at several locations (position 34, 37, 48, and 49) including wobble position, which is
suggested to affect the affinity of codon-anticodon binding (23). 3-methylcytosine (m3C) is
located at position 32 and e2 in bacterial and eukaryotic tRNA. 1-methyladenosine (m1A) is
formed at position 58 of tRNA in Mycobacterium tuberculosis and many organisms (19, 24);
mutants with deletion of the gene trm6 or trm6l, which is the m1A-methyltransferase in S.
cerevisiae, are nonviable. 7-methylguanosine (m7G) is found at tRNA position 36 and 46 of
many organisms, such as E. coli, mammalian cells, and plants; this modification promotes tRNA
aminoacylation and enhances the stability of tRNA (25-27). 2'-O-methylcytosine (Cm) is located
at position 32, 34, and 56; Cm34 in E. coli affects fidelity of codon reading (28). Inosine (1) is
found at wobble position of tRNA from all three phylogenetic domains; genes that are
responsible for the formation of 134 are essential in S. cerevisiae (29). 5-methyluridine (m5 U) is
located at position 54; m-U54 is conserved in all three domains of life (3). 2'-0-
methylguanosine (Gm) can be formed at position 18 and 34; Gm34 promotes the accuracy of
mRNA decoding (30). 2-methylguanosine (m2G) forms at position 6, 10, and 26; m2G10
promotes the efficiency of aminoacylation in some tRNA (31). N -theonylcarbamoyladenosine
(t6A) is located at position 37; it promotes the codon-anticodon interactions (32). As these
highly conserved tRNA modifications play important roles in other organisms, they may also be
involved in centric biological processes of Mycobacterium.
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Among these modifications, one of them was previously not observed in tRNA. This
modification has a m/z value of 296.13. To obtain information of the structure of this
ribonucleoside, we used high mass accuracy MS, MS2 and pseudo-MS3 analysis to study its
fragmentation patterns. The modification is confirmed to be N6,N6-dimethyladenosine (m62A)
by comparing with the synthetic standard. m6 2A is only reported to be present in rRNA of
several organisms, including yeast, human and rat (9, 10, 33). It is possible that this
modification may be originated from contaminating rRNA in the tRNA sample. For validation,
we quantified m6 2A in tRNA samples from M. bovis BCG, yeast, human TK6 cells, and rat liver
tissue that were isolated with the same method. The results show that there was about one
m 2A per 51 copies of tRNA in M. bovis BCG; levels of m62A in samples from human TK6 cells
and rat liver tissue were below detection limit. These results suggest that m62A is from tRNA in
M. bovis BCG.
There are 14 unidentified candidates of ribonucleosides. All of these candidates have a
loss of m/z 132 or m/z 146 in collision-induced dissociation. These fragmentations are common
features of ribonucleosides corresponding to the loss of a ribose or a 2'-0-methylribose.
Molecular transitions of some candidates are the same as that of monomethylated adenosine
(m/z 282 to m/z 150), monomethylated guanosine (m/z 298 to m/z 166), N6-(cis-
hydroxyisopentenyl)adenosine (m/z 352 to m/z 220), and 4-demethylwyosine (m/z 322 to m/z
190). These modifications have been observed in tRNA. Molecular transitions of nine
candidates are unique to all known RNA modifications. These candidates can possibly be
modifications that have not been discovered yet.
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Besides characterizing the spectrum of tRNA modifications in M. bovis BCG, here we also
present a general strategy to identify modified ribonucleosides. In this strategy, candidates of
RNA modifications were identified with LC/QQQ in neutral loss mode based upon the
characteristic loss of ribose or 2'-O-methylribose during collision-induced dissociation. The
highly accurate mass of these candidates were identified with LC/QTOF to predict their
chemical formulae. Then, these candidates were analyzed with MS2 and MS3 (i.e., in-source
fragmentation) by using LC/QTOF to gain structural information. This strategy can potentially
be used to characterize the spectrum of modifications of all species of RNA in any kind of
organisms.
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